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Symbols 
 
0 1 9, ,...A A A   Real constant coefficients for second order surface. 
,T RD  Mass averaged absorbed dose in tissue T due to radiation of type R, Gy or 
Gy/day. 
( , , )D L r Ω   Spectral distribution of absorbed dose in terms of L associated with the ray  
emanating from the target point r  in the direction of Ω , Gy or Gy/day. 
E    Effective dose computed using equivalent dose, Sv or Sv/day. 
E    Effective dose computed using dose equivalent, Sv or Sv/day. 
E    Effective dose with error due to point distributions included, Sv or Sv/day. 
compE    Computed effective dose using recommended point distributions for VCAM,  
VCAF, MAX, or FAX, Sv or Sv/day. 
errorE    Effective dose error using recommended point distributions for VCAM, VCAF,  




T iε  Percent difference of the mass averaged tissue dose equivalent computing using 
the ith point distribution of the jth group from the average group 1 dose for tissue 
T, %. 
( )j
Tε  Maximum percent difference (taken over 10 point distributions in a group) of 
the mass averaged tissue dose equivalent computing using the ith point 
distribution of the jth group from the average group 1 dose for tissue T, %. 
Tε    Error associated with the recommended set of point distributions for VCAM,  
VCAF, MAX, or FAX for tissue T, %. 
Tε

   Error associated with the recommended set of point distributions for VCAM,  
VCAF, MAX, or FAX for tissue T divided by 100. 
TH    Mass averaged equivalent dose for tissue T, Sv or Sv/day. 
TH    Mass averaged dose equivalent for tissue T, Sv or Sv/day. 
( , )h r Ω  Dose equivalent associated with the ray emanating from the target point r  in the 




T iH  Mass averaged tissue dose equivalent for tissue T computed using the i
th
 point 
distribution from the jth group, Sv or Sv/day. 
(1)
TH    Average group 1 dose for tissue T, Sv or Sv/day. 
L    Linear energy transfer, keV/µm. 
M    Mass of a tissue, g. 
N
r
   Number of tissue target points. 
N
Ω
   Number of unit direction vectors. 
ρ    Volume density of a tissue, g/cm3. 
PD    Percent difference from the average tissue dose between two phantoms for a  
given effective dose tissue, %. 
( )Q L    LET dependent quality factor. 
T    Tissue type. 
R    Radiation type. 
r    Tissue target point. 
ir    Set of tissue target points. 
Tw    Effective dose weighting factor for tissue T. 
  iv 
Rw    Radiation weighting factor for radiation R. 
Ω    Unit direction vector. 
jΩ    Set of unit direction vectors. 
V    Volume of a tissue, cm3.  
, ,x y z    Cartesian coordinate variables, cm.
  v 
Abbreviations 
 
BFO   Blood Forming Organs. 
CAF   Computerized Anatomical Female. 
CAM   Computerized Anatomical Man. 
CAMERA  visualization and ray-tracing software for CAM and CAF. 
CT   Computed Tomography. 
ET   ExtraThoracic. 
FAX   Female Adult voXel model. 
GCR   Galactic Cosmic Rays. 
HZETRN  High charge (Z) and Energy TRaNsport.  
ICRP    International Commission on Radiological Protection. 
LEO   Low Earth Orbit. 
LET   Linear Energy Transfer. 
MAX   Male Adult voXel model. 
NCRP   National Council on Radiation Protection & measurements. 
OLTARIS  On-Line Tool for the Assessment of Radiation In Space. 
SPE   Solar Particle Event. 
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Abstract 
 
To estimate astronaut health risk due to space radiation, one must have the ability to 
calculate various exposure-related quantities that are averaged over specific organs and 
tissue types. Such calculations require computational models of the ambient space 
radiation environment, particle transport, nuclear and atomic physics, and the human 
body. While significant efforts have been made to verify, validate, and quantify the 
uncertainties associated with many of these models and tools, relatively little work has 
focused on the uncertainties associated with the representation and utilization of the 
human phantoms. These models are used to study common biological risks associated 
with space radiation exposure and ensure that current space operations meet existing 
guidelines. In this study, we first examine the anatomical properties of the Computerized 
Anatomical Man (CAM), Computerized Anatomical Female (CAF), Male Adult voXel 
(MAX), and Female Adult voXel (FAX) models by comparing the masses of various 
model tissues used to calculate effective dose to the reference values specified by the 
International Commission on Radiological Protection (ICRP). Since MAX and FAX have 
been developed specifically to meet the ICRP recommendations, their tissue masses are 
found to be in good agreement with the reference values. Major discrepancies are found 
between the CAM and CAF tissue masses and the ICRP reference data for almost all of 
the effective dose tissues. We next examine the distribution of target points used with the 
deterministic transport code HZETRN (High charge (Z) and Energy TRaNsport) to 
compute mass averaged exposure quantities. To our knowledge, only one set of point 
distributions has been published for CAM and CAF, and no reference point sets have 
been published for MAX and FAX. Hence, the question of how many points to use and 
how to distribute them has yet to be studied. A numerical algorithm is presented and used 
to generate multiple point distributions of varying fidelity for many of the effective dose 
tissues identified in CAM, CAF, MAX, and FAX. The point distributions are used to 
compute mass averaged dose equivalent values under both a galactic cosmic ray (GCR) 
and solar particle event (SPE) environment impinging isotropically on three spherical 
Aluminum shells with areal densities of 0.4 g/cm2, 2.0 g/cm2, and 10.0 g/cm2. The dose 
equivalent values are examined to identify a recommended set of target points for each of 
the tissues and to further assess the differences between CAM, CAF, MAX, and FAX. It is 
concluded that the previously published CAM and CAF point distributions were 
significantly under-sampled and that the set of point distributions presented here should 
be adequate for future studies involving CAM, CAF, MAX, or FAX. It is also found that 
the errors associated with the mass and location of certain tissues in CAM and CAF have 
a significant impact on the mass averaged dose equivalent values, and it is concluded 
that MAX and FAX are more accurate than CAM and CAF for space radiation analyses. 
1. Introduction 
 
Mitigating the health risks of astronaut exposure to space radiation is a critical step toward 
satisfying the goals identified in NASA’s 2006 Strategic Plan [NASA Strategic Plan 2006] and the Vision 
for Space Exploration [The Vision for Space Exploration 2004]. Since exposure guidelines are often 
expressed in terms of effective dose, mass averaged dose, or mass averaged dose equivalent, a significant 
need naturally arises for computational tools capable of estimating such quantities in human phantoms 
protected by various shielding structures. Several tools have been developed to meet this need, including 
models of the natural space environment, nuclear and atomic physics, particle transport, shielding, and the 
human body. Despite significant efforts toward verifying, validating, and quantifying the uncertainty 
associated with each of these models, relatively little work has been done to study the uncertainty 
associated with the representation and utilization of the human phantoms. These models are necessary to 
estimate the mass averaged tissue doses used to calculate effective dose and provide the means to estimate 
health risks such as carcinogenesis, degenerative tissue effects, and vascular diseases.  
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The CAM (Computerized Anatomical Man) [Billings et al. 1973] and CAF (Computerized 
Anatomical Female) [Yucker et al. 1990, 1992] human phantoms were developed in 1973 and 1992, 
respectively, and have a long history in space radiation research at NASA. These phantoms have been 
coupled to the deterministic radiation transport code HZETRN (High charge (Z) and Energy TRaNsport) 
[Wilson et al. 1991; Slaba et al. 2008] through an interpolation-based procedure capable of generating point 
values, mass averaged tissue values, and effective dose. The term "value" in this context refers to some 
exposure-related quantity such as particle fluence, dose, dose equivalent, or linear energy transfer (LET). In 
this paper, only dose equivalent is considered, and the terms dose and dose equivalent are used 
interchangeably.   
In order to calculate the dose at a single point using the interpolation-based procedure mentioned 
above, ray tracing techniques are used to determine the amount of tissue and shielding material along each 
of a large number of rays covering the full 4pi  steradian, emanating from the specified target point and 
terminating at the exterior surface of the shield. The distribution of thicknesses generated by the ray tracing 
procedure is then analyzed, and HZETRN is used to generate a dose versus depth database encompassing 
the necessary material types and depths. A point dose is calculated by integrating over the dose values for 
each of the ray traced shield and target thicknesses. Note that the dose values for each of the ray traced 
shield and target thicknesses are computed by interpolating over the dose versus depth database. Mass 
averaged organ doses are computed by repeating this process for several target points within a given organ 
and averaging over the selected point doses.  
Anderson et al. [2007] have provided one of the few uncertainty estimates for a portion of this 
process by examining spatial discretization in the interpolation databases and angular discretization in the 
ray distributions. It was found that 512 rays were sufficient for the lunar lander and habitat studied, and that 
for solar particle events (SPE), at least 20 approximately log-distributed spatial grid points were necessary 
to provide sufficient accuracy in the interpolation database. No human phantoms were included in the 
study, and therefore, a potentially large gap exists in the uncertainty estimate associated with the 
interpolation-based procedure described above. In particular, to the authors’ knowledge, the fidelity of 
target point distributions used to calculate mass averaged tissue dose has never been studied and could have 
a significant impact on mass averaged dose estimates. Further, the CAM and CAF were developed to 
model the 50th percentile U.S. Air Force male and female using extremely limited computational resources 
by modern standards. Since no published updates exist for either model, it is expected that significant 
differences could exist between these models and the anatomical properties of the International 
Commission on Radiological Protection (ICRP) reference male and female [ICRP 2001].  
In this paper, we make comparisons between CAM, CAF, MAX (Male Adult voXel model) 
[Kramer et al. 2003], and FAX (Female Adult voXel model) [Kramer et al. 2004] human phantoms. The 
CAM and CAF are mathematical geometric models of the human body composed of more than one 
thousand three dimensional geometric solids. Each solid piece of the CAM and CAF is defined by a 
number of mathematical surfaces that intersect to form the object’s boundaries and create a topologically 
closed volume. An example of such an object is shown in Figure 1. Each object defines the physical extent 
of a small region of the body that, by definition, is comprised of a single type of body tissue. In general, 
adjacent objects share common boundary surfaces so that there are no gaps between parts, and the body is a 
contiguous solid. 
Alternatively, the MAX and FAX models have been constructed using a voxel representation of 
the body’s tissues. The term "voxel" is a blend of the words "volumetric" and "element". Voxels are 
typically used as a convenient method of specifying data values within a regularly spaced, three 
dimensional grid. They are a three dimensional analog of pixels (picture elements) used to store digital 
image data in two dimensions. The MAX and FAX models used in these analyses are composed of arrays 
of cubic voxels, with each voxel measuring 3.6 mm on a side. Similar to the geometric solids that comprise 
the CAM and CAF, each MAX and FAX voxel has a single tissue type associated with it as shown in 
Figure 2. 
To allow direct comparisons of the two very different types of models (geometry based and voxel 
based) using identical tools, algorithms, and analysis software, a computational procedure was developed to 
convert the CAM and CAF models from their geometric solid representation into a voxel representation 
identical to that used in MAX and FAX. Figure 3 shows the CAM in its original form as a geometric model 
(A), the CAM after its conversion into a voxel based model (B), and the MAX (C). 
Volumetric and mass comparisons for the effective dose tissues are made between the CAM, 
MAX, and ICRP reference male [ICRP 2001] as well as the CAF, FAX, and ICRP reference female [ICRP 
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2001]. This examination provides insight into the anatomical accuracy of CAM and CAF and reveals 
significant deviations from published quantities for the ICRP reference humans. Alternatively, since the 
MAX and FAX were developed specifically to meet the ICRP recommendations, these models are found to 
be in good agreement with the reference anatomical data of the ICRP.  
We next introduce a numerical method for generating tissue target point distributions in a voxel 
model. This target point distribution method is used to obtain multiple point distributions of varying fidelity 
and character in many of the ICRP effective dose tissues identified in the MAX, FAX, CAM, and CAF 
models. The only published set of target point distributions for CAM and CAF are also included in this 
comparison. Mass averaged tissue doses are computed using each of the target point distributions under a 
variety of shielding conditions and space radiation environments.  
2. Comparison of Human Phantoms 
 
The CAM and CAF are mathematical geometric models based on second order (quadric) surfaces 
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where A0, A1,…A9 are real constant coefficients and x , y , z are the usual Cartesian coordinate variables. 
Roughly 1100 unique quadric surfaces are used to create some 2450 solid objects. An integer value 
specifying a particular tissue type is assigned to each object, and multiple objects are combined to form 
geometrically complex organs. The computer program CAMERA [Billings et al. 1973; Yucker et al. 1990, 
1992] was developed to enable various geometric analyses of the CAM and CAF. Most notably, it will ray 
trace any number of target points supplied in an input list, ray trace points created by an internal random 
target point generator, and identify the specific tissue type associated with each target point. It should be 
noted that many target point distribution sets have been developed and used for CAM and CAF, but to our 
knowledge, only one set of point distributions has ever been published. Further, no work has been found 
that addresses the uncertainty associated with any of these target point distributions.  
The MAX and FAX phantoms are voxel (tomographic) models based on CT (Computed 
Tomography) images of human bodies. The MAX was developed using a combination of the voxel models 
VOXELMAN, MANTISSUE3-6, and VOXTISS8 [Kramer et al. 2003]. The FAX model was developed 
using CT images of a 37 year old female for the neck and torso, CT images of a 62 year old female for the 
legs and feet, and scaled versions of the MAX for the head and arms. More detailed descriptions of these 
models, with references, can be found in Kramer et al. [2003, 2004]. The MAX and FAX are comprised of 
478 and 453 voxel layers, respectively, with each layer being 158 voxels (left to right) by 74 voxels (back 
to front). It should also be noted that Kramer et al. [2006] have provided updated versions of both models, 
but those results were not available when this work was performed. The versions of MAX and FAX used 
here are those published by Kramer et al. in 2003 and 2004.    
In order to compare the characteristically different sets of models, the CAMERA code was used to 
create voxel versions of the CAM and CAF, hereafter referred to as VCAM and VCAF. A uniform, cubic 
grid of target points with 3.6 mm spacing was generated, and CAMERA was used to determine the tissue 
type associated with each target point. The resulting array of target points and material types was then 
written in binary form with the same binary format as the MAX and FAX data. For each effective dose 
tissue in MAX, FAX, VCAM, and VCAF, search algorithms were used to count the number of tissue 
voxels. The volume of each tissue was obtained by summing the volumes of the voxels. Since each tissue is 
assumed to be homogeneous in the models, the mass of each organ was obtained by multiplying the total 
volume by the appropriate density. The densities used for VCAM and VCAF were those given by Billings 
et al. [1973] and Yucker et al. [1990, 1992] for CAM and CAF, respectively. The densities used for MAX 
and FAX were those given by Kramer et al. [2003, 2004]. Most tissue masses in MAX and FAX have 
already been computed by Kramer et al. [2003, 2004], but they have been included here to verify our 
methodology of isolating individual tissues in the voxel models. Table 1 shows the density (ρ in units of 
g/cm3), mass (M in units of g), and volume (V in units of cm3), comparisons for VCAM, MAX, and the 
ICRP reference male, and Table 2 gives the density, mass, and volume comparisons for VCAF, FAX, and 
the ICRP reference female for the effective dose tissues. The symbol "-" in the density, mass, or volume 
columns of a given tissue and model indicates that this tissue type was not represented in the model.  
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Comparisons for the lymphatic nodes, extrathoracic (ET) region, gall bladder, salivary glands, and 
oral mucosa are not given in the tables because they are not represented in any of the models and contribute 
very little to effective dose. Bone surface was also left out because mass and volume comparisons are not 
appropriate, and surface area approximations are difficult in voxel models. Along with the tissues 
mentioned above, it is clear from Tables 1 and 2 that MAX and FAX are missing the BFO (Blood Forming 
Organs) and male breasts. The latest versions of MAX and FAX include these tissues as well as the 
lymphatic nodes, ET, gall bladder, salivary glands, and oral mucosa. These improved versions were not 
available in time for this report but will be analyzed in a future study. VCAM and VCAF do not have 
salivary glands, skin, adrenals, a thymus, a male prostate, or male breasts. The colon and small intestines 
are grouped together as a single organ in VCAM and VCAF, so their masses cannot be computed 
separately. The VCAM intestines have a volume of 6020.11 cm3, a mass of 2715.07 g, and a density of 
0.451 g/cm3. The VCAF intestines have a volume of 4897.48 cm3, a mass of 2208.76 g, and a density of 
0.451 g/cm3. The absence of specific tissues in the CAM and CAF has been verified by existing 
documentation [Billings et al. 1973; Yucker et al. 1990, 1992] and was determined not to be a result of 
insufficient fidelity in the voxel conversion process. No updates are expected for CAM and CAF, so these 
tissues are likely to remain absent.   
MAX and FAX compare extremely well to the ICRP reference values for all of the tissues given in 
Tables 1 and 2, except for the heart and skin. The skin representation has been improved in MAX06 and 
FAX06 [Kramer et al. 2006] by reducing the voxel size from 3.6 mm to 1.2 mm, and the heart masses have 
also improved. Conversely, VCAM and VCAF compare poorly to the ICRP reference data values. In some 
cases, the models and reference data differ by more than a factor of two. Note that the esophagus has been 
given a mass and density of zero because it is modeled as a cylindrical internal void with zero density in 
CAM and CAF. If the common density of 1.058 g/cm3 were assumed, the mass of the esophagus would still 
be significantly underestimated in both CAM and CAF. It is concluded that major discrepancies exist 
between CAM and CAF and the ICRP reference data for almost all of the effective dose tissues.  
3. Numerical Target Point Distribution Method 
 
Only a single set of published tissue target point distributions have been found in the literature for 
CAM [Billings et al. 1973] and CAF [Yucker et al. 1992]. In these distributions, single points were used to 
represent the CAM testes, heart, and thyroid, while a random target point generator was used to distribute 
points in the BFO and skin. In the previously published CAF target point distributions, single points were 
used to represent the esophagus, stomach, heart, liver, pancreas, colon, kidneys, bladder, ovaries, and 
uterus, while a random point generator was used to distribute target points in the thyroid, breasts, lungs, 
BFO, and skin. Note that skin is not explicitly modeled in the CAM and CAF; these points were placed at a 
depth of 0.1 mm along the inward normal direction of various external surfaces. Undocumented target 
points have been added to and removed from this initial set over the years, but these points were either 
manually selected or chosen with a pseudorandom point generator. In this section, we examine the 
interpolation based procedure for calculating effective dose and introduce a new numerical method for 
distributing target points in many of the effective dose tissues.  





E w H=∑ , (2) 
 
where Tw  is the tissue weighting factor, TH  is the mass averaged equivalent dose for tissue T, and the 
summation is taken over all relevant tissues. Equivalent dose is defined as [ICRP 2007] 
 
 ,T R T R
R
H w D=∑ , (3) 
 
where Rw  is the radiation weighting factor for radiation R, and ,T RD  is the mass averaged absorbed dose 
in tissue T due to radiation of type R. The National Council on Radiation Protection and Measurements 
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(NCRP) reports 132, 142, and 153 [NCRP 2000, 2002, 2006] recommend the use of mass averaged tissue 
dose equivalent instead of equivalent dose to calculate effective dose in low Earth orbit (LEO) space 
environments. Dose equivalent is defined in terms of linear energy transfer (LET) dependent quality factors 
as  
 
 ( , ) ( ) ( , , )
L
h Q L D L dL= ∫r rΩ Ω , (4) 
 
where L is LET, ( , , )D L r Ω  is the spectral distribution of dose in terms of L associated with the ray 
emanating from the target point r  in the direction of Ω , and ( )Q L  is the LET dependent quality factor 
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where L is in units of /keV mµ .  
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where Tw  are the same tissue weighting factors used in equation (2), and TH  is the mass averaged dose 
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where ( , )h r Ω  is the dose equivalent (scalar quantity) associated with the ray emanating from the target 
point r  in the direction of Ω . For a set of points ir  within the volume V and a set of direction vectors jΩ , 





















 are the number of discrete points within V, andN
Ω
 are the number of discrete angles. The 
approximation in equation (8) is a simple discretization of the integrals in equation (7), but it is based on 
several assumptions. First, the solid angles subtended by each jΩ  must be approximately equal, disjoint, 
and cover the unit sphere. Similarly, the set of target points, ir , must be evenly distributed throughout the 
volume V so that the small volumes accounted for by each point are approximately equal, disjoint, and 
extend throughout V.  Finally, one must have enough rays and target points so that the radiation field within 
any element of volume and solid angle is nearly uniform.   
In this report, we focus on the distribution of target points within the effective dose tissues and use 
the 968 ray distribution used by Anderson et al. [2007]. The distribution is depicted in Figure 4; each angle 
can be visualized as the set of rays emanating from the center of the sphere and exiting through the vertices 
at the corners of the surface elements. 
The distmesh3d MATLAB program [Persson et al. 2004] was originally developed to generate a 
tetrahedral mesh for any volume with a boundary defined by a signed distance function. The signed 
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distance function gives the distance from any point in space to the nearest boundary of the volume; the sign 
is negative for points inside the volume and positive for points outside the volume. Computing the values 
of a discrete signed distance function for a given tissue in a voxel model is relatively simple. Voxels of the 
desired tissue type were first separated from voxels that were not of the desired tissue type, and the voxels 
of the desired type were then separated into boundary and interior voxels. Boundary voxels were specified 
as having at least one shared face with an exterior voxel, and interior voxels were specified as having no 
shared faces with an exterior voxel. Finally, the signed distance was calculated at the center of each exterior 
and interior voxel, and points in the center of the boundary voxels were assigned the constant distance 
value of negative 1.8 mm. The array of discrete distances was then stored and interpolated on to generate a 
continuous signed distance function.  An illustration of the boundary, interior, and exterior voxels in a slice 
of the FAX heart is given in Figure 5.  
The distmesh3d program is initialized with a seed number that specifies a pseudorandom 
distribution of points in and around the volume of interest. An iterative procedure is used to create, destroy, 
and reposition the points within and on the surface of the volume to achieve some user specified grid 
spacing. Boundary or surface nodes are separated from interior nodes as a post processing step. For this 
application, the program was modified to ensure that each tetrahedron was nearly regular and had 
approximately the same volume, criteria that were established by specifying a single spacing parameter, h. 
The spacing parameter represented the desired distance between any two nodes on a tetrahedron and was 
found to be inversely proportional to the number of target points generated in the tissue. It is important to 
note that the quality of the distmesh3d results is not dependent on the initialization process mentioned 
above. The code requires some initial distribution, and we have chosen a pseudorandom approach to reduce 
any initialization bias. Further, the only other documented target point distribution method [Billings et al. 
1973; Yucker et al. 1990, 1992] for this application relies entirely on pseudorandom point selection (no 
conditioning algorithm is applied to adjust the point locations), and so a pseudorandom initialization 
approach allows for more informative comparisons to be made.    
For the MAX and FAX, the modified distmesh3d program was used to distribute target points in 
the colon, lungs, stomach, female breasts, gonads, bladder wall, liver, thyroid, brain, skin, adrenals, heart, 
kidneys, pancreas, small intestine, spleen, thymus, prostate, and uterus. For the VCAM and VCAF, the 
modified distmesh3d program was used to distribute target points in the lungs, stomach, female breasts, 
gonads, bladder wall, liver, thyroid, brain, heart, kidneys, pancreas, skin, spleen, and uterus. The colon and 
small intestine are identified in CAM and CAF simply as the intestines, and so these tissues were meshed 
as one.  
It was noted above that a post processing step was added to distmesh3d to separate interior and 
boundary nodes. Interior nodes were used to represent all of the tissues meshed in MAX, FAX, VCAM, 
and VCAF except for the bladder wall and skin; further modifications were made to distribute target points 
in these tissues. The bladder was isolated in each of the models and was filled in with bladder voxels. The 
resulting mass of bladder was meshed, and the boundary nodes were kept. This ensured that all target 
points would lie near the bladder wall and not in the bladder interior. A similar approach was used for the 
skin point distribution with an additional post processing step of shifting the nodes to a precise depth of 0.1 
mm under the surface of the skin, as recommended by the ICRP [ICRP 2007]. The CAM and CAF do not 
have skin, and so every voxel in VCAM and VCAF was replaced with a common tissue type to allow a full 
body mesh. The boundary nodes were kept and then shifted to the 0.1 mm skin depth.  
It was initially hoped that distmesh3d could be used to distribute target points in all of the effective 
dose tissues given in Tables 1 and 2; however, applying it to certain tissues revealed a weakness in the 
algorithm that could not be resolved. For highly segmented or non contiguous volumes, the signed distance 
function is not smooth, and distmesh3d produces malformed point distributions that do not accurately 
represent the tissue volumes. As a result, target points were manually selected in these tissues to enable the 
most complete and balanced effective dose comparison between the models.     
In both sets of models, the muscle, bone, and esophagus tissues could not be meshed, and in the 
VCAM and VCAF, the BFO tissues could not be meshed. Since the esophagus in these models resembles a 
long, right circular cylinder, target points were manually placed along the primary axis of the tissue. Two 
different techniques were used for the muscle in MAX and FAX and the muscle in VCAM and VCAF. 
Muscle tissues in MAX and FAX were first segmented into the following regions: head and neck, left arm, 
right arm, upper torso, mid torso, lower torso, upper legs, and lower legs. The number of muscle voxels in 
each region was then used to provide guidance on the number of target points to create. Conversely, muscle 
tissue in CAM and CAF appears to have been used to fill empty regions throughout the body and so 
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segmentation was difficult. As a result, we chose the 50 muscle target points currently used by OLTARIS 
(On-Line Tool for the Assessment of Radiation In Space) [OLTARIS, 2008]. 
A very similar approach was taken to select target points in the bone. In MAX and FAX, bone 
tissues are already segmented into left and right arms, left and right legs, skull, mandible, pelvis, ribs, and 
spine; approximately 20 target points were selected in each of these regions. Since BFO was not identified 
in this version of MAX and FAX, but has a high effective dose weighting factor, BFO target points were 
taken to be the same as the bone points. For CAM and CAF, we chose the 50 bone points and 50 BFO 
points used by OLTARIS [OLTARIS, 2008].   
The adrenals and thymus are not identified in CAM and CAF, but target points were manually 
selected with guidance from the MAX and FAX models to represent these tissues. Salivary glands are not 
identified in any of the models, but, because it has a weighting factor of 0.01, 12 target points were placed 
in each model to represent this tissue. It should be noted that the motivation behind manually placing these 
points was to provide the most complete and balanced effective dose comparison between the models. 
4. Mass Averaged Tissue Dose Error Analysis 
 
The distmesh3d software is initialized by specifying a spacing parameter h and a seed number, 
both of which were explained in the previous section. Seven target point groups were created by adjusting 
the value of the spacing parameter, and within each group, ten different point distributions were generated 
by changing the initial seed number. A group is defined here as a set of point distributions with each 
distribution having approximately the same number of points. For MAX, FAX, VCAM, and VCAF, and for 
all of the tissues except skin, group one contained point distributions with 500±50 points, group two 
contained point distributions with 250±25 points, group three contained point distributions with 100±10 
points, group four contained point distributions with 50±5 points, group five contained point distributions 
with 30±4 points, group six contained point distributions with 15±3 points, and group seven contained 
point distributions with 7±2 points. For the MAX, FAX, VCAM, and VCAF skin, the distribution sizes in 
the various groups were increased to 8000±800 points, 6000±600 points, 4000±400 points, 2000±200 
points, 1000±100 points, 500±50 points, and 250±25 points. Tolerances in each group were used to account 
for variability in the point distributions that results from using different seed numbers.  
Each target point distribution was analyzed by computing mass averaged doses according to 
equation (8). Single point distributions have also been published for the CAF bladder, breasts, heart, 
kidneys, liver, lungs, ovaries, pancreas, stomach, thyroid, and uterus [Yucker 1992], as well as the CAM 
heart, testes, and thyroid [Billings 1973]. Mass averaged doses were computed using these distributions as 
well. Average group doses were calculated by taking the ten distributions in a given group and averaging 
over the doses computed with each distribution. The group with the largest number of points will be 
referred to as group 1 and used in later analysis.  
We considered separately the 1977 solar minimum GCR spectrum [O’Neill 2006] and August 
1972 King SPE spectrum [King 1974] impinging isotropically on the human phantoms shielded by a 
spherical Aluminum shell and calculated the mass averaged tissue dose equivalent according to equation 
(8). Three different shell areal densities of 0.4 g/cm2, 2.0 g/cm2, and 10.0 g/cm2 of Aluminum were chosen 
to represent typical values for a space suit, thinly shielded locations in a space vehicle, and thicker shields, 
respectively. Figures 6-79 give the results from this analysis. The data marked FAX, MAX, VCAF, or 
VCAM dose were computed using point distributions generated in the FAX, MAX, VCAF, or VCAM, 
respectively. The symbols with lines labeled as average group dose were obtained by averaging over the 
individual groups as described above. The data points marked VCAF or VCAM documentation dose were 
obtained using the previously published target point distributions described above. In certain plots, the 
results for the 2.0 g/cm2 or 10.0 g/cm2 Aluminum shells have been left off due to data overlap.  
It is apparent that, for many of the organs analyzed, the trend lines continue to increase with the 
number of tissue points instead of rapidly approaching an asymptotic limit. This is caused by a systematic 
error associated with the distmesh3d point distribution method. As more mesh points are added (resulting in 
a smaller node spacing), the distance between the tissue boundary and the mesh boundary decreases. Thus, 
the shielding provided by the body to the mesh points decreases. Therefore, the average group dose 
continues to rise slightly as more target points are added. It is also clear that this trend is amplified in the 
SPE environment. For SPE environments, the dose declines rapidly as a function of depth over the first 10-
20 g/cm2 of shielding and tissue. For GCR environments, the dose declines very slowly even over the first 
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few g/cm2 of shielding. Hence, small variations in the total shield-tissue thickness can dramatically change 
the interpolated dose for SPE environments, while having only a small effect in GCR environments. For 
almost all of the tissues studied, this systematic error is reduced by using a larger number of target points. 
However, the male and female brains, CAM and CAF intestines, and CAM and CAF hearts appear to have 
non-negligible systematic errors even when more than 250 points are used. These errors are most 
noticeable for the 0.4 g/cm2 Aluminum shell in the SPE environment and are much less apparent in the 
thicker shields and GCR environment cases. It should also be noted that the vertical axis of these plots has 
been adjusted to amplify the systematic error, and even in the 0.4 g/cm2 Aluminum shell in the SPE 
environment case, the differences between the 250 point group and 500 point group are bounded by 5%.   
The systematic error described above is the dominant source of error for most of the tissues in 
Figures 6-79; however, the statistical error, or data-spread within the individual groups is also important. 
This error is caused by differences between target point distributions generated with different random 
number seeds. Large statistical errors within a particular group of target points indicate that they do not 
accurately sample the tissue volume, and more points should be used.  
With that said, all of the previously published target point distributions generated for CAM and 
CAF lie in the regions of highest statistical error. While these point distributions have been modified over 
the past three decades, it is now common to use roughly 10-50 points per organ, generated either randomly 
or manually. Given that this point distribution method was initialized with a random distribution of points 
and was unable to sufficiently reduce the statistical error to acceptable levels if only 10-50 points are used, 
it must be concluded that large statistical errors are likely to occur if purely random methods are used. 
Furthermore, manually placed points are unlikely to be placed uniformly and could therefore introduce a 
large bias or systematic error. In all of the figures, the statistical error is reduced to an acceptable level by 
adding a sufficient number of target points. It is concluded that the most accurate point distributions that 
can be chosen at this time are those we have designated as group 1 (500±50 points in each non-skin 
distribution, 8000±800 in each skin distribution) and verifies the applicability of our point distribution 
method. 
If one now examines Figures 6-79 and compares the results across body phantom models instead 
of comparing the characteristics of the individual target point distributions, it is obvious that large 
differences exist between FAX and VCAF as well as MAX and VCAM. Reasonable agreement is achieved 
between the models only for the female heart, female stomach, and male gonads. Errors routinely exceed 
15% for the remaining tissues with almost a full order of magnitude difference between the VCAM and 
MAX thyroid doses behind 0.4 g/cm2 of Aluminum in the SPE environment (see Figure 61). These large 
differences were investigated and it was found that the MAX thyroid has at least 1.44 cm of other body 
tissues shielding it, while the VCAM has a large portion of the thyroid directly exposed to the environment 
with no other tissue shielding it. Since the CAM and CAF have no skin, the thyroid actually appears as an 
external region in both of these models. Given the large discrepancies between the mass and volume 
comparisons given in Tables 1 and 2, these differences are to be expected and reiterate the deficiencies of 
CAM and CAF. 
Recommended sets of target points to be used for future studies with VCAM, VCAF, MAX, or 
FAX are given in Appendices A-D, respectively. Since CAM and CAF are still widely used in radiation 
analyses, we have verified that, except for the skin points, all VCAM target points can be used in CAM and 
all VCAF target points can be used in CAF. Due to the voxel conversion process, the external body 
boundaries of the VCAM and VCAF differ slightly from the original boundaries of the CAM and CAF. 
Hence, skin target points shifted to a precise depth of 0.1 mm in VCAM and VCAF voxels will likely not 
be at the correct depth in CAM and CAF. We have shifted the VCAM and VCAF skin points to the 
required distance inside the CAM and CAF boundaries, and these target points are given in Appendices E 
and F, respectively. It should be noted that the coordinate system for all of the models has its origin placed 
at the top of the head with the positive x axis pointing in the direction the phantom is facing, the positive y 
axis pointing to the phantom’s right, and the positive z axis pointing down. Note that the data has been 
arranged in a two column format. The number of tissue target points used in these distributions is 
summarized for VCAM and VCAF in Table 3 and for MAX and FAX in Table 4. The symbol "-" is used to 
indicate the absence of a gender specific tissue.  
We have selected the smallest target point distribution in the smallest group that has a within-
group error that is less than 15% for all three Aluminum shield depths in both environments. The terms and 
error metrics used in defining this selection criterion are defined below, but to be clear, the 15% error 
tolerance only includes error due to the target point distribution. It does not include errors due to the 
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modeling of the space radiation environment, particle transport, dose versus depth database interpolation, 
nuclear physics, or human phantoms. 
The size of a point distribution is simply the number of points in the distribution, and the size of a 
group is the average number of target points used in each of the distributions in the group. Below is a 
summary of the remaining terms and error metrics used in this selection criterion. Consider the average 
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and can be computed for each of the 10 distributions in each of the 7 groups so that, for a given group, the 
group error can be taken as the maximum of these percent differences 
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The selection criterion can now be reworded in the following way: for each effective dose tissue, 
select the smallest point distribution in the smallest group, j, satisfying ( ) 15%jTε <  for all three Aluminum 
shield depths in both environments. The mass averaged tissue dose equivalent results and the errors 
generated by these point distributions are given in Tables 5-12 along with the 2007 ICRP effective dose 
weighting factor of each tissue [ICRP 2007] and the number of points used. For those effective dose tissues 
to which distmesh3d could not be applied, only the manually generated point distribution exists, and the 
error is taken to be the average of the available errors over those tissues that have error estimates. Also, 
note that the 2007 ICRP recommendations specify that a 0.12 weighting factor be divided evenly among 
the remainder tissues. Since the ET, gall bladder, oral mucosa, and lymphatic nodes were not used in this 
study, a common weighting factor of 0.013333 = 0.12/9 was used for the nine remainder tissues that were 
used in this study.  
5. Effective Dose Comparisons 
 
As a final comparison, we use the mass averaged dose equivalent values and error estimates given 
in Tables 5-12 to estimate the error associated with using these point distributions to compute effective 
dose. Using the errors computed in the previous section, equation (6) can now expressed as  
 
 (1 )T T T
T
E w H ε= ±∑  , (12) 
 
where /100T Tε ε=  is the error identified in the previous section. It can be easily shown that    
 
 errorcomp EE E ≤− , (13) 
 
where the computed effective dose is 
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 comp T T
T
E w H=∑ , (14) 
 
and the error term is 
 
 error T T T
T
E w H ε=∑  . (15) 
 
The values of compE  and errorE  are given in Tables 13 and 14 for all four phantoms in all three 
Aluminum shield thicknesses and both environments. As expected, significant differences exist between 
the CAM and MAX as well as CAF and FAX. The sources of these differences can be found by examining 
the dose estimates for individual tissues found in Tables 5-12. These differences are summarized Tables 15 
and 16 by considering the percentage difference from the average tissue dose between two phantoms for 

















where T is the tissue type, A refers to FAX or MAX, and B refers to VCAF or VCAM, respectively. Table 
15 shows that the differences exceed 50% for the male adrenals, breasts, muscle, esophagus, pancreas, 
prostate, thymus, and thyroid. Table 16 shows that differences exceed 50% for the female adrenals, muscle, 
esophagus, pancreas, thyroid, and uterus. Recall that the adrenals, prostate and thymus are not identified in 
the CAM or CAF, so these differences are likely due to poor point placement. The differences in the 
thyroid have already been determined to be caused by a poor representation in the CAM and CAF. The 
male breasts are not identified in either model, and so the large differences are most likely caused by target 
point placement. The differences in the esophagus and muscle could be caused by both point selection and 
model differences since these tissues are included in both models. Differences in the pancreas and uterus 
are caused entirely by model differences, since the point distributions have been determined to satisfy the 
accuracy requirement defined above.  
6. Segmentation of BFO and Muscle in MAX and FAX 
 
Recall that the muscle and BFO tissues in MAX and FAX were segmented into various regions. 
This segmentation provides the ability to compute mass averaged doses in each region and use mass 
fractions as weighting factors to compute the total muscle or BFO dose. The non-gender specific mass 
fraction weighting factors used for BFO were taken from ICRP 70 [ICRP 1995] and are given in Table 17. 
The mass fraction weighting factors for muscle were found by counting the number of muscle voxels in 
each region and dividing by the total number of muscle voxels in the body. The muscle weighting factors 
for MAX and FAX are given in Table 18. 
The effect of using these weighting factors instead of a pure average, as was shown in Tables 5-
12, is shown in Tables 19-26. It appears that using the weighted average tends to reduce the calculated 
dose. The reduction is significant enough to have a non-negligible impact on effective dose as well. The 
effective dose values calculated in MAX and FAX using the segmented muscle and BFO are given in 
Tables 27 and 28.  
7. Conclusions 
 
The CAM and CAF human phantoms were converted into a voxel representation to enable 
detailed comparisons to the MAX and FAX models and the ICRP reference data. Mass and volume 
comparisons reveal significant differences between the two sets of models and show that CAM and CAF 
compare poorly to the ICRP recommended values. Mass differences exceed 30% in the CAM BFO, 
stomach, bladder, esophagus, thyroid, heart, kidneys, muscle, pancreas, and spleen. Similarly, mass 
differences exceed 30% in the CAF BFO, bladder, esophagus, thyroid, heart, kidneys, muscle, pancreas, 
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spleen, uterus, and ovaries. These CAM and CAF tissues account for approximately 40% of the effective 
dose weights. These comparisons have also revealed deficiencies in the MAX and FAX models, but it was 
noted that Kramer et al. have resolved these issues in recent versions of MAX and FAX [Kramer et al. 
2006]. It is concluded that MAX and FAX provide a more accurate representation of the human body than 
CAM and CAF for analyses attempting to conform to ICRP recommendations.  
A computational procedure for generating point distributions in many of the effective dose tissues, 
based on the distmesh3d algorithm, was introduced and tested. Approximately 70 point distributions were 
generated in most of these tissues, and mass averaged tissue dose equivalents were calculated in various 
shielding conditions using both an SPE and a GCR environment. Results indicated that statistical and 
systematic errors were present, but in every case the error was reduced by using a sufficient number of 
points. A selection criterion was developed to identify reasonably accurate point distributions, and these 
point distributions, along with their error estimates, were used to compute whole body effective doses. 
Large differences in the effective dose estimates were found between the models. For the SPE environment, 
effective dose differences ranged from 33%-60% for the male and 13%-27% for the female depending on 
the shield thickness. For the GCR environment, effective dose differed by 4%-13% for the male phantoms 
and 2%-3% for the female phantoms, depending on shield thickness. If the segmented BFO and muscle 
doses are used in MAX and FAX, these differences increase to 37%-65% for the male, 17%-34% for the 
female in the SPE environment. In the GCR environment, the differences are 5%-7% for the male 
phantoms, and 2%-3% for the female phantoms.  
Future work will focus on developing a point distribution method that can accommodate more 
complex structures such as the BFO, bone surface, and muscle. It has also been shown that segmentation of 
these tissues has a large impact on mass averaged dose equivalent, and due to the high effective dose 
weighting factor of BFO, has a non-negligible impact on effective dose. Therefore, when a viable point 
distribution method is developed for these tissues, the impact of tissue segmentation should be studied in 
detail. This type of study should also be repeated, using both isotropic and anisotropic low earth orbit 
environments, for more complex and realistic shielding distributions such as those inside the International 
Space Station and the Crew Exploration Vehicle.   
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Figure 1. The CAM and CAF models are constructed of over 1000 solid objects, with each object defined 






Figure 2. Each voxel in MAX and FAX is cubic, measuring 3.6 mm along each edge, and has associated 
with it a single integer that identifies its tissue type. A voxel can only be associated with a single tissue type 
and has constant properties throughout its volume. 




Figure 3. Close up views of the three male human phantoms models used in this study: the CAM in its 
original form as a geometry model (A), the CAM after its conversion into a voxel-based model (B), and the 







Figure 4. A 968 ray distribution. 
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Figure 6. Mass averaged tissue dose equivalent in female adrenals behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 7. Mass averaged tissue dose equivalent in female bladder behind various Aluminum shields 





Figure 8. Mass averaged tissue dose equivalent in female brain behind various Aluminum shields exposed 
to the August 1972 King SPE spectrum. 
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Figure 9. Mass averaged tissue dose equivalent in female breast behind various Aluminum shields exposed 





Figure 10. Mass averaged tissue dose equivalent in FAX colon behind various Aluminum shields exposed 
to the August 1972 King SPE spectrum. 
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Figure 11. Mass averaged tissue dose equivalent in FAX small intestine behind various Aluminum shields 





Figure 12. Mass averaged tissue dose equivalent in VCAF colon/intestines behind various Aluminum 
shields exposed to the August 1972 King SPE spectrum. 
  20 
 
 
Figure 13. Mass averaged tissue dose equivalent in female heart behind various Aluminum shields exposed 





Figure 14. Mass averaged tissue dose equivalent in female kidneys behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 15. Mass averaged tissue dose equivalent in female liver behind various Aluminum shields exposed 





Figure 16. Mass averaged tissue dose equivalent in female lungs behind various Aluminum shields exposed 
to the August 1972 King SPE spectrum. 
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Figure 17. Mass averaged tissue dose equivalent in female ovaries behind various Aluminum shields 





Figure 18. Mass averaged tissue dose equivalent in female pancreas behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 19. Mass averaged tissue dose equivalent in female skin behind various Aluminum shields exposed 





Figure 20. Mass averaged tissue dose equivalent in female spleen behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 21. Mass averaged tissue dose equivalent in female stomach behind various Aluminum shields 





Figure 22. Mass averaged tissue dose equivalent in female thymus behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 23. Mass averaged tissue dose equivalent in female thyroid behind various Aluminum shields 





Figure 24. Mass averaged tissue dose equivalent in female uterus behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 25. Mass averaged tissue dose equivalent in female adrenals behind various Aluminum shields 





Figure 26. Mass averaged tissue dose equivalent in female bladder behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
  27 
 
 
Figure 27. Mass averaged tissue dose equivalent in female brain behind various Aluminum shields exposed 





Figure 28. Mass averaged tissue dose equivalent in female breast behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 29. Mass averaged tissue dose equivalent in FAX colon behind various Aluminum shields exposed 





Figure 30. Mass averaged tissue dose equivalent in FAX small intestine behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 31. Mass averaged tissue dose equivalent in VCAF colon/intestines behind various Aluminum 





Figure 32. Mass averaged tissue dose equivalent in female heart behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Figure 33.  Mass averaged tissue dose equivalent in female kidneys behind various Aluminum shields 





Figure 34. Mass averaged tissue dose equivalent in female liver behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Figure 35.  Mass averaged tissue dose equivalent in female lungs behind various Aluminum shields 





Figure 36. Mass averaged tissue dose equivalent in female ovaries behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 37. Mass averaged tissue dose equivalent in female pancreas behind various Aluminum shields 





Figure 38.  Mass averaged tissue dose equivalent in female skin behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Figure 39. Mass averaged tissue dose equivalent in female spleen behind various Aluminum shields 





Figure 40. Mass averaged tissue dose equivalent in female stomach behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 41. Mass averaged tissue dose equivalent in female thymus behind various Aluminum shields 





Figure 42. Mass averaged tissue dose equivalent in female thyroid behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 43. Mass averaged tissue dose equivalent in female uterus behind various Aluminum shields 





Figure 44. Mass averaged tissue dose equivalent in male adrenals behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 45. Mass averaged tissue dose equivalent in male bladder behind various Aluminum shields exposed 





Figure 46. Mass averaged tissue dose equivalent in male brain behind various Aluminum shields exposed 
to the August 1972 King SPE spectrum. 
  37 
 
 
Figure 47. Mass averaged tissue dose equivalent in MAX colon behind various Aluminum shields exposed 





Figure 48. Mass averaged tissue dose equivalent in MAX small intestines behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 49. Mass averaged tissue dose equivalent in VCAM colon/intestines behind various Aluminum 





Figure 50. Mass averaged tissue dose equivalent in male heart behind various Aluminum shields exposed to 
the August 1972 King SPE spectrum. 
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Figure 51. Mass averaged tissue dose equivalent in male kidneys behind various Aluminum shields 





Figure 52. Mass averaged tissue dose equivalent in male liver behind various Aluminum shields exposed to 
the August 1972 King SPE spectrum. 
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Figure 53. Mass averaged tissue dose equivalent in male lungs behind various Aluminum shields exposed 





Figure 54. Mass averaged tissue dose equivalent in male pancreas behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 55. Mass averaged tissue dose equivalent in male prostate behind various Aluminum shields 





Figure 56. Mass averaged tissue dose equivalent in male skin behind various Aluminum shields exposed to 
the August 1972 King SPE spectrum. 
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Figure 57. Mass averaged tissue dose equivalent in male spleen behind various Aluminum shields exposed 





Figure 58. Mass averaged tissue dose equivalent in male stomach behind various Aluminum shields 
exposed to the August 1972 King SPE spectrum. 
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Figure 59. Mass averaged tissue dose equivalent in male testes behind various Aluminum shields exposed 





Figure 60. Mass averaged tissue dose equivalent in male thymus behind various Aluminum shields exposed 
to the August 1972 King SPE spectrum. 
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Figure 61. Mass averaged tissue dose equivalent in male thyroid behind various Aluminum shields exposed 





Figure 62. Mass averaged tissue dose equivalent in male adrenals behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 63. Mass averaged tissue dose equivalent in male bladder behind various Aluminum shields exposed 





Figure 64. Mass averaged tissue dose equivalent in male brain behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Figure 65. Mass averaged tissue dose equivalent in MAX colon behind various Aluminum shields exposed 





Figure 66. Mass averaged tissue dose equivalent in MAX small intestine behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 67. Mass averaged tissue dose equivalent in VCAM colon/intestines behind various Aluminum 





Figure 68. Mass averaged tissue dose equivalent in male heart behind various Aluminum shields exposed to 
the 1977 solar minimum GCR spectrum. 
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Figure 69. Mass averaged tissue dose equivalent in male kidneys behind various Aluminum shields 





Figure 70. Mass averaged tissue dose equivalent in male liver behind various Aluminum shields exposed to 
the 1977 solar minimum GCR spectrum. 
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Figure 71. Mass averaged tissue dose equivalent in male lungs behind various Aluminum shields exposed 





Figure 72. Mass averaged tissue dose equivalent in male pancreas behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 73. Mass averaged tissue dose equivalent in male prostate behind various Aluminum shields 





Figure 74. Mass averaged tissue dose equivalent in male skin behind various Aluminum shields exposed to 
the 1977 solar minimum GCR spectrum. 
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Figure 75. Mass averaged tissue dose equivalent in male spleen behind various Aluminum shields exposed 





Figure 76. Mass averaged tissue dose equivalent in male stomach behind various Aluminum shields 
exposed to the 1977 solar minimum GCR spectrum. 
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Figure 77. Mass averaged tissue dose equivalent in male testes behind various Aluminum shields exposed 





Figure 78. Mass averaged tissue dose equivalent in male thymus behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Figure 79. Mass averaged tissue dose equivalent in male thyroid behind various Aluminum shields exposed 
to the 1977 solar minimum GCR spectrum. 
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Table 1. Density (ρ in units of g/cm3), mass (M in units of g), and volume (V in units of cm3) comparisons 
for effective dose tissues in VCAM, MAX, and the ICRP Reference Male (lymphatic nodes, extrathoracic 
region, oral mucosa, gall bladder, salivary glands, and bone surface not listed). The symbol "-" in the 
density, mass, and volume columns of a given tissue and model indicates that this tissue type was not 
represented in the model. 
 
VCAM MAX ICRP89 Tissue 
ρ M V ρ M V M 
BFO 1.43 3815.40 2668.07 - - - 1170 
Colon - - - 1.05 607.020 578.114 670 
Lung 0.257 1113.93 4334.34 0.26 1061.50 4082.68 1200 
Stomach 1.058 568.947 537.757 1.05 399.993 380.946 400 
Breast - - - - - - 25 
Bladder 1.058 204.655 193.436 1.05 50.0176 47.6358 50 
Esophagus 0.0 0.0 22.3949 1.05 40.0239 38.1180 40 
Liver 1.058 1976.36 1868.01 1.05 1799.99 1714.28 1800 
Thyroid 1.058 13.2290 12.5038 1.05 19.8405 18.8957 20 
Brain 1.058 1383.52 1307.67 1.05 1450.02 1380.97 1450 
Skin - - - 1.09 6063.90 5563.21 3300 
Adrenals - - - 1.05 14.6962 13.9968 14 
Heart 1.058 1472.42 1391.70 1.05 77.4023 73.7165 330 
Kidneys 1.058 530.247 501.179 1.05 310.001 295.239 310 
Muscle 1.06 46845.2 44193.6 1.05 30809.8 29342.7 29000 
Pancreas 1.058 93.8866 88.7397 1.05 140.010 133.343 140 
Small Intestine - - - 1.05 1000.01 952.389 1000 
Spleen 1.058 90.6287 85.6604 1.05 150.004 142.861 150 
Thymus - - - 1.05 24.9843 23.7946 25 
Prostate - - - 1.05 21.4571 20.4353 17 
Testes 1.058 35.6888 33.7323 1.05 34.7331 33.0791 35 
  55 
Table 2. Density (ρ in units of g/cm3), mass (M in units of g), and volume (V in units of cm3) comparisons 
for effective dose tissues in VCAF, FAX, and the ICRP Reference Male (lymphatic nodes, extrathoracic 
region, oral mucosa, gall bladder, salivary glands, and bone surface not listed). The symbol "-" in the 
density, mass, or volume columns of a given tissue and model indicates that this tissue type was not 
represented in the model. 
 
VCAF FAX ICRP89 Tissue 
ρ M V ρ M V M 
BFO 1.43 3074.33 2148.79 - - - 900 
Colon - - - 1.05 680.014 647.632 680 
Lung 0.257 871.256 3376.96 0.26 950.004 3653.86 950 
Stomach 1.058 444.456 420.091 1.05 370.013 352.393 370 
Breast 1.02 610.033 598.223 1.05 500.000 476.171 500 
Bladder 1.058 172.669 163.203 1.05 40.024 38.1180 40 
Esophagus 0.0 0.0 13.1570 1.05 35.0270 33.3590 35 
Liver 1.058 1548.69 1463.79 1.05 1400.00 1333.33 1400 
Thyroid 1.058 9.28007 8.77133 1.05 17.0000 16.1896 17 
Brain 1.058 1075.80 1016.82 1.05 1300.02 1238.11 1300 
Skin - - - 1.09 4995.39 4582.93 2300 
Adrenals - - - 1.05 13.0310 12.4105 13 
Heart 1.058 1137.26 1074.91 1.05 620.002 590.478 250 
Kidneys 1.058 414.987 392.237 1.05 275.023 261.927 275 
Muscle 1.06 37635.3 35505.0 1.05 17553.1 16717.2 17500 
Pancreas 1.058 73.1546 69.1442 1.05 120.022 114.307 120 
Small Intestine - - - 1.05 879.986 838.082 880 
Spleen 1.058 69.4030 65.5983 1.05 130.016 123.825 130 
Thymus - - - 1.05 19.9874 19.0356 20 
Uterus 1.058 49.5595 46.8426 1.05 80.0000 76.1892 80 
Ovaries 1.058 18.6589 17.6360 1.05 10.7075 10.4976 11 
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Table 3. Number of tissue target points used in the recommended distributions for VCAM and VCAF. The 
symbol "-" is used to indicate the absence of a gender specific tissue. 
 
Tissue  VCAM points VCAF points 
Adrenals 6 6 
BFO 50 50 
Bladder 16 14 
Bone 50 50 
Brain 96 90 
Breast 10 225 
Esophagus 11 11 
Heart 90 92 
Intestines 90 45 
Kidneys 12 5 
Liver 94 46 
Lungs 5 6 
Muscle 50 50 
Ovaries - 6 
Pancreas 26 45 
Prostate 9 - 
Salivary Glands 12 12 
Skin 224 493 
Spleen 26 13 
Stomach 5 12 
Testes 12 - 
Thymus 5 9 
Thyroid 5 5 
Uterus - 5 
Total 904 1290 
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Table 4. Number of tissue target points used in the recommended distributions for MAX and FAX. The 
symbol "-" is used to indicate the absence of a gender specific tissue.  
 
Tissue  MAX points  FAX points 
Adrenals 5 5 
BFO 193 191 
Bladder 7 6 
Bone 193 191 
Brain 94 90 
Breast 10 90 
Colon 27 45 
Esophagus 12 11 
Heart 5 26 
Kidneys 5 5 
Liver 90 95 
Lungs 6 14 
Muscle 108 115 
Ovaries - 5 
Pancreas 5 5 
Salivary Glands 12 12 
Skin 241 229 
Small Intestine 5 12 
Spleen 5 5 
Stomach 92 13 
Testes 13 - 
Thymus 5 12 
Thyroid 5 13 
Uterus - 5 
Total 1144 1195 
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Table 5. Tissue doses ( TH  in units of cSv/day) and errors ( Tε  in units of %) in FAX protected by various 
thicknesses of Aluminum exposed to the 1977 solar minimum GCR spectrum.  
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 0.134569 0.544736 0.130895 0.505835 0.117107 0.358942 
BFO 0.12 0.163785 0.43054 0.157231 0.403286 0.133818 0.286737 
Bladder 0.04 0.135862 0.039909 0.132035 0.035731 0.117771 0.022627 
Bone 0.01 0.163785 0.43054 0.157231 0.403286 0.133818 0.286737 
Brain 0.01 0.175331 0.705142 0.167876 0.648509 0.141082 0.453967 
Breast 0.12 0.185848 0.559465 0.176919 0.514202 0.145909 0.360181 
Colon 0.12 0.146497 0.501341 0.141635 0.467254 0.123876 0.338366 
Heart 0.01333 0.144002 0.412037 0.139507 0.38088 0.122817 0.266897 
Kidneys 0.01333 0.140724 0.491448 0.136467 0.452809 0.120675 0.314431 
Liver 0.04 0.146327 0.223136 0.141546 0.204226 0.123976 0.138958 
Lungs 0.12 0.171179 0.053225 0.164018 0.061922 0.138397 0.074088 
Muscle 0.01333 0.174593 0.43054 0.166933 0.403286 0.139901 0.286737 
Esophagus 0.04 0.147643 0.43054 0.142811 0.403286 0.124951 0.286737 
Ovaries 0.08 0.134562 0.076791 0.130879 0.072026 0.117075 0.053087 
Pancreas 0.01333 0.134483 0.037381 0.13083 0.033391 0.117102 0.019717 
Salivary Glands 0.01 0.183223 0.43054 0.174599 0.403286 0.144493 0.286737 
Skin 0.01 0.215096 2.008794 0.203907 1.945034 0.160706 1.391962 
Small Intestine 0.01333 0.142157 0.51509 0.137731 0.481683 0.121413 0.349756 
Spleen 0.01333 0.147859 0.120915 0.142941 0.111476 0.124886 0.080204 
Stomach 0.12 0.14432 0.287011 0.139741 0.262521 0.122833 0.178322 
Thymus 0.01333 0.165556 0.471692 0.15893 0.43434 0.135115 0.305146 
Thyroid 0.04 0.171659 0.454666 0.164291 0.417636 0.138243 0.290839 
Uterus 0.01333 0.131767 0.246951 0.128346 0.229677 0.115447 0.163776 
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Table 6. Tissue doses ( TH  in units of cSv) and errors ( Tε  in units of %) in FAX protected by various 
thicknesses of Aluminum exposed to the August 1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 38.854 7.99134 29.26396 7.125602 9.814522 4.079884 
BFO 0.12 340.4682 6.253128 186.3838 5.182756 29.97509 2.872593 
Bladder 0.04 53.96372 2.399935 38.75756 1.879615 11.25939 0.731996 
Bone 0.01 340.4682 6.253128 186.3838 5.182756 29.97509 2.872593 
Brain 0.01 220.9121 11.24714 145.5799 9.260968 30.28954 5.000866 
Breast 0.12 600.218 11.76631 338.5703 8.62753 49.57179 4.154405 
Colon 0.12 115.8606 4.704768 77.48583 4.177092 17.62111 2.721737 
Heart 0.01333 63.15146 7.100423 45.84783 6.116112 13.32985 3.324728 
Kidneys 0.01333 62.28215 9.627124 45.11786 8.263433 12.94124 4.390473 
Liver 0.04 96.56272 5.03809 65.84141 4.212742 16.10711 2.16625 
Lungs 0.12 247.081 7.538501 158.1387 5.314912 30.71601 1.82689 
Muscle 0.01333 396.517 6.253128 231.3393 5.182756 37.54691 2.872593 
Ovaries 0.08 40.30139 0.438774 30.2773 0.447516 10.00816 0.362433 
Esophagus 0.04 75.97644 6.253128 54.33501 5.182756 14.96856 2.872593 
Pancreas 0.01333 36.90725 1.109174 27.98405 1.056422 9.602227 0.635459 
Salivary Glands 0.01 907.8467 6.253128 424.5596 5.182756 51.22705 2.872593 
Skin 0.01 5163.727 11.39566 1429.82 9.827907 107.5164 7.302136 
Small Intestine 0.01333 80.92663 1.600157 56.52276 2.17077 14.56118 2.38652 
Spleen 0.01333 95.39568 4.157492 66.30304 3.153247 16.62124 1.214423 
Stomach 0.12 76.64496 6.993247 54.4222 5.883854 14.60759 2.961808 
Thymus 0.01333 213.2616 7.376755 137.3422 6.077362 27.36069 3.32374 
Thyroid 0.04 372.0256 8.448009 218.6002 6.45496 35.60503 3.293231 
Uterus 0.01333 31.14806 3.623404 23.94731 3.239569 8.685125 1.829687 
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Table 7. Tissue doses ( TH  in units of cSv/day) and errors ( Tε  in units of %) in MAX protected by various 
thicknesses of Aluminum exposed to the 1977 solar minimum GCR spectrum. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 0.127517 0.022989 0.124458 0.021654 0.112844 0.016973 
BFO 0.12 0.156889 0.578773 0.151012 0.54362 0.129848 0.39081 
Bladder 0.04 0.133925 0.142929 0.130243 0.131121 0.116508 0.09042 
Bone 0.01 0.156889 0.578773 0.151012 0.54362 0.129848 0.39081 
Brain 0.01 0.170234 0.852295 0.163274 0.787876 0.138142 0.559717 
Breast 0.12 0.15749 0.578773 0.151605 0.54362 0.130367 0.39081 
Colon 0.12 0.140078 0.411586 0.135823 0.380428 0.120117 0.267447 
Heart 0.01333 0.147624 1.16745 0.142755 1.093095 0.124818 0.806311 
Kidneys 0.01333 0.135105 0.160052 0.131337 0.152227 0.117272 0.116816 
Liver 0.04 0.138672 0.530908 0.134585 0.491706 0.119414 0.347134 
Lungs 0.12 0.157042 0.837926 0.151301 0.79576 0.130379 0.615942 
Muscle 0.01333 0.168552 0.578773 0.1615 0.54362 0.13646 0.39081 
Esophagus 0.04 0.14248 0.578773 0.138108 0.54362 0.12186 0.39081 
Pancreas 0.01333 0.127617 0.856899 0.124548 0.799852 0.1129 0.579023 
Prostate 0.01333 0.130818 0.002062 0.127448 0.002072 0.114754 0.00175 
Salivary Glands 0.01 0.178716 0.578773 0.170527 0.54362 0.141875 0.39081 
Skin 0.01 0.215036 2.211794 0.203834 2.143926 0.160537 1.53297 
Small Intestine 0.01333 0.137879 0.410415 0.133842 0.373875 0.118862 0.246884 
Spleen 0.01333 0.141688 0.227862 0.137324 0.210253 0.121198 0.147503 
Stomach 0.12 0.140516 0.885198 0.136262 0.822142 0.120513 0.588801 
Testes 0.08 0.174321 0.276306 0.166415 0.258773 0.139008 0.187468 
Thymus 0.01333 0.14747 0.434878 0.142666 0.404904 0.124886 0.291869 
Thyroid 0.04 0.15367 0.407592 0.148137 0.371872 0.128092 0.246747 
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Table 8. Tissue doses ( TH  in units of cSv) and errors ( Tε  in units of %) in MAX protected by various 
thicknesses of Aluminum exposed to the August 1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 22.57753 0.506346 17.83119 0.445307 7.232978 0.226087 
BFO 0.12 260.001 6.653977 145.1948 5.70835 24.98988 3.378763 
Bladder 0.04 52.47376 4.657749 37.5229 3.781636 10.85739 1.672259 
Bone 0.01 260.001 6.653977 145.1948 5.70835 24.98988 3.378763 
Brain 0.01 184.9891 11.38064 124.0079 9.665095 27.05103 5.535749 
Breast 0.12 185.4311 6.653977 118.6345 5.70835 23.73213 3.378763 
Colon 0.12 76.39754 6.536713 53.393 5.67296 13.87676 3.201204 
Heart 0.01333 86.16912 10.11588 60.60715 9.119222 15.82185 5.941057 
Kidneys 0.01333 47.87228 1.607904 35.24983 1.075144 10.83803 0.015064 
Liver 0.04 63.07226 8.141043 44.92247 7.077709 12.51504 3.997371 
Lungs 0.12 131.2113 0.087125 89.15244 0.90358 20.7103 1.938025 
Muscle 0.01333 313.9468 6.653977 189.4852 5.70835 32.77876 3.378763 
Esophagus 0.04 59.76495 6.653977 43.59103 5.70835 12.85864 3.378763 
Pancreas 0.01333 22.97772 10.67654 18.11223 9.658089 7.292625 5.641159 
Prostate 0.01333 33.08429 0.44672 25.09002 0.310049 8.763748 0.070515 
Salivary Glands 0.01 888.4779 6.653977 408.6492 5.70835 48.5747 3.378763 
Skin 0.01 5254.18 12.57518 1453.053 10.72319 108.849 7.982068 
Small Intestine 0.01333 61.35929 10.02272 44.10258 8.631302 12.43842 4.527 
Spleen 0.01333 74.90449 4.91194 52.79783 4.038344 14.00789 1.957382 
Stomach 0.12 69.7464 12.42046 49.26329 10.73213 13.32579 6.141184 
Testes 0.08 600.3036 9.208908 327.9336 5.93256 45.28581 2.467789 
Thymus 0.01333 71.14749 5.312577 51.536 4.712702 14.63944 2.812399 
Thyroid 0.04 159.07 4.509165 103.5474 4.562926 21.5948 3.312654 
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Table 9. Tissue doses ( TH  in units of cSv/day) and errors ( Tε  in units of %) in VCAF protected by 
various thicknesses of Aluminum exposed to the 1977 solar minimum GCR spectrum. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 0.147417 0.59921 0.14256 0.561331 0.124696 0.40743 
BFO 0.12 0.15837 0.59921 0.152361 0.561331 0.130774 0.40743 
Bladder 0.04 0.141484 0.421926 0.137173 0.3943 0.121206 0.286773 
Bone 0.01 0.172481 0.59921 0.165044 0.561331 0.138739 0.40743 
Brain 0.01 0.175055 0.801782 0.167672 0.742595 0.141061 0.531329 
Breast 0.12 0.188995 0.292986 0.179679 0.274266 0.14752 0.192367 
Heart 0.01333 0.145337 1.221636 0.140741 1.139914 0.123681 0.827678 
Intestines 0.13333 0.159546 0.168832 0.153544 0.14232 0.131775 0.066261 
Kidneys 0.01333 0.14818 0.754392 0.143258 0.6957 0.125153 0.486933 
Liver 0.04 0.141421 0.638644 0.137157 0.591391 0.121293 0.416064 
Lungs 0.12 0.164397 0.038379 0.157969 0.030345 0.134697 0.012848 
Muscle 0.01333 0.176123 0.59921 0.168288 0.561331 0.140527 0.40743 
Esophagus 0.04 0.181996 0.59921 0.173535 0.561331 0.143966 0.40743 
Ovaries 0.08 0.145136 0.229131 0.140541 0.214066 0.123495 0.156499 
Pancreas 0.01333 0.14724 1.340154 0.142411 1.249113 0.124636 0.901303 
Salivary Glands 0.01 0.190804 0.59921 0.181486 0.561331 0.148874 0.40743 
Skin 0.01 0.212242 1.422622 0.201326 1.383201 0.159349 0.979701 
Spleen 0.01333 0.145655 0.14614 0.140994 0.144295 0.123759 0.124722 
Stomach 0.12 0.14439 0.304578 0.139845 0.281032 0.123024 0.19607 
Thymus 0.01333 0.16302 0.59921 0.156644 0.561331 0.133677 0.40743 
Thyroid 0.04 0.19837 0.930345 0.188081 0.882138 0.152631 0.754903 
Uterus 0.01333 0.143655 0.276599 0.139204 0.255285 0.12266 0.177996 
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Table 10. Tissue doses ( TH  in units of cSv) and errors ( Tε  in units of %) in VCAF protected by various 
thicknesses of Aluminum exposed to the August 1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 90.08251 7.500921 63.10714 6.460531 16.13872 3.732861 
BFO 0.12 242.1857 7.500921 143.9125 6.460531 25.60895 3.732861 
Bladder 0.04 70.8384 2.633481 49.79629 2.817132 13.42552 2.190281 
Bone 0.01 407.5006 7.500921 229.2738 6.460531 36.27371 3.732861 
Brain 0.01 200.904 9.883536 134.3492 8.45244 29.03414 4.933166 
Breast 0.12 826.9308 7.980724 428.6347 5.25715 55.83973 2.340269 
Heart 0.01333 64.09584 13.42012 46.59067 11.94248 13.58885 7.281193 
Intestines 0.13333 152.9014 10.70866 102.4048 8.253269 22.72558 3.62458 
Kidneys 0.01333 87.7629 12.85576 62.12285 11.03251 16.23864 6.041343 
Liver 0.04 58.89951 9.284264 42.65793 8.293674 12.50208 4.84824 
Lungs 0.12 163.303 5.229509 110.3733 3.901589 24.58905 1.411373 
Muscle 0.01333 812.2219 7.500921 353.7194 6.460531 43.95657 3.732861 
Esophagus 0.04 636.3318 7.500921 334.5423 6.460531 46.2102 3.732861 
Ovaries 0.08 62.97325 2.620022 46.23178 2.328627 13.67081 1.390894 
Pancreas 0.01333 87.63355 13.01544 61.50911 11.98094 15.88355 7.882668 
Salivary Glands 0.01 1086.234 7.500921 482.5002 6.460531 56.46993 3.732861 
Skin 0.01 4808.764 9.33035 1339.934 7.790247 102.2423 5.588047 
Spleen 0.01333 72.84912 4.534058 52.36164 3.488616 14.5265 1.078752 
Stomach 0.12 71.30305 5.813468 50.93521 4.88489 14.06049 2.527756 
Thymus 0.01333 206.6582 7.500921 130.8396 6.460531 25.87427 3.732861 
Thyroid 0.04 1568.494 0.091858 682.7796 2.021948 71.75787 2.417568 
Uterus 0.01333 58.1069 5.112563 42.83031 4.462461 12.94462 2.436786 
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Table 11. Tissue doses ( TH  in units of cSv/day) and errors ( Tε  in units of %) in VCAM protected by 
various thicknesses of Aluminum exposed to the 1977 solar minimum GCR spectrum. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 0.144209 0.740173 0.13963 0.693826 0.122739 0.499321 
BFO 0.12 0.154962 0.740173 0.149264 0.693826 0.128739 0.499321 
Bladder 0.04 0.138296 0.714517 0.134263 0.667404 0.119268 0.485266 
Bone 0.01 0.168758 0.740173 0.161686 0.693826 0.136582 0.499321 
Brain 0.01 0.170141 0.843997 0.16324 0.780803 0.138244 0.555432 
Breast 0.12 0.186536 0.740173 0.177393 0.693826 0.145925 0.499321 
Heart 0.01333 0.142758 1.146804 0.138369 1.070833 0.122061 0.778989 
Intestines 0.13333 0.155707 0.300854 0.150062 0.268424 0.129508 0.16426 
Kidneys 0.01333 0.144349 0.743789 0.139763 0.689777 0.122833 0.491852 
Liver 0.04 0.137866 0.692661 0.1339 0.643486 0.1191 0.458796 
Lungs 0.12 0.161484 0.007846 0.15533 0.00412 0.132987 0.028361 
Muscle 0.01333 0.173211 0.740173 0.165319 0.693826 0.138765 0.499321 
Esophagus 0.04 0.179013 0.740173 0.170824 0.693826 0.142181 0.499321 
Pancreas 0.01333 0.143856 1.381705 0.139325 1.289928 0.122586 0.934189 
Prostate 0.01333 0.137585 0.740173 0.133537 0.693826 0.118619 0.499321 
Salivary Glands 0.01 0.187998 0.740173 0.178937 0.693826 0.14721 0.499321 
Skin 0.01 0.211727 2.172955 0.200851 2.10276 0.158907 1.494436 
Spleen 0.01333 0.140886 0.219416 0.136646 0.199772 0.120884 0.13162 
Stomach 0.12 0.140334 0.657457 0.13615 0.607024 0.120583 0.42361 
Testes 0.08 0.165659 0.305172 0.158613 0.289405 0.13407 0.213016 
Thymus 0.01333 0.164318 0.740173 0.15773 0.693826 0.13419 0.499321 
Thyroid 0.04 0.193996 0.43507 0.184107 0.405996 0.150079 0.33134 
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Table 12. Tissue doses ( TH  in units of cSv) and errors ( Tε  in units of %) in VCAM protected by various 
thicknesses of Aluminum exposed to the August 1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 Tissue Tw  
TH  Tε  TH  Tε  TH  Tε  
Adrenals 0.01333 79.69402 9.30282 56.30277 7.941633 14.84844 4.661721 
BFO 0.12 214.6112 9.30282 129.5632 7.941633 23.74173 4.661721 
Bladder 0.04 60.09813 6.640493 42.80729 6.214722 12.11152 4.074245 
Bone 0.01 359.8549 9.30282 204.8836 7.941633 33.51519 4.661721 
Brain 0.01 168.353 11.2411 114.3493 9.601927 25.90263 5.509579 
Breast 0.12 1080.917 9.30282 514.7048 7.941633 59.13779 4.661721 
Heart 0.01333 60.43199 11.95082 43.97222 10.71815 12.91444 6.659857 
Intestines 0.13333 134.5774 9.778067 90.57371 7.851398 20.67911 3.828275 
Kidneys 0.01333 76.06511 10.77816 54.25214 9.360399 14.66378 5.310855 
Liver 0.04 50.44275 9.702686 36.9836 8.568474 11.30283 4.943407 
Lungs 0.12 146.4818 7.196548 99.98841 5.605998 22.94397 2.221986 
Muscle 0.01333 741.7924 9.30282 334.0532 7.941633 42.09457 4.661721 
Esophagus 0.04 624.4971 9.30282 325.7814 7.941633 44.72931 4.661721 
Pancreas 0.01333 74.942 11.50947 53.31769 10.87178 14.39966 7.597537 
Prostate 0.01333 158.0366 9.30282 81.11972 7.941633 14.67722 4.661721 
Salivary Glands 0.01 1060.492 9.30282 470.3265 7.941633 54.86903 4.661721 
Skin 0.01 4938.289 13.03713 1369.943 11.16275 103.5588 8.249982 
Spleen 0.01333 58.37476 5.983289 42.59319 5.092792 12.55621 2.55187 
Stomach 0.12 56.83063 11.98137 41.45817 10.32724 12.28699 5.544734 
Testes 0.08 545.8215 10.95634 292.1713 6.75657 39.66848 2.78812 
Thymus 0.01333 290.0156 9.30282 170.1229 7.941633 29.2332 4.661721 
Thyroid 0.04 1401.954 0.181194 627.4691 1.109023 67.57739 1.321927 
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Table 13. Computed effective dose ( compE  in units of cSv) and effective dose error ( errorE  in units of cSv) 
in VCAM, VCAF, MAX, and FAX protected by various thicknesses of Aluminum exposed to the August 
1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Model Points 
compE  errorE  compE  errorE  compE  errorE   
VCAM 904 412.7445 35.65472 203.7957 14.46095 29.78305 1.204615 
VCAF 1278 360.0135 23.49756 182.5079 9.83182 28.65358 0.851838 
MAX 1144 223.7977 18.58547 118.0012 7.284768 21.27758 0.736365 
FAX 1195 272.7068 23.9954 146.036 9.574895 25.2135 0.784092 
 
 
Table 14. Computed effective dose ( compE  in units of cSv/day) and effective dose error ( errorE  in units of 
cSv/day) in VCAM, VCAF, MAX, and FAX protected by various thicknesses of Aluminum exposed to the 
1977 solar minimum GCR spectrum. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Model Points 
compE  errorE  compE  errorE  compE  errorE  
VCAM 904 0.160447 0.000897 0.154186 0.000804 0.131785 0.000493 
VCAF 1278 0.16188 0.000658 0.155546 0.000588 0.132799 0.000358 
MAX 1144 0.151003 0.000884 0.145708 0.000799 0.126460 0.000501 
FAX 1195 0.157137 0.000573 0.151247 0.000514 0.13004 0.000314 
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Table 15. Percent difference (%) between mass averaged tissue doses in MAX and VCAM. 
 
1977 solar min. GCR August 1972 SPE Tissue 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Adrenals 12.28591 11.49011 8.400436 111.6958 103.7894 68.9762 
BFO 1.235847 1.164262 0.857738 19.12711 11.37845 5.122548 
Bladder 3.211361 3.039629 2.341205 13.54578 13.15667 10.92024 
Bone 7.289488 6.827034 5.054986 32.21842 34.10025 29.14383 
Brain 0.054646 0.020826 0.07381 9.416427 8.104307 4.337377 
Breast 16.88593 15.67669 11.262 141.4281 125.0737 85.44876 
Heart 3.351447 3.120331 2.233483 35.11178 31.81302 20.23511 
Kidneys 6.615758 6.216156 4.63214 45.49528 42.46233 30.00375 
Liver 0.582922 0.510271 0.263297 22.2517 19.3853 10.179 
Lungs 2.789097 2.627914 1.980514 10.99811 11.4581 10.23345 
Muscle 2.726451 2.337073 1.674993 81.05138 55.22728 24.88419 
Esophagus 22.72709 21.18007 15.39231 165.0631 152.7945 110.6852 
Pancreas 11.96362 11.20008 8.226391 106.1365 98.57343 65.52592 
Prostate 5.042418 4.666169 3.312294 130.7574 105.5076 50.45416 
Salivary Glands 5.062256 4.813085 3.690956 17.6518 14.0339 12.16957 
Skin 1.550744 1.474233 1.020523 6.198518 5.888071 4.981173 
Spleen 0.567639 0.494945 0.259416 24.80466 21.39539 10.92964 
Stomach 0.129607 0.082228 0.058068 20.40776 17.20678 8.111576 
Testes 5.095594 4.800817 3.616549 9.507182 11.53427 13.22436 
Thymus 10.80734 10.02943 7.182448 121.2018 106.9994 66.52784 
Thyroid 23.19813 21.65276 15.80826 159.2396 143.3406 103.1321 
 
 
Table 16. Percent difference (%) between mass averaged tissue doses in FAX and VCAF. 
 
1977 solar min. GCR August 1972 SPE Tissue 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Adrenals 9.112509 8.531568 6.277011 79.46316 73.27656 48.73532 
BFO 3.361736 3.146076 2.300901 33.73615 25.71709 15.71005 
Bladder 4.054142 3.817123 2.874754 27.0423 24.93111 17.55024 
Bone 5.172096 4.848654 3.610988 17.92385 20.63718 19.01505 
Brain 0.157541 0.121592 0.014886 9.486646 8.02396 4.232374 
Breast 1.679103 1.547962 1.098051 31.77143 23.47857 11.89232 
Heart 0.922793 0.880649 0.70102 1.484322 1.607209 1.924313 
Kidneys 5.161576 4.855483 3.643198 33.96413 31.71368 22.6005 
Liver 3.409928 3.149589 2.187802 48.4532 42.73479 25.2019 
Lungs 4.042005 3.757295 2.70969 40.82908 35.57785 22.15696 
Muscle 0.872501 0.808422 0.44646 68.78324 41.83515 15.72856 
Esophagus 20.8428 19.4243 14.14191 176.1753 166.803 128.7908 
Ovaries 7.561012 7.119593 5.337324 18.7164 16.11512 9.062699 
Pancreas 9.056414 8.476766 6.233195 81.46134 74.92206 49.29277 
Salivary Glands 4.053718 3.868178 2.986703 17.89168 12.77548 9.736355 
Skin 1.335711 1.273835 0.847979 7.118843 6.49054 5.028731 
Spleen 1.501802 1.371441 0.906513 26.80209 23.49713 13.45035 
Stomach 0.048492 0.074396 0.155375 7.221334 6.619354 3.816789 
Thymus 1.543631 1.448789 1.069972 3.145077 4.849397 5.584375 
Thyroid 14.43725 13.50278 9.892943 123.3142 102.9931 67.34699 
Uterus 8.632571 8.116614 6.058621 60.40861 56.55488 39.38553 
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Upper arm bones 0.023 




Upper leg bones 0.067 
 
 








Head and Neck 0.038592 0.014214 
Upper Torso 0.104058 0.196370 
Mid Torso 0.087828 0.122788 
Lower Torso 0.214296 0.204651 
Upper Legs 0.301527 0.232155 
Lower Legs 0.121689 0.140482 
Left Arm 0.069350 0.054665 
Right Arm 0.062660 0.034674 
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Table 19. BFO doses (cSv/day) in FAX protected by various thicknesses of Aluminum exposed to the 1977 
solar minimum GCR spectrum. 
 
BFO Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Left Arm 20 0.0115 0.173374 0.165947 0.139493 
Left Leg 22 0.0335 0.150736 0.145585 0.126657 
Mandible 14 0.042 0.177783 0.169772 0.14166 
Pelvis 27 0.175 0.137154 0.133198 0.118484 
Ribs 23 0.228 0.169537 0.162393 0.137068 
Right Arm 20 0.0115 0.173699 0.166241 0.139686 
Right Leg 22 0.0335 0.150574 0.145439 0.126564 
Skull 19 0.042 0.198934 0.188633 0.153183 
Spine 24 0.422 0.142277 0.137866 0.121566 
Average   0.163785 0.157231 0.133818 
Weighted Avg.   0.152604 0.147137 0.127364 
 
 
Table 20. BFO doses (cSv) in FAX protected by various thicknesses of Aluminum exposed to the August 
1972 King SPE spectrum. 
 
BFO Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Left Arm 20 0.0115 283.9716 178.06 33.20581 
Left Leg 22 0.0335 90.99732 64.65514 16.98474 
Mandible 14 0.042 546.2884 293.9371 42.09913 
Pelvis 27 0.175 56.48458 40.79156 11.82719 
Ribs 23 0.228 372.797 212.3238 34.15437 
Right Arm 20 0.0115 287.8256 179.9867 33.41457 
Right Leg 22 0.0335 90.3248 64.20605 16.89988 
Skull 19 0.042 1258.331 589.699 67.10554 
Spine 24 0.422 77.19295 53.79457 14.08455 
Average   340.4682 186.3838 29.97509 
Weighted Avg.   215.9019 123.7968 22.2885 
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Table 21. Muscle doses (cSv/day) in FAX protected by various thicknesses of Aluminum exposed to the 
1977 solar minimum GCR spectrum. 
 
Muscle Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Head and Neck 10 0.014241 0.179651 0.171411 0.142597 
Left Arm 13 0.054665 0.189767 0.180497 0.148278 
Lower Legs 26 0.140482 0.193546 0.18415 0.151117 
Lower Torso 10 0.204651 0.149495 0.144334 0.12557 
Mid Torso 9 0.122788 0.162436 0.155903 0.132733 
Right Arm 13 0.034674 0.190071 0.180761 0.148429 
Upper Legs 24 0.232155 0.160722 0.15458 0.132357 
Upper Torso 10 0.19637 0.171056 0.163832 0.138127 
Average   0.174593 0.166933 0.139901 
Weighted Avg.   0.168155 0.161185 0.13636 
 
 
Table 22. Muscle doses (cSv) in FAX protected by various thicknesses of Aluminum exposed to the August 
1972 King SPE spectrum. 
 
Muscle Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Head and Neck 10 0.014241 517.3076 292.5508 43.59989 
Left Arm 13 0.054665 635.2365 353.3013 51.34395 
Lower Legs 26 0.140482 442.8185 270.9234 46.30972 
Lower Torso 10 0.204651 135.7951 89.77725 19.54899 
Mid Torso 9 0.122788 325.1653 189.9399 31.18337 
Right Arm 13 0.034674 647.0215 359.1617 51.80875 
Upper Legs 24 0.232155 166.1254 110.3334 23.81901 
Upper Torso 10 0.19637 302.666 184.7264 32.76161 
Average   396.517 231.3393 37.54691 
Weighted Avg.   292.4534 177.5774 31.52248 
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Table 23. BFO doses (cSv/day) in MAX protected by various thicknesses of Aluminum exposed to the 
1977 solar minimum GCR spectrum. 
 
BFO Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Left Arm 21 0.0115 0.161014 0.15483 0.132462 
Left Leg 22 0.0335 0.151738 0.146495 0.127235 
Mandible 10 0.042 0.176932 0.168954 0.141005 
Pelvis 25 0.175 0.129808 0.126496 0.114037 
Ribs 22 0.228 0.154524 0.148862 0.128458 
Right Arm 21 0.0115 0.159849 0.153773 0.131777 
Right Leg 21 0.0335 0.149999 0.144927 0.126245 
Skull 26 0.042 0.190985 0.181559 0.148889 
Spine 25 0.422 0.137156 0.133214 0.118526 
Average   0.156889 0.151012 0.129848 
Weighted Avg.   0.145078 0.140327 0.122969 
 
 
Table 24. BFO doses (cSv) in MAX protected by various thicknesses of Aluminum exposed to the August 
1972 King SPE spectrum. 
 
BFO Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Left Arm 21 0.0115 161.1005 108.4844 23.97357 
Left Leg 22 0.0335 92.21236 65.65507 17.29918 
Mandible 10 0.042 629.4114 322.1284 43.64194 
Pelvis 25 0.175 33.99325 25.70251 8.809441 
Ribs 22 0.228 196.5614 122.318 23.3944 
Right Arm 21 0.0115 155.9451 105.1774 23.38416 
Right Leg 21 0.0335 83.8085 60.09838 16.2853 
Skull 26 0.042 932.7517 458.0146 56.57986 
Spine 25 0.422 54.22514 39.17484 11.54107 
Average   260.001 145.1948 24.98988 
Weighted Avg.   148.8014 88.35409 17.62492 
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Table 25. Muscle doses (cSv/day) in MAX protected by various thicknesses of Aluminum exposed to the 
1977 solar minimum GCR spectrum. 
 
Muscle Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Head and Neck 12 0.038592 0.168483 0.161483 0.136567 
Left Arm 11 0.06935 0.182158 0.173713 0.144097 
Lower Legs 22 0.121689 0.197087 0.187291 0.153016 
Lower Torso 10 0.214296 0.14554 0.140772 0.123301 
Mid Torso 11 0.087828 0.149352 0.144074 0.125124 
Right Arm 11 0.06266 0.182065 0.173629 0.14405 
Upper Legs 20 0.301527 0.168089 0.161144 0.136366 
Upper Torso 11 0.104058 0.155645 0.149895 0.129156 
Average   0.168552 0.1615 0.13646 
Weighted Avg.   0.165712 0.158958 0.13488 
 
 
Table 26. Muscle doses (cSv) in MAX protected by various thicknesses of Aluminum exposed to the 
August 1972 King SPE spectrum. 
 
Muscle Segment Points Weight 0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Head and Neck 12 0.038592 314.3328 186.3992 31.96685 
Left Arm 11 0.06935 441.6388 263.4978 42.98172 
Lower Legs 22 0.121689 523.5933 311.2327 50.28734 
Lower Torso 10 0.214296 103.5952 70.22006 16.66036 
Mid Torso 11 0.087828 214.5244 129.0625 22.96425 
Right Arm 11 0.06266 453.5755 267.9762 43.15708 
Upper Legs 20 0.301527 278.9247 170.904 30.84224 
Upper Torso 11 0.104058 181.3897 116.589 23.37029 
Average   313.9468 189.4852 32.77876 
Weighted Avg.   278.9146 170.1794 30.35687 
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Table 27. Computed effective dose ( compE  in units of cSv) and effective dose error ( errorE  in units of cSv) 
using segmented muscle and BFO in FAX and MAX protected by various thicknesses of Aluminum 
exposed to the August 1972 King SPE. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Model Points 
compE  errorE  compE  errorE  compE  errorE  
FAX 1195 253.3713 22.97392 137.8087 9.148496 24.21078 0.755288 
MAX 1144 209.9866 17.66649 110.9229 6.880713 20.36149 0.705413 
 
 
Table 28. Computed effective dose ( compE  in units of cSv/day) and effective dose error ( errorE  in units of 
cSv/day) using segmented muscle and BFO in FAX and MAX protected by various thicknesses of 
Aluminum exposed to the 1977 solar minimum GCR spectrum. 
 
0.4 g/cm2 2.0 g/cm2 10.0 g/cm2 
Model Points 
compE  errorE  compE  errorE  compE  errorE  
FAX 1195 0.15571 0.000567 0.149959 0.000509 0.129182 0.000311 
MAX 1144 0.149548 0.000876 0.144392 0.000792 0.125613 0.000498 
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9. Appendix A – Target Point Locations in VCAM 
 
 
Table A1. Target points in the VCAM adrenals. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.060 5.940 59.580 -3.060 5.940 58.860 
-3.060 5.940 58.140 -3.060 -6.300 56.700 
-3.060 -6.300 55.980 -3.060 -6.300 55.260 
 
 
Table A2. Target points in the VCAM BFO. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.994 -1.988 16.620 0.138 0.055 1.353 
8.338 -0.083 6.737 8.089 1.518 9.304 
-5.108 -5.660 11.209 5.494 2.512 16.869 
-0.055 1.684 29.127 6.930 0.110 35.781 
7.013 0.000 35.532 6.985 0.000 35.670 
7.068 -0.193 35.477 -5.825 3.948 35.808 
-0.911 0.690 35.256 -2.153 -0.248 34.980 
8.807 0.911 40.640 8.890 2.982 42.352 
8.780 0.939 40.557 9.304 -3.451 50.883 
6.737 -7.703 60.905 -8.255 2.595 40.695 
-8.034 -2.512 40.530 -9.249 3.009 48.260 
-9.415 2.927 48.260 -9.359 -3.285 48.398 
-3.865 0.028 44.119 -6.240 1.215 44.450 
-3.755 -0.193 50.717 -5.218 2.098 51.656 
-5.328 -0.028 55.328 -5.025 -0.110 55.797 
-5.218 -0.801 55.852 -7.620 0.000 55.825 
-2.761 -1.877 66.040 -1.298 0.911 64.383 
-3.865 0.138 68.635 -2.288 0.850 70.761 
-2.203 0.464 72.086 -4.874 0.000 79.485 
-5.680 0.375 76.890 -7.707 -0.446 82.053 
-0.522 -12.136 76.200 -6.636 7.395 77.691 
-6.627 -7.265 79.513 -7.383 -3.871 81.308 
-1.830 -7.696 82.909 -2.125 -6.884 85.973 
-0.842 5.164 89.342 -0.597 -4.544 91.247 
0.705 -4.567 91.385 -5.025 -0.110 55.797 
 
 
Table A3. Target points in the VCAM bladder. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.551 4.997 86.675 -1.123 -1.260 86.401 
3.388 4.193 86.591 -3.578 -1.864 86.803 
5.231 0.456 86.580 2.256 -4.902 86.580 
2.372 1.536 86.401 -0.974 -4.860 86.601 
-0.708 2.085 86.401 1.134 2.826 89.820 
-3.515 2.203 86.622 3.060 -0.127 89.799 
4.563 -2.637 86.622 0.222 -2.805 89.852 
1.620 -1.536 86.401 -1.249 0.551 90.169 
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Table A4. Target points in the VCAM bone. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.001 -0.361 1.515 -1.799 20.626 65.182 
-8.281 -0.033 7.698 -2.043 0.106 70.212 
-4.913 -5.199 10.938 -3.727 4.140 78.957 
7.698 0.033 16.073 -9.911 0.635 79.932 
0.359 0.033 27.942 -8.597 -0.540 76.298 
-2.711 0.085 27.942 -6.268 7.561 79.454 
-0.666 -14.772 33.492 -4.266 9.361 81.414 
7.559 0.106 35.841 3.759 6.555 85.892 
6.681 -0.001 35.534 5.378 8.323 88.729 
6.713 -8.365 42.479 2.816 -9.043 83.319 
8.534 0.911 40.319 5.378 -8.344 88.898 
8.809 0.879 40.723 0.721 -19.833 81.275 
9.721 -1.959 50.273 -0.085 -19.441 93.071 
0.540 3.452 24.883 3.578 9.900 119.763 
-7.559 2.955 39.927 3.769 -9.774 119.329 
-7.919 -2.456 40.616 -7.401 -3.452 7.020 
-9.687 3.536 48.643 3.769 -9.666 119.382 
-9.414 -3.367 48.283 3.822 -9.645 119.382 
0.687 19.102 36.138 4.319 -9.656 118.885 
1.079 17.449 39.812 3.081 -8.841 118.801 
1.186 19.323 39.504 7.317 -6.576 129.599 
1.271 19.439 39.622 4.776 5.940 139.871 
1.715 19.439 39.144 4.828 5.580 139.723 
1.239 19.439 39.643 1.959 -8.641 135.921 
1.239 19.302 39.622 7.178 -7.624 60.765 
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Table A5. Target points in the VCAM brain. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.076 3.679 5.771 2.027 2.156 4.262 
0.004 2.200 4.414 -2.005 1.098 5.566 
-2.506 1.973 4.068 -4.363 1.688 5.224 
5.184 0.011 5.314 3.434 0.018 3.992 
1.285 0.396 3.359 -0.720 0.608 3.355 
-3.982 -0.245 4.360 3.575 -1.800 4.781 
1.573 -1.490 4.014 -0.356 -1.649 3.953 
-2.236 -0.338 3.787 1.372 -3.229 5.004 
-0.792 -3.406 5.368 -2.545 -2.344 4.439 
3.301 3.182 6.228 -0.061 4.356 7.394 
-1.300 3.539 5.371 5.263 1.926 6.649 
3.726 1.782 4.975 1.469 1.750 6.516 
-0.612 2.124 6.808 -3.352 3.254 6.124 
-5.227 2.063 7.182 5.994 -0.439 7.423 
3.517 0.202 6.552 1.800 0.112 5.530 
-0.115 0.094 5.443 -0.983 0.166 7.585 
-3.568 -0.097 6.667 -5.724 0.173 6.008 
4.806 -1.901 6.451 2.182 -1.649 6.462 
0.101 -1.768 6.347 -2.048 -1.228 5.990 
-4.403 -2.023 5.630 -5.771 -1.508 6.980 
3.287 -3.398 6.480 1.235 -3.935 6.883 
-0.871 -4.140 7.358 -2.822 -3.499 6.422 
0.248 4.248 9.371 -2.048 3.913 7.585 
3.240 1.685 7.999 1.987 1.199 8.852 
0.338 2.272 8.593 -2.959 1.688 7.409 
5.303 0.875 8.204 3.582 -0.688 8.222 
1.033 -0.166 7.830 -2.390 -0.108 8.849 
-4.759 0.162 8.395 -6.703 0.137 8.172 
4.910 -2.531 8.291 2.545 -2.156 8.406 
-3.632 -1.786 8.042 -4.590 -3.334 7.762 
0.616 -2.560 8.334 -1.570 -2.228 7.834 
2.120 3.744 7.848 2.362 3.456 9.810 
-1.746 2.243 9.018 -3.982 1.620 9.428 
-3.996 3.546 8.622 -6.170 2.070 9.101 
-0.371 0.572 9.850 -4.176 -0.752 10.256 
-0.482 -1.483 9.464 -2.570 -2.185 9.968 
-5.890 -1.843 9.180 -6.404 -0.162 10.307 
1.386 -3.146 10.422 -2.740 -4.064 8.824 
-4.590 -3.164 10.109 0.648 -4.748 9.050 
0.756 2.599 11.005 -0.972 2.812 10.876 
-3.060 3.571 10.861 -4.979 3.190 10.685 
-0.450 0.756 11.963 -2.826 1.192 10.811 
-4.046 2.308 12.481 0.310 -1.256 11.376 
-2.131 -0.533 11.218 -5.533 1.310 11.066 
-5.468 -2.048 11.585 -1.127 -2.527 11.588 
-3.078 -3.805 11.268 -2.066 1.778 12.496 
-1.498 -0.706 13.133 -3.359 0.137 13.414 
-4.511 -0.007 12.175 -3.514 -2.088 12.402 
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Table A6. Target points in the VCAM breast. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
5.940 6.660 33.300 5.940 -7.020 33.300 
6.300 3.780 33.300 6.300 -4.500 33.300 
6.660 4.860 34.020 6.660 -5.940 34.020 
6.660 6.660 34.740 6.660 -7.020 34.740 
7.020 3.780 34.740 7.020 -4.500 34.740 
 
 
Table A7. Target points in the VCAM esophagus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.700 0.180 30.780 2.700 0.180 30.060 
2.700 0.180 29.340 3.060 0.180 28.620 
3.060 0.180 27.900 3.060 0.180 27.180 
3.060 0.180 26.460 3.060 0.180 25.740 
3.060 0.180 25.020 3.060 0.180 24.300 
3.060 0.180 23.580    
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Table A8. Target points in the VCAM heart. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.369 2.444 35.302 4.388 2.437 40.518 
3.874 -1.534 40.885 2.452 1.289 41.760 
5.018 0.925 41.191 0.302 0.216 41.764 
5.180 -0.896 41.400 4.957 2.826 42.865 
3.298 3.341 42.224 1.454 2.668 42.451 
0.047 1.436 42.854 6.138 0.886 43.265 
4.140 1.004 42.952 1.919 -0.569 42.955 
5.886 -0.504 44.064 5.281 -1.602 43.168 
3.359 -0.810 43.052 0.310 -1.699 42.815 
4.709 -2.822 43.924 3.377 -2.801 42.167 
1.915 -2.966 43.517 4.406 3.838 46.696 
3.067 3.942 44.291 1.289 3.438 43.974 
5.728 2.099 45.014 4.730 3.352 45.058 
3.136 1.696 44.287 0.655 2.545 45.004 
-0.720 1.577 45.328 4.241 0.108 45.122 
1.735 0.738 44.305 0.976 0.734 46.480 
-0.313 0.086 44.284 5.540 -2.117 45.896 
3.463 -1.393 45.220 1.868 -1.336 45.202 
-0.007 -1.328 44.777 3.416 -3.532 44.708 
0.911 -3.096 45.238 2.189 4.255 46.217 
6.574 0.878 46.012 2.725 2.358 46.170 
0.522 3.344 46.706 -0.824 0.342 46.793 
4.522 1.217 46.598 2.650 0.396 46.634 
-0.821 -0.284 48.496 6.383 -0.734 46.112 
4.363 -0.932 47.588 3.143 -2.102 47.509 
1.415 -1.357 47.092 -0.547 -1.501 46.544 
4.788 -3.355 46.512 2.632 -3.740 46.328 
0.652 -3.254 47.362 5.814 2.804 47.563 
4.792 3.794 49.050 3.002 4.252 48.211 
6.865 1.210 48.038 4.223 1.796 48.398 
2.477 2.444 48.164 -0.583 2.059 48.060 
-0.576 2.005 50.126 5.814 0.126 48.352 
3.143 0.101 48.632 1.102 1.361 48.406 
6.764 -1.415 48.182 5.580 -2.502 48.564 
3.517 -1.933 49.990 1.285 -0.882 48.618 
-0.238 -2.264 48.906 4.180 -3.712 48.377 
1.948 -3.582 48.546 4.777 3.467 50.504 
2.617 4.406 50.346 0.929 3.920 48.629 
6.473 1.973 50.054 4.892 1.292 50.134 
2.668 2.495 50.213 0.706 3.100 50.263 
2.790 0.623 50.314 1.051 0.428 50.378 
-0.760 0.130 50.137 6.800 -0.392 50.180 
4.741 -0.727 50.242 -0.032 -1.966 50.540 
5.717 -2.650 50.407 3.744 -3.971 50.166 
2.084 -1.750 50.152 1.487 -3.748 50.256 
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Table A9. Target points in the VCAM intestine. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.626 -1.080 65.776 5.573 -1.066 67.291 
5.321 -3.323 66.017 4.450 -5.886 66.283 
5.900 1.105 68.980 1.667 1.879 67.986 
5.731 -2.117 69.635 2.383 -3.172 68.083 
5.648 -4.536 68.929 2.074 -5.609 66.276 
2.221 -8.618 66.395 4.288 -7.610 68.501 
0.943 -9.688 68.681 -0.338 9.626 71.215 
4.748 6.628 69.728 2.894 5.407 72.313 
5.299 3.244 70.268 2.902 3.067 69.408 
3.175 0.241 70.906 2.567 -0.994 69.192 
3.046 -5.249 69.768 0.760 -6.556 68.947 
-0.670 -4.435 69.466 3.100 -9.004 70.178 
1.328 -6.858 71.802 -2.347 -7.380 70.798 
-0.511 -9.518 70.974 1.735 11.135 71.366 
4.334 8.748 72.137 2.794 9.065 69.397 
-0.230 6.246 73.228 1.894 3.524 71.993 
3.640 1.955 73.285 3.395 -3.517 71.564 
2.333 -4.889 73.516 -0.666 -5.213 72.295 
-3.830 -4.824 72.252 1.418 7.304 71.161 
-3.946 4.741 72.767 6.181 -1.094 71.917 
3.625 -1.325 73.163 4.720 -2.995 75.074 
0.770 -6.833 75.370 1.609 8.942 77.537 
0.338 7.589 75.928 2.282 5.602 75.661 
4.565 3.510 74.984 2.693 2.135 76.921 
2.880 -0.634 76.126 4.478 -4.766 78.066 
2.142 -4.194 77.069 0.198 -5.843 78.858 
2.902 -7.330 76.982 1.930 -8.730 78.455 
-2.135 -8.161 76.633 -0.295 9.302 79.340 
2.855 7.265 78.746 -2.016 8.053 79.394 
-3.683 7.020 78.415 3.931 4.993 78.332 
-0.205 5.792 78.437 0.983 3.902 78.782 
5.069 2.844 78.430 3.589 2.218 81.000 
1.588 1.688 79.873 5.170 0.155 78.595 
1.998 -0.774 78.620 5.033 -2.365 78.239 
3.622 -2.930 81.155 -1.642 -2.966 80.813 
3.593 -5.976 80.017 1.289 -2.977 79.376 
-0.202 -9.173 78.048 -3.272 -7.218 78.869 
-1.318 -8.701 80.194 4.183 5.540 81.133 
1.566 4.993 81.389 2.952 2.192 83.560 
0.500 2.966 83.174 -1.454 2.891 81.230 
4.493 -0.479 81.191 1.076 -0.716 81.896 
-2.812 -0.778 83.189 3.370 -3.064 83.970 
1.231 -4.532 81.864 -0.076 -2.776 83.682 
-0.684 0.706 83.902 -6.235 0.727 84.323 
-3.931 1.393 83.254 2.408 -0.346 83.963 
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Table A10. Target points in the VCAM kidneys. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.074 -6.343 59.976 -3.604 -5.216 61.700 
-2.945 -7.531 62.791 -2.581 -4.982 63.724 
-3.002 6.538 63.335 -2.696 4.864 64.656 
-2.232 -6.340 65.401 -1.462 7.625 66.175 
-3.413 6.970 66.017 -3.013 5.353 67.540 
-1.044 5.112 66.449 -1.872 6.556 68.450 
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Table A11. Target points in the VCAM liver. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.678 -0.644 51.080 -0.637 -9.547 55.181 
3.308 8.143 54.047 -0.385 6.862 53.654 
-1.681 6.649 55.228 5.551 4.162 54.007 
2.822 4.010 53.978 0.821 5.069 54.306 
-1.714 4.741 53.593 6.703 2.102 54.702 
4.291 2.336 54.259 2.020 1.404 53.975 
0.198 2.981 54.007 5.864 0.403 54.007 
3.769 -0.335 54.151 -0.583 0.572 54.122 
5.774 -2.333 53.737 1.170 -1.084 54.036 
3.190 -2.236 54.122 -0.536 -2.632 53.777 
-2.459 -3.953 53.802 4.180 7.808 55.714 
2.149 9.176 56.124 1.105 8.194 54.288 
-0.277 8.683 56.016 5.584 6.397 55.541 
2.646 6.142 55.026 0.929 6.926 56.074 
-1.181 6.408 56.981 6.476 4.363 55.724 
4.014 4.856 55.937 2.344 3.139 55.742 
-0.630 4.529 55.944 -2.952 4.406 55.865 
7.024 2.560 57.240 0.299 2.376 55.919 
-1.645 3.067 57.341 7.070 -0.734 54.922 
4.032 0.904 55.861 1.534 0.486 55.642 
6.912 -3.323 55.404 5.144 -1.332 55.980 
2.581 -1.141 56.290 2.102 8.741 58.378 
0.418 9.677 57.978 -1.609 8.395 57.758 
5.152 6.347 57.787 4.111 8.482 57.406 
2.804 6.505 57.600 0.482 7.034 58.324 
-2.873 5.706 57.589 5.868 4.579 57.888 
3.334 4.100 57.946 1.238 4.874 56.844 
-0.781 4.878 58.651 -3.478 3.906 58.561 
4.939 2.686 56.606 2.678 1.922 57.445 
0.695 2.984 58.018 6.822 0.670 56.574 
4.954 0.227 57.625 1.152 0.317 57.762 
-0.785 0.914 56.693 7.034 -1.638 57.355 
3.110 -0.061 58.514 -0.428 -1.382 55.735 
2.228 8.820 60.455 -0.353 8.755 59.864 
4.108 7.528 59.587 1.894 6.818 60.088 
6.149 3.665 59.602 3.874 5.159 59.688 
1.606 4.734 59.188 6.581 1.685 59.062 
4.360 2.416 59.033 0.655 3.791 60.725 
-1.494 3.265 59.814 6.962 -0.328 58.914 
2.002 1.984 59.821 -0.256 1.609 59.324 
6.646 -1.274 60.638 -0.374 -0.911 58.032 
0.328 8.554 61.607 3.888 6.948 61.765 
2.531 7.852 62.568 5.569 5.695 60.340 
2.174 5.206 61.798 -0.169 6.080 60.566 
3.305 3.697 60.916 -0.144 2.383 61.859 
6.613 1.303 61.067 0.346 0.464 61.589 
4.748 0.061 59.864 2.808 6.138 64.415 
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Table A12. Target points in the VCAM lungs. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.714 -7.283 44.114 -0.306 7.816 44.924 
-3.262 7.326 48.654 0.554 -8.737 47.866 
-4.090 -6.242 49.342    
 
 
Table A13. Target points in the VCAM muscle. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-7.624 -0.033 14.220 1.260 -20.700 100.260 
-1.302 2.542 20.955 0.022 11.637 92.214 
2.711 -2.456 27.942 -8.100 0.540 3.357 
2.626 7.538 30.675 -4.193 6.353 97.932 
8.313 -2.487 35.841 -5.982 8.428 122.772 
-2.847 -16.593 38.043 2.256 7.614 119.351 
8.978 3.812 40.679 2.085 7.391 119.214 
-10.165 -10.271 48.262 4.045 9.233 101.763 
-0.254 13.416 50.633 0.022 -2.308 101.605 
10.218 5.104 62.226 -0.001 -9.285 92.182 
10.134 -5.052 62.226 -7.603 -7.146 94.755 
9.414 -0.033 67.860 0.275 -6.237 99.498 
2.595 18.551 40.637 2.256 -7.359 119.159 
0.169 -21.144 38.096 -6.776 -9.614 116.978 
2.456 -18.498 40.637 1.599 -7.751 119.298 
4.944 -21.144 55.662 -3.588 -9.466 124.041 
-7.666 -12.197 79.517 3.822 -9.414 101.795 
8.767 0.372 79.041 -5.580 6.660 129.420 
-10.462 -9.361 85.342 -1.302 6.458 154.715 
-2.584 4.713 88.932 -1.715 3.504 157.944 
-1.683 -4.447 89.292 4.172 3.759 162.306 
-6.014 -6.978 92.595 0.805 -3.675 137.106 
-7.624 7.233 82.799 -4.087 -7.146 137.106 
0.900 16.740 91.620 12.622 -8.725 174.239 
3.294 -19.757 76.287 0.022 15.121 89.292 
 
 
Table A14. Target points in the VCAM pancreas. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.642 -6.055 58.500 3.600 -1.523 61.484 
5.533 1.876 63.302 4.892 -0.295 63.166 
4.831 -1.066 62.435 4.525 3.319 64.379 
5.321 3.632 64.379 5.418 2.646 63.497 
4.774 2.524 64.098 6.091 1.238 63.828 
5.526 2.264 64.721 5.591 0.554 63.288 
5.940 1.750 63.637 4.867 2.153 64.523 
5.641 0.162 63.331 4.882 1.184 64.235 
5.454 2.819 63.112 5.530 3.604 64.451 
4.849 3.463 64.199 6.199 3.492 64.256 
6.210 2.534 64.159 6.336 3.028 64.184 
5.911 2.189 64.541 5.818 0.986 64.091 
4.687 1.498 64.476 4.777 0.810 64.127 
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Table A15. Target points in the VCAM prostate. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.620 0.180 91.260 -1.260 0.180 91.260 
0.540 1.260 91.260 0.540 -1.260 91.260 
0.900 -0.180 91.620 1.620 0.180 91.980 
-1.260 0.180 91.980 0.540 1.260 91.980 
0.540 -1.260 91.980    
 
 
Table A16. Target points in the VCAM salivary glands. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.980 5.940 14.580 1.980 -5.940 14.580 
4.140 5.580 18.180 4.140 -5.580 18.180 
6.660 3.420 21.420 6.660 -3.420 21.420 
4.860 4.140 20.700 4.860 -4.140 20.700 
5.940 1.260 19.620 4.860 1.260 19.620 
5.940 -1.260 19.620 4.500 -1.260 19.620 
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Table A17. Target points in the VCAM skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
6.470 2.150 2.170 -2.510 5.030 1.810 
-1.620 9.350 10.980 8.630 -5.030 8.290 
1.070 -4.670 1.450 -7.550 -3.950 4.690 
6.470 6.110 9.540 12.230 0.710 14.410 
-0.180 -8.630 10.260 -6.830 -5.390 14.750 
1.070 11.510 29.530 -8.990 3.590 7.930 
6.830 -0.900 26.100 -8.630 1.790 16.910 
8.990 -3.590 18.540 -3.230 -3.230 24.660 
5.390 16.910 34.930 -2.870 6.470 16.910 
-6.110 11.700 33.490 5.750 5.390 20.150 
-2.150 4.310 24.300 1.980 -6.470 18.710 
-6.830 -10.790 34.210 -1.430 -21.230 34.930 
-2.510 18.710 33.130 5.750 6.470 30.970 
8.270 -3.590 34.930 -5.750 5.030 31.330 
4.670 -8.990 30.610 -10.790 -5.410 41.050 
3.950 -16.550 32.770 -2.510 -11.510 29.890 
6.830 20.870 44.460 -1.790 22.670 38.340 
-3.230 16.380 44.100 8.270 11.510 39.250 
-10.070 5.220 39.970 11.510 -4.310 43.930 
-7.190 -2.340 34.210 8.270 -11.510 39.250 
-4.310 -20.150 49.860 -2.510 22.670 48.780 
-8.990 13.670 47.700 7.190 11.870 46.810 
6.110 19.790 54.900 -8.990 13.670 39.970 
9.350 3.590 37.810 11.870 4.670 46.090 
7.190 -20.510 39.970 -6.470 -17.990 37.980 
-1.070 -23.030 43.380 8.990 11.150 54.180 
-1.790 23.030 58.860 -11.150 6.830 52.910 
12.590 -5.030 52.020 -11.510 3.610 46.090 
7.910 -11.150 48.230 3.230 -15.300 45.540 
-9.350 3.060 59.940 6.830 -20.150 48.230 
-8.630 -14.030 43.740 0.540 -23.390 53.460 
0.180 14.770 52.020 7.550 10.430 61.550 
12.590 4.140 55.260 -7.190 14.030 55.980 
11.510 -5.390 60.110 8.630 -9.350 66.250 
-11.150 -3.610 52.190 0.900 -13.670 56.340 
-11.510 -8.990 48.230 6.110 -18.370 55.790 
-3.950 -20.870 60.110 1.790 14.030 61.740 
-8.270 10.790 61.910 7.550 -11.870 56.510 
-8.990 -6.660 70.020 2.870 -22.310 63.180 
-7.910 -13.310 54.540 -3.230 -21.590 68.580 
-5.390 12.590 68.220 11.870 2.510 75.060 
-8.990 4.500 69.300 11.510 2.340 64.620 
-7.910 -12.590 77.410 4.670 -20.510 71.460 
-5.390 -12.590 65.890 3.950 13.670 79.380 
3.950 21.230 68.770 -3.590 19.980 67.140 
-0.710 9.710 156.590 4.670 10.790 137.510 
-5.030 -3.250 142.380 2.510 10.430 146.870 
-5.030 7.910 151.190 -3.950 2.170 148.670 
1.430 -10.790 145.980 -5.390 7.550 140.220 
3.950 3.970 154.430 -1.070 -10.070 154.790 
7.550 2.170 167.050 -2.870 3.250 162.900 
3.950 -8.270 160.570 -2.870 -3.250 162.540 
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Table A17 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-10.430 8.460 77.580 9.350 8.630 77.220 
3.230 13.310 71.270 11.510 -4.310 70.570 
-8.990 -10.070 60.110 11.510 -1.980 81.540 
-2.340 -14.030 73.620 2.870 -13.310 64.620 
-3.230 -21.590 77.030 8.990 9.350 68.770 
-5.750 13.310 75.420 -4.310 15.830 83.170 
-11.870 1.070 76.330 10.070 -7.550 78.470 
-8.990 -3.250 62.820 3.230 -14.390 82.260 
-11.510 -7.190 78.850 3.950 -21.230 80.270 
1.070 22.670 88.740 -11.870 11.510 84.970 
3.950 21.230 80.270 10.790 3.590 86.390 
-2.510 22.310 76.140 -14.390 4.330 85.690 
5.750 -11.870 74.700 4.670 -2.530 92.340 
-1.430 -22.670 86.750 -5.750 -15.110 84.250 
-12.950 -11.150 86.940 -11.510 12.950 95.030 
8.270 8.990 84.950 7.550 10.260 94.500 
3.420 1.620 92.150 -5.580 1.090 92.340 
7.910 -10.790 86.410 -14.390 -3.610 86.580 
-12.590 -3.610 94.310 3.230 -16.190 90.900 
-7.190 -16.550 92.170 7.550 -11.340 95.580 
6.110 19.430 97.930 -3.590 22.310 97.380 
4.310 15.110 89.100 -6.470 16.190 90.370 
-14.030 6.490 93.950 -8.990 3.250 100.430 
9.710 -4.670 88.910 -1.620 -1.090 95.940 
9.350 -0.710 97.910 -3.780 -15.470 101.700 
-12.950 -10.070 96.110 -3.230 -23.030 98.820 
-8.630 -14.750 101.150 -2.150 21.060 105.830 
9.710 10.430 101.700 -3.420 16.550 99.540 
9.900 1.070 94.690 -8.990 10.790 103.670 
4.500 -1.810 99.900 -7.910 -2.530 101.150 
9.710 -10.430 101.700 -3.420 -14.750 109.260 
-2.150 -21.060 105.830 3.230 20.530 108.350 
3.420 16.550 106.380 7.910 13.670 110.870 
-4.140 2.170 102.420 -6.830 3.610 109.070 
8.990 -4.690 107.990 -5.750 -2.890 111.420 
6.110 -19.260 100.980 2.150 -23.030 95.050 
2.870 -21.230 108.710 -4.310 14.750 109.430 
8.630 4.690 116.100 -8.270 9.710 114.110 
1.620 -0.370 107.460 8.990 4.690 107.100 
-8.990 -9.180 106.740 7.910 -13.670 109.980 
4.310 -15.470 116.270 -7.910 -9.710 116.630 
0.370 15.110 117.540 7.550 12.590 119.870 
0.540 0.730 116.460 -6.470 4.330 119.700 
8.630 -4.690 115.380 6.830 -12.590 124.190 
-1.620 1.810 123.300 7.910 -3.970 122.750 
-4.310 -14.390 111.420 8.270 5.770 125.630 
1.980 -1.450 127.620 -6.110 -4.330 122.750 
-3.230 -13.310 122.030 4.670 13.310 128.150 
-4.670 12.230 123.110 6.110 3.250 133.550 
-4.670 3.970 129.590 7.550 -5.770 131.390 
5.750 -5.410 140.030 -5.390 -7.910 131.030 
-0.540 -13.310 129.060 -2.510 11.150 132.470 
4.310 2.890 143.460 -1.260 -1.810 135.540 
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Table A17 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
15.470 -1.090 171.370 -3.590 -8.270 171.710 
5.750 8.630 164.890 8.820 9.350 175.670 
7.910 -8.630 168.130 11.700 -9.710 175.670 
2.870 -2.170 174.950 21.950 -7.550 174.590 
20.150 8.990 173.530 -3.590 8.270 171.710 
-3.950 -9.710 140.410 3.950 -11.870 134.990 
4.670 -4.330 150.660 -5.390 -5.940 151.550 
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Table A18. Target points in the VCAM spleen. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.372 -4.709 56.977 -2.002 -5.623 56.754 
-1.746 -6.610 56.916 -2.581 -7.434 56.794 
-2.484 -3.924 57.524 -1.487 -4.406 57.730 
-1.210 -5.522 57.467 -1.022 -6.512 57.715 
-1.055 -7.553 58.093 -1.555 -7.499 57.337 
-2.146 -8.284 57.233 -1.526 -3.456 58.730 
-1.595 -8.446 58.093 -2.419 -9.047 57.895 
-3.380 -9.011 58.212 -2.394 -2.920 59.238 
-0.727 -7.697 59.112 -1.130 -8.492 58.849 
-1.976 -9.317 58.669 -2.916 -9.533 58.907 
-1.390 -3.265 59.846 -0.878 -8.446 59.926 
-1.476 -9.144 59.450 -2.174 -9.652 59.713 
-0.436 -7.351 60.026 -1.487 -9.238 60.538 
 
 
Table A19. Target points in the VCAM stomach. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.570 -6.923 55.728 4.082 -6.660 55.915 
4.943 -5.807 58.147 2.592 -8.327 58.028 
3.161 -7.225 60.520    
 
 
Table A20. Target points in the VCAM testes. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
6.235 1.350 96.649 5.191 1.382 97.092 
5.533 1.393 96.232 6.318 -1.368 97.474 
5.947 -1.404 96.736 5.335 -1.508 97.135 
6.246 1.476 97.596 5.530 1.408 98.082 
5.879 -2.146 97.999 5.213 -1.228 97.988 
6.268 -1.321 98.374 5.587 -1.307 98.752 
 
 
Table A21. Target points in the VCAM thymus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.620 0.180 32.940 2.700 0.900 32.220 
1.980 -0.900 32.220 2.700 -0.900 31.140 
1.980 10.980 31.140    
 
 
Table A22. Target points in the VCAM thyroid. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
5.177 1.940 27.680 5.620 1.192 28.292 
5.134 -1.969 28.372 5.173 2.110 29.153 
5.342 -1.598 29.840    
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10. Appendix B – Target Point Locations in VCAF 
 
 
Table B1. Target points in the VCAF adrenals. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.060 5.220 54.900 -3.060 5.220 54.180 
-3.060 5.220 53.460 -2.340 -5.580 52.020 
-2.340 -5.580 51.300 -2.340 -5.580 50.580 
 
 
Table B2. Target points in the VCAF BFO. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.914 -1.829 15.291 0.127 0.051 1.245 
7.671 -0.076 6.198 7.442 1.397 8.560 
-4.699 -5.207 10.312 5.055 2.311 15.519 
-0.051 1.549 26.797 6.375 0.102 32.918 
6.452 0.000 32.690 6.426 0.000 32.817 
6.502 -0.178 32.639 -5.359 3.632 32.944 
-0.838 0.635 32.436 -1.981 -0.229 32.182 
8.103 0.838 37.389 8.179 2.743 38.964 
8.077 0.864 37.313 8.560 -3.175 46.812 
6.198 -7.087 56.032 -7.595 2.388 37.440 
-7.391 -2.311 37.287 -8.509 2.769 44.399 
-8.661 2.692 44.399 -8.611 -3.023 44.526 
-3.556 0.025 40.589 -5.740 1.118 40.894 
-3.454 -0.178 46.660 -4.801 1.930 47.523 
-4.902 -0.025 50.902 -4.623 -0.102 51.333 
-4.801 -0.737 51.384 -7.010 0.000 51.359 
-2.540 -1.727 60.757 -1.194 0.838 59.233 
-3.556 0.127 63.144 -2.108 0.787 65.100 
-2.032 0.432 66.319 -4.521 0.000 73.127 
-5.258 0.356 70.739 -7.163 -0.432 75.489 
-0.483 -11.481 70.104 -6.147 7.036 71.476 
-6.147 -6.960 73.152 -6.858 -3.734 74.803 
-1.702 -7.468 76.276 -1.981 -6.756 79.096 
-0.787 5.131 82.194 -0.559 -4.547 83.947 
0.660 -4.572 84.074 -4.623 -0.102 51.333 
 
 
Table B3. Target points in the VCAF bladder. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.727 3.483 79.761 3.801 -3.409 79.751 
0.414 5.262 79.708 0.666 -5.262 79.719 
0.508 1.483 79.561 -2.361 -3.748 79.782 
-2.826 3.049 79.824 2.732 0.614 82.599 
4.902 0.001 79.698 -0.075 2.784 82.652 
0.732 -1.407 79.561 -1.704 -0.614 82.662 
-3.515 -0.403 79.708 1.155 -2.763 82.694 
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Table B4. Target points in the VCAF bone. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.001 -0.001 1.397 -1.833 18.974 59.972 
-7.593 -0.022 7.083 -1.875 0.106 64.588 
-4.532 -4.776 10.058 -3.452 3.961 72.645 
7.201 0.022 14.759 -9.191 0.614 73.536 
0.327 0.022 25.708 -7.919 -0.508 70.178 
-2.487 0.075 25.708 -5.908 7.201 73.134 
-0.614 -13.584 30.812 -4.066 9.001 74.997 
7.041 0.106 32.972 3.504 6.426 79.020 
6.481 -0.001 32.685 5.039 8.258 81.635 
6.174 -7.698 39.092 2.519 -8.788 76.658 
7.921 0.837 37.441 5.028 -8.281 81.719 
8.100 0.816 37.462 0.359 -19.441 74.774 
9.001 -1.799 46.249 -0.075 -19.441 85.626 
-8.460 0.254 8.652 3.304 9.275 110.182 
-7.009 2.721 36.732 3.483 -9.169 109.778 
-7.199 -2.256 37.365 1.991 -2.001 1.260 
-8.915 3.252 44.757 3.483 -9.064 109.833 
-8.662 -3.102 44.428 3.536 -9.043 109.833 
0.635 17.576 33.119 3.993 -9.064 109.376 
0.995 16.052 36.624 2.847 -8.302 109.292 
1.092 17.778 36.348 6.734 -6.045 119.308 
1.165 17.999 36.445 4.395 5.399 128.679 
1.578 17.883 36.022 4.447 5.136 128.553 
1.144 17.999 36.477 1.812 -7.932 125.047 
1.144 17.757 36.445 6.607 -7.009 55.799 
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Table B5. Target points in the VCAF brain. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.756 3.139 5.108 2.844 2.736 4.853 
1.480 1.480 3.676 -0.486 2.246 3.668 
-2.268 1.354 3.924 4.784 -0.457 5.033 
3.226 0.558 4.079 1.674 -0.673 3.103 
-0.328 0.392 3.157 -2.358 -0.662 3.503 
-4.212 0.130 4.219 -4.885 0.871 5.814 
3.928 -2.326 5.731 2.956 -1.552 4.396 
0.965 -2.477 4.334 -0.342 -1.555 3.434 
-1.811 -2.502 4.439 -3.820 -1.714 5.000 
1.894 -3.384 5.612 -0.547 -3.514 5.584 
1.969 3.521 6.714 4.363 1.570 5.443 
1.984 1.436 5.911 -0.259 1.375 5.461 
-1.656 3.125 5.101 -3.560 2.232 5.321 
5.353 -0.781 6.890 3.161 -0.140 6.383 
1.206 -0.317 4.925 -0.911 -0.374 5.040 
-2.650 0.241 5.584 1.854 -1.746 6.491 
-2.264 -1.951 6.088 -5.281 -1.141 6.127 
-0.126 -1.825 6.109 -3.485 -4.032 5.537 
3.676 2.635 7.016 0.648 4.716 7.970 
-0.428 3.668 6.613 -2.736 3.503 7.002 
2.322 1.188 7.985 0.536 2.243 7.571 
-1.595 1.912 6.782 -3.197 1.084 7.391 
-4.522 2.606 7.333 5.152 1.058 7.027 
0.742 0.094 6.880 -1.213 -0.112 7.146 
-3.575 -0.734 7.243 -5.580 0.742 7.423 
4.068 -2.038 7.434 2.092 -1.148 8.258 
-1.742 -2.167 7.888 -3.931 -2.779 7.178 
-5.490 -1.487 8.111 2.873 -3.373 7.589 
0.623 -3.654 7.250 -1.746 -3.870 7.204 
-2.772 -3.758 8.928 2.264 3.287 8.734 
0.115 3.384 9.490 -1.436 3.816 8.528 
-3.427 3.931 9.187 -5.198 2.171 9.130 
1.102 1.757 9.918 -0.652 1.480 10.735 
-1.030 1.588 8.719 -2.898 2.052 8.860 
0.464 0.227 8.809 -1.818 -0.382 8.885 
-4.140 0.252 9.065 -4.792 0.702 10.883 
-6.178 0.061 9.079 0.875 -1.908 10.134 
0.094 -1.768 8.204 -3.280 -1.566 9.295 
-5.098 -1.372 10.372 1.724 -3.244 9.050 
-0.396 -3.928 8.957 -4.712 -2.995 9.184 
-1.865 2.790 10.573 -3.863 2.462 10.714 
-2.909 1.253 12.006 -0.299 -0.490 10.307 
-2.524 0.486 10.314 -1.789 -1.534 11.192 
-3.496 -0.799 11.815 -1.195 -2.560 9.961 
-3.348 -2.794 10.890 -1.220 0.094 12.179 
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Table B6. Target points in the VCAF breast. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
7.927 9.680 39.344 8.986 8.334 38.920 
9.853 7.229 39.168 9.983 -6.750 39.366 
8.964 -8.204 38.923 8.086 -9.439 39.208 
6.404 11.437 40.738 7.200 10.631 40.122 
8.942 9.162 39.935 9.864 8.244 39.964 
10.678 6.977 39.996 10.735 5.854 39.992 
10.865 -5.828 39.931 10.786 -7.200 40.133 
9.781 -7.877 39.874 10.156 -8.356 40.590 
9.094 -8.971 39.967 8.482 -9.918 40.450 
7.337 -10.433 39.845 6.293 -11.250 40.622 
8.100 10.541 41.569 9.169 9.774 41.137 
8.233 10.127 40.547 11.120 8.989 40.259 
10.606 9.018 41.105 9.558 8.845 40.900 
11.473 7.481 40.964 10.411 7.848 40.615 
10.627 6.746 41.252 12.071 6.624 41.641 
11.538 6.134 40.759 11.254 4.939 40.784 
11.254 -5.062 40.828 11.650 -6.347 40.939 
10.616 -6.408 40.986 11.516 -7.571 41.188 
10.393 -7.427 41.213 9.727 -9.421 40.993 
9.155 -8.971 41.339 7.535 -10.782 41.026 
7.196 11.192 41.836 6.170 11.891 42.401 
9.054 10.494 42.163 10.098 9.706 42.016 
8.759 9.572 42.469 11.012 9.108 42.419 
9.634 8.752 42.030 11.444 8.330 41.634 
10.357 7.942 41.756 12.208 7.510 42.181 
11.059 7.078 42.300 11.120 5.681 41.789 
12.247 5.458 41.746 11.592 4.392 41.836 
11.603 -4.356 41.738 12.265 -5.414 41.738 
11.034 -6.804 42.239 12.197 -7.700 42.293 
11.758 -8.600 42.174 10.930 -8.586 41.332 
10.033 -8.320 42.019 8.546 -10.184 41.512 
7.481 -11.009 42.221 6.332 -11.750 42.080 
7.078 11.250 43.369 8.989 10.303 43.502 
8.071 10.832 42.865 9.968 10.055 43.052 
12.103 8.935 43.589 11.016 9.317 43.398 
9.799 8.964 43.229 12.978 7.610 43.153 
11.840 8.237 42.804 10.530 8.136 42.851 
12.920 6.469 42.487 12.082 6.970 43.337 
10.811 7.304 43.412 11.542 6.196 42.746 
12.456 4.849 42.714 11.502 5.141 42.959 
11.862 3.802 42.854 11.981 -3.773 42.862 
12.740 -4.370 43.726 11.621 -4.662 42.790 
12.560 -5.116 42.872 11.524 -5.933 42.865 
12.845 -6.167 42.545 11.902 -7.074 43.132 
9.515 -10.494 43.348 8.312 -10.750 43.427 
8.158 10.685 45.472 11.401 9.313 45.320 
8.964 9.990 45.115 12.416 8.723 44.780 
9.968 8.950 45.313 11.772 8.006 45.130 
10.703 8.060 45.148 13.619 6.998 44.676 
12.366 7.157 45.403 13.842 5.828 44.989 
11.646 6.037 44.960 13.032 4.669 44.748 
11.779 4.910 44.035 12.236 -3.784 44.921 
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Table B6 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
13.064 -4.576 45.004 13.756 -5.710 44.939 
12.650 -6.728 45.050 11.491 -6.196 44.856 
13.630 -7.146 45.184 11.837 -7.330 44.428 
10.678 -7.477 44.809 13.064 -8.024 44.554 
11.992 -8.888 45.608 10.966 -8.460 44.734 
9.925 -8.906 45.346 11.218 -9.461 44.885 
10.303 -9.896 44.266 9.004 -9.742 44.611 
9.133 -10.616 44.568 7.974 -10.822 44.298 
6.941 -11.297 44.611 11.084 9.137 46.202 
10.238 9.904 45.461 13.230 7.801 45.270 
12.244 8.474 45.997 12.949 7.704 46.440 
11.254 6.833 45.792 13.637 6.786 45.976 
13.457 5.627 46.303 12.409 6.401 46.163 
12.434 -6.678 46.008 12.089 -5.634 45.986 
11.311 -6.790 45.706 13.619 -6.869 46.206 
11.862 -7.780 45.396 12.917 -8.024 45.598 
10.757 -8.158 45.961 10.897 -9.288 46.044 
10.048 -9.914 45.338 9.011 -10.127 45.860 
8.050 -10.660 45.342 9.209 9.918 46.170 
10.102 9.263 46.703 11.819 8.435 47.081 
10.796 8.176 46.130 12.474 7.258 47.207 
11.509 7.456 46.487 11.581 6.368 47.088 
12.460 4.766 46.735 13.021 -5.648 46.908 
12.269 -4.932 47.110 13.014 -6.566 47.113 
11.711 -6.181 46.976 12.791 -7.776 46.512 
12.269 -7.351 47.315 11.408 -7.326 46.559 
11.869 -8.482 46.588 10.487 -8.813 47.045 
9.774 -9.544 46.541 10.732 8.392 47.297 
11.419 7.510 47.830 13.108 6.350 47.066 
12.046 6.379 47.999 12.431 5.486 47.344 
12.092 -6.041 47.844 11.506 -7.243 47.959 
11.106 -8.158 47.376 9.104 -9.612 43.524 
10.303 9.886 44.255 11.200 9.248 44.514 
9.382 9.338 44.186 12.906 7.974 44.078 
11.527 8.053 43.927 10.350 8.366 44.147 
13.435 6.577 43.747 12.305 7.013 44.341 
11.030 7.135 44.611 13.504 5.386 43.956 
12.856 5.731 42.998 12.359 5.767 43.952 
11.221 6.206 43.852 12.744 4.424 43.675 
12.200 3.784 44.845 11.876 3.539 43.884 
11.801 -3.564 43.916 11.948 -4.810 44.136 
12.326 4.043 45.947 12.236 -4.151 46.102 
13.082 -4.910 45.972 11.794 -4.892 45.295 
13.543 -5.908 45.868 12.618 -5.717 44.824 
13.316 -5.198 43.949 11.488 -5.418 43.924 
13.637 -6.660 44.230 13.432 -6.048 43.517 
12.344 -6.228 43.794 12.931 -7.474 43.880 
11.549 -8.050 43.600 10.624 -7.729 43.618 
12.452 -8.456 43.315 10.030 -8.824 44.226 
12.236 -8.716 44.464 11.372 -9.284 43.729 
10.994 -6.674 43.715 13.115 -7.207 42.966 
10.850 -7.675 42.458 11.214 -8.867 42.761 
10.105 -8.640 43.171 10.508 -9.421 41.998 
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Table B6 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
9.590 -10.134 42.138 9.263 -9.306 42.455 
8.528 -10.555 42.509 7.261 -11.632 43.240 
7.027 11.189 44.719 6.023 11.880 43.992 
9.299 10.588 44.593 8.125 10.739 44.201 
10.411 -9.749 43.164 11.981 5.519 46.094 
11.250 -5.641 41.875 12.254 -6.696 41.861 
13.212 4.914 45.680 11.941 4.939 45.176 
12.841 6.016 45.047    
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Table B7. Target points in the VCAF esophagus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.700 0.180 28.260 2.700 0.180 27.540 
2.700 0.180 26.820 2.700 0.180 26.100 
2.700 0.180 25.380 3.060 -0.180 24.660 
3.060 -0.180 23.940 3.060 0.180 23.220 
3.060 0.180 22.500 3.060 0.180 21.780 
2.700 -0.180 21.060    
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Table B8. Target points in the VCAF heart. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.663 2.174 32.220 0.731 2.210 38.405 
2.794 -2.430 38.686 2.243 3.431 39.582 
3.766 2.333 38.045 5.368 0.965 38.779 
4.388 2.311 39.211 2.059 1.490 38.822 
0.421 0.234 38.556 0.040 0.259 39.816 
5.468 -1.044 39.470 3.658 0.054 38.754 
0.648 -1.649 38.318 4.162 -2.156 39.168 
4.115 3.240 41.234 2.290 4.172 42.257 
5.476 2.196 41.022 3.258 3.049 40.378 
0.958 2.963 40.532 -0.043 1.850 40.320 
5.555 0.536 40.504 3.740 0.799 40.540 
2.059 1.127 40.248 3.528 -0.878 40.655 
2.092 -0.774 38.711 2.034 -0.947 40.363 
-0.140 -0.803 40.489 0.616 -2.182 40.183 
1.980 -2.912 40.068 3.521 3.582 42.844 
5.368 1.782 42.732 2.365 1.836 42.300 
1.282 3.082 41.951 -0.058 2.498 42.754 
5.623 -0.418 41.796 3.780 1.217 42.131 
1.534 0.580 41.796 -0.176 1.152 41.828 
3.258 -1.271 42.451 1.602 -0.778 42.163 
-0.756 0.094 42.512 5.389 -1.710 41.386 
4.115 -2.812 40.828 1.649 -2.819 42.502 
0.443 -2.758 42.037 -0.306 -1.213 42.278 
2.761 -3.121 41.461 1.807 2.545 44.248 
6.311 0.547 42.797 4.597 0.648 44.431 
1.015 1.058 43.841 -0.886 0.446 44.089 
6.138 -0.385 44.194 3.960 -0.176 42.829 
1.249 -0.752 43.855 5.508 -1.638 43.704 
4.612 -2.664 42.847 1.055 -3.010 44.428 
-0.292 -2.077 43.960 3.560 -3.244 43.700 
5.044 3.132 43.319 3.182 4.140 44.518 
1.195 3.935 44.104 5.929 1.915 44.791 
4.669 3.110 45.094 3.449 1.937 44.194 
0.065 2.448 45.947 -0.364 2.268 44.442 
4.129 0.932 46.156 2.588 0.371 44.147 
0.788 0.756 45.882 -0.864 0.648 46.130 
6.106 -0.464 45.810 3.895 -1.116 44.734 
5.562 -1.829 46.098 3.816 -0.929 46.285 
2.459 -1.793 44.384 -0.252 -0.868 44.831 
6.044 -3.736 44.342 4.716 -2.956 45.238 
2.606 -4.046 43.902 2.675 4.162 46.087 
1.098 3.326 46.152 4.550 3.103 46.436 
2.610 2.246 46.026 5.879 1.195 46.253 
1.750 -1.206 46.022 2.290 0.518 45.846 
3.528 -3.042 46.148 0.760 -2.790 46.091 
-0.360 -1.404 46.314 2.398 -3.416 45.997 
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Table B9. Target points in the VCAF intestine. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
5.238 -3.222 61.956 2.423 -1.692 61.135 
3.395 -5.418 61.171 2.570 1.300 64.051 
5.090 0.428 63.680 3.020 -2.264 63.799 
0.828 -4.241 64.069 3.809 -6.080 64.174 
0.526 -8.305 63.889 2.045 -7.801 61.848 
1.660 9.223 65.272 3.658 6.754 64.537 
5.191 4.147 65.498 2.344 3.766 65.048 
4.723 -4.230 65.754 0.720 -4.925 66.085 
-3.290 -4.633 66.539 -1.843 -6.419 66.470 
0.119 -8.838 66.312 2.628 -2.844 69.941 
-3.337 -5.652 70.229 -1.541 -6.970 69.242 
-1.908 7.934 71.460 -0.828 5.382 70.078 
2.542 6.563 70.967 4.295 1.552 70.405 
2.534 3.359 70.830 4.122 -3.654 72.425 
1.652 -0.612 70.963 3.532 -4.766 75.820 
3.164 -6.008 71.899 0.374 -5.375 71.114 
-1.253 -8.377 72.479 1.847 7.862 72.698 
-0.065 8.766 72.914 3.960 4.374 73.120 
-0.007 4.518 72.752 4.104 1.426 73.861 
1.091 1.480 73.174 4.439 -0.821 72.785 
1.897 -2.538 73.879 -2.722 -6.624 73.285 
0.810 -8.413 72.799 5.072 -1.667 76.514 
3.132 2.498 76.558    
 
 
Table B10. Target points in the VCAF kidneys. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.013 -5.537 55.786 -2.509 -5.339 58.032 
-2.048 -5.612 59.965 -1.908 6.797 60.869 
-2.052 5.537 62.417    
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Table B11. Target points in the VCAF liver. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.768 -9.144 50.170 1.026 -9.130 50.213 
2.171 -9.166 50.188 2.102 6.343 49.442 
0.439 7.085 50.522 4.295 5.738 50.054 
4.842 3.344 49.763 2.138 3.416 49.979 
0.151 3.949 50.965 5.814 1.116 50.422 
3.121 0.846 49.882 0.490 1.098 50.360 
4.982 -1.530 49.896 2.070 -1.418 49.964 
-0.547 -1.393 50.634 0.828 8.521 52.679 
2.977 7.700 51.721 -1.098 6.984 53.140 
4.579 5.936 52.888 3.006 4.604 51.840 
1.505 5.785 52.448 -1.364 5.688 51.113 
-2.452 4.439 53.320 5.713 3.841 51.898 
1.375 2.686 52.747 5.962 1.760 53.219 
3.611 1.926 51.872 3.697 3.161 53.978 
6.314 -0.850 52.070 4.100 -0.443 52.308 
1.598 0.011 52.322 3.391 6.768 54.695 
1.588 7.470 54.540 -0.374 7.826 55.494 
2.074 4.414 54.943 -0.061 4.824 53.701 
5.119 4.288 54.893 -0.724 1.904 52.780 
3.582 0.619 54.551 1.336 1.606 54.904 
5.846 -0.468 54.781 0.245 -0.396 54.133 
3.712 5.375 56.693 0.702 5.519 56.473 
-0.558 3.157 55.296 0.706 2.941 57.380 
 
 
Table B12. Target points in the VCAF lungs. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.804 6.257 40.741 -0.288 -6.862 39.326 
-4.302 5.260 44.392 -0.590 -7.996 44.096 
-0.853 8.125 44.363 -3.946 -5.447 46.645 
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Table B13. Target points in the VCAF muscle. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-7.009 -0.022 13.077 1.037 -20.521 92.096 
-1.197 2.340 19.281 0.022 11.679 84.833 
2.487 -2.256 25.708 -4.500 0.359 0.900 
2.414 6.936 28.218 -3.938 6.447 90.096 
7.645 -2.287 32.972 -5.517 7.793 112.955 
-2.616 -15.268 35.005 2.085 7.136 109.801 
8.258 3.504 37.439 1.927 6.936 109.673 
-9.348 -9.445 44.397 3.780 9.243 93.622 
-0.233 12.346 46.588 0.022 -2.308 93.473 
9.403 4.702 57.252 -0.001 -9.317 84.812 
9.317 -4.647 57.252 -7.136 -7.243 87.174 
8.662 -0.022 62.428 0.254 -6.300 91.546 
2.393 17.068 37.386 2.085 -6.904 109.631 
0.148 -19.452 35.047 -6.279 -9.096 107.618 
2.256 -17.016 37.386 1.473 -7.264 109.757 
4.542 -19.452 51.205 -3.304 -8.715 114.121 
-7.115 -11.679 73.155 3.578 -9.424 93.654 
8.132 0.359 72.721 -5.028 6.024 119.456 
-9.753 -9.169 78.513 -1.197 5.940 142.338 
-2.414 4.668 81.816 -1.578 3.228 145.313 
-1.578 -4.416 82.144 3.833 3.452 149.325 
-5.643 -7.009 85.193 0.732 -3.378 126.138 
-7.083 7.009 76.172 -3.759 -6.576 126.138 
0.540 17.100 84.420 11.605 -8.026 160.296 
3.049 -18.698 70.178 -0.001 14.727 82.144 
 
 
Table B14. Target points in the VCAF ovaries. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.308 3.067 75.600 -3.326 -3.042 75.676 
-3.240 3.035 76.334 -3.200 -3.049 76.370 
-3.344 -3.049 77.040 -3.348 3.046 77.076 
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Table B15. Target points in the VCAF pancreas. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.424 -3.049 54.540 4.203 0.382 58.944 
1.767 -3.155 55.557 3.452 -1.906 58.500 
2.795 -1.620 55.896 5.856 4.214 59.283 
1.788 -3.197 55.536 5.220 3.367 59.273 
3.420 -0.414 55.938 5.982 2.763 59.136 
4.881 1.260 59.007 4.702 3.399 59.220 
4.203 1.652 59.188 4.298 3.186 59.199 
5.378 0.603 58.447 4.256 2.955 59.178 
4.426 1.079 59.018 5.167 3.315 59.157 
4.256 0.784 59.041 4.235 2.340 59.209 
4.692 0.719 57.896 5.357 1.567 58.308 
4.532 2.298 58.468 5.527 2.532 58.521 
5.748 3.283 59.157 5.475 0.582 58.734 
6.066 2.902 59.209 4.986 1.271 58.923 
5.146 2.172 59.443 4.035 1.715 59.115 
5.685 3.420 59.188 5.824 1.652 58.986 
5.231 2.287 59.485 4.266 2.795 59.167 
5.357 1.557 58.298 5.336 1.864 59.443 
5.252 2.487 58.532 4.161 1.980 59.104 
5.052 2.424 58.605 4.797 0.169 58.140 
6.003 2.329 58.860 5.866 1.609 58.881 
5.136 0.424 58.098 4.161 -1.715 57.197 
4.849 1.176 59.052    
 
 
Table B16. Target points in the VCAF salivary glands. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.980 5.580 13.500 1.980 -5.580 13.500 
4.500 4.860 16.740 4.500 -4.860 16.740 
6.660 2.340 19.980 6.660 -2.340 19.980 
4.500 3.420 19.260 4.500 -3.420 19.260 
4.140 1.260 18.180 5.220 1.260 18.180 
4.140 -1.260 18.180 5.220 -1.260 18.180 
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Table B17. Target points in the VCAF skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.870 4.670 2.170 -2.150 3.950 1.090 
6.110 -1.070 1.810 1.260 -1.070 0.010 
-6.470 -0.710 1.810 -2.150 -3.950 1.090 
7.910 4.670 7.570 3.590 6.470 6.130 
-5.750 4.670 3.970 8.990 0.350 5.770 
-8.990 1.430 6.490 4.140 -5.030 4.140 
-2.150 -6.470 4.690 -7.190 -4.310 6.130 
8.630 3.590 13.500 -0.540 7.910 11.870 
-2.870 6.830 7.570 -7.550 4.310 11.150 
-8.990 -0.350 13.310 7.910 -3.950 9.010 
3.230 -6.830 9.180 -1.980 -8.630 11.150 
-7.550 -4.310 11.150 4.310 6.110 13.860 
11.510 -0.350 13.500 -3.950 5.390 15.830 
7.550 -4.670 14.750 2.340 -6.110 15.660 
-2.870 -6.110 15.110 3.230 5.750 17.630 
8.990 2.150 19.430 -6.470 2.150 17.270 
8.270 -2.870 19.430 -1.790 -4.310 22.690 
-5.030 -3.950 17.630 2.510 5.030 21.780 
5.750 2.150 23.580 2.510 -5.030 21.780 
0.180 10.070 27.010 -1.790 4.310 22.690 
-4.310 1.070 22.310 5.750 -1.790 25.740 
1.070 -10.070 27.010 -2.870 -10.430 27.730 
-0.710 20.150 32.770 2.510 17.270 30.610 
-1.430 14.750 28.810 5.390 13.670 31.330 
3.950 8.990 28.090 -5.750 9.540 30.610 
-4.670 6.110 27.730 7.190 -0.180 30.610 
5.390 5.940 28.810 -5.750 2.700 29.530 
7.910 -4.310 33.130 -5.030 -4.310 27.900 
4.670 -7.190 28.090 5.750 -11.510 30.970 
3.590 -15.470 30.250 1.070 -17.630 30.250 
-3.590 -14.750 29.890 6.830 18.710 36.730 
3.230 21.230 36.540 -4.310 19.430 35.100 
6.830 13.310 36.710 -4.670 14.030 30.610 
-6.110 16.190 35.100 7.190 9.540 34.210 
-3.590 16.020 39.060 -8.630 8.460 34.930 
7.910 4.310 33.130 9.710 -1.980 37.810 
-7.190 1.260 33.300 -7.190 -3.590 32.770 
7.550 -9.350 34.930 -6.470 -8.820 31.690 
6.470 -14.220 35.460 -7.910 -11.510 34.570 
-0.180 -20.510 34.020 -4.310 -19.430 35.100 
6.470 17.460 43.020 -8.270 12.590 36.730 
6.110 12.590 41.940 11.150 8.270 39.250 
-9.350 3.970 36.730 11.510 5.410 39.250 
9.710 1.980 37.810 -10.430 3.610 40.330 
6.830 -18.710 36.730 3.230 -21.230 36.540 
1.260 -21.230 41.580 4.670 20.150 46.980 
-1.070 21.230 41.220 0.180 13.140 43.910 
-7.910 12.950 44.270 -7.910 12.950 40.500 
12.590 10.070 45.350 9.710 11.150 46.070 
-10.430 8.990 43.740 13.670 3.610 43.570 
12.590 -2.530 44.990 7.020 -11.870 45.710 
9.710 -0.180 39.780 -10.790 -7.190 43.740 
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Table B17 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-9.710 -1.090 41.050 14.030 -5.770 42.130 
11.150 -7.190 38.890 -9.350 -3.250 37.090 
6.660 -10.430 37.980 -10.070 -8.270 38.890 
-5.750 -16.910 35.100 -8.270 -12.590 37.980 
9.350 -11.510 41.770 6.110 -18.350 45.350 
3.950 -14.220 40.500 -5.390 -13.670 40.860 
6.830 -17.290 41.750 -3.230 -19.790 41.580 
-0.350 21.590 47.700 5.750 17.460 50.220 
-3.950 18.710 47.340 1.430 13.690 50.390 
-0.180 13.690 46.980 6.830 11.150 48.420 
14.750 6.830 46.790 10.790 0.180 46.260 
-10.070 2.890 48.590 11.510 -0.900 49.140 
-9.710 -1.090 47.150 -10.430 -4.140 47.510 
11.870 -10.430 45.710 6.830 -11.150 51.470 
1.620 -12.590 44.460 -0.540 -13.690 46.260 
-6.470 -13.310 46.070 -8.990 -11.150 45.900 
5.750 -16.930 49.860 -3.950 -18.710 46.620 
2.510 -21.230 46.620 0.350 21.590 53.100 
4.670 19.070 54.710 -3.590 19.430 54.350 
-5.390 13.310 53.630 -6.470 12.950 48.420 
9.350 8.270 53.630 -0.540 12.950 53.460 
-9.710 8.270 49.310 11.510 5.390 51.470 
-8.990 7.190 53.270 11.510 -3.420 52.550 
-8.630 -1.810 54.350 14.390 -7.550 47.150 
10.430 -6.830 52.910 -9.350 -6.830 51.110 
8.990 -8.990 52.910 2.340 -12.230 52.740 
-8.630 -8.990 53.630 -0.180 -13.690 50.940 
-6.470 -12.230 55.430 -5.580 -13.310 51.660 
5.390 -17.990 53.270 -3.950 -16.930 52.380 
-0.350 -21.590 50.220 1.430 21.230 60.300 
3.950 16.210 57.590 -3.590 18.710 59.220 
6.830 10.790 52.910 -7.190 11.150 56.150 
10.430 4.670 58.670 -8.630 3.420 55.260 
9.350 -7.190 59.390 3.230 -12.230 57.780 
0.180 -12.590 59.580 -7.190 -8.990 62.820 
-7.910 -7.550 59.390 -3.950 -12.590 58.670 
3.590 -15.490 56.340 -3.590 -19.070 57.420 
1.790 -21.230 54.900 -1.790 21.590 66.780 
4.310 19.070 63.730 -3.230 18.010 65.150 
-2.510 12.950 60.850 3.590 12.230 57.060 
-6.470 10.430 59.220 10.070 -6.110 64.450 
10.430 -3.060 59.940 -8.270 -3.250 59.030 
6.470 -10.430 58.860 -4.670 -12.590 65.530 
1.430 -21.230 60.300 3.230 21.230 68.580 
3.950 12.230 64.980 -1.790 14.030 69.130 
7.910 9.350 63.370 1.070 12.590 61.380 
-6.830 10.070 64.980 10.430 1.450 62.290 
8.270 8.630 59.580 -8.990 6.830 66.970 
10.790 3.230 66.420 -9.350 -4.500 67.690 
-8.270 3.250 63.540 -8.270 -2.530 64.450 
4.670 -11.870 64.620 -0.180 -12.950 65.700 
3.950 -16.930 61.210 4.310 -16.930 65.700 
-3.230 -17.290 64.070 -1.430 -21.590 64.810 
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Table B17 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.230 20.510 72.900 4.310 17.650 72.350 
3.230 12.590 68.410 -4.670 12.590 66.420 
8.990 7.550 67.140 3.950 13.310 72.900 
-10.790 2.870 70.210 11.150 1.260 70.190 
-7.190 0.180 66.060 10.430 -4.670 67.860 
-9.350 -7.550 69.490 7.190 -9.710 67.140 
-7.190 -11.150 68.410 -0.180 -14.030 70.380 
4.670 -19.070 69.830 0.180 -22.310 70.020 
2.510 22.310 81.710 -0.710 22.670 74.700 
3.590 19.260 77.390 -0.540 15.830 77.220 
-4.670 14.750 72.900 -7.910 12.590 72.900 
8.270 8.990 71.820 -9.350 10.070 71.650 
10.790 2.510 73.620 -10.430 0.180 81.540 
10.430 -4.670 71.820 -11.150 -0.180 71.290 
6.830 -10.430 72.540 3.420 -13.310 73.070 
-11.510 -7.190 74.170 1.260 -15.470 77.220 
-3.950 -15.110 73.980 -7.190 -13.310 72.900 
3.950 -18.370 75.590 -3.230 -20.510 71.820 
3.950 15.470 79.740 -5.030 15.830 78.850 
9.350 7.190 75.590 -12.230 9.350 77.050 
10.430 1.620 79.550 -12.950 5.220 77.050 
-13.310 -3.610 80.270 10.070 -5.390 75.420 
10.070 -3.950 79.550 -11.870 -2.530 75.970 
-3.950 -16.190 78.490 -10.430 -11.510 76.690 
1.430 -22.670 75.970 -0.010 23.390 87.490 
-2.510 21.950 80.820 3.590 16.190 84.780 
-4.670 16.910 83.170 -8.990 13.310 78.490 
7.190 11.510 79.740 0.180 16.910 86.220 
-12.950 10.790 82.260 8.630 6.110 82.430 
3.590 1.810 85.140 -11.510 2.530 85.140 
-12.950 2.700 79.740 8.270 1.070 84.950 
-3.420 1.090 85.860 -5.580 0.900 84.950 
8.630 -4.500 83.150 3.780 -1.980 84.950 
7.910 -8.990 82.070 -13.310 -8.630 79.380 
7.550 -10.790 79.740 4.310 -15.110 79.570 
-8.990 -13.670 79.570 -13.310 -10.790 83.890 
4.310 -15.470 84.060 -4.310 -16.910 82.450 
2.510 -22.310 81.710 -2.510 -21.950 79.020 
-3.950 20.170 89.630 5.390 19.070 95.030 
-7.550 16.190 86.390 -10.790 14.030 85.140 
7.550 9.350 82.430 -11.870 8.990 89.630 
-6.830 2.170 93.060 -13.670 6.850 84.950 
-1.260 -1.450 88.740 -3.060 -1.450 88.020 
-9.350 -2.170 88.190 -12.230 -3.250 85.140 
7.550 -6.850 89.100 -12.950 -7.380 87.110 
6.830 -11.510 86.410 3.230 -16.550 91.260 
1.620 -16.910 86.220 -10.790 -14.030 85.140 
5.390 -18.540 94.860 -5.750 -16.190 90.710 
-6.110 -16.910 86.030 0.710 -23.030 86.050 
-3.950 -21.590 86.580 -2.870 21.590 93.950 
2.870 19.620 100.070 5.750 14.030 86.940 
4.310 22.310 90.540 1.430 16.910 93.590 
-5.390 16.190 91.070 7.550 9.180 87.850 
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Table B17 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-9.710 10.260 93.060 7.190 5.410 89.290 
0.540 0.730 91.980 -10.070 3.610 89.990 
5.750 -3.250 88.570 -2.340 -1.450 95.580 
-6.110 -1.810 93.230 6.830 -13.310 90.730 
-1.430 -15.470 97.190 -11.150 -9.710 90.710 
5.750 -18.540 91.980 -1.260 -16.550 93.060 
1.620 -23.390 90.710 -3.230 -21.420 92.510 
-1.430 19.980 98.630 8.270 12.590 94.670 
5.750 14.750 91.980 -8.270 14.030 93.230 
-8.270 6.130 96.300 7.550 2.890 93.610 
-4.670 2.170 98.460 6.470 -1.810 93.610 
1.980 -0.370 97.020 -8.270 -6.490 98.990 
8.990 -7.020 94.140 -9.350 -5.050 93.590 
8.630 -11.510 94.860 -7.190 -11.870 97.910 
-8.270 -14.030 93.230 3.950 -21.230 96.110 
-1.790 -19.980 97.910 7.190 13.310 100.070 
-0.350 15.470 98.630 8.990 7.380 95.580 
-5.030 13.670 98.270 -8.270 8.990 100.070 
7.550 2.890 99.710 0.540 0.730 99.180 
-4.670 2.170 102.230 8.270 -4.330 98.820 
1.980 -0.370 103.500 -2.340 -1.450 103.860 
-5.750 -2.890 99.900 7.190 -13.670 98.270 
3.780 -15.470 98.820 -3.950 -13.670 101.870 
1.790 -19.260 100.790 4.310 15.110 100.980 
-3.950 13.310 103.670 8.630 8.820 101.700 
1.620 0.730 107.460 -7.910 8.270 104.030 
7.550 3.250 106.190 6.830 -2.170 103.500 
-4.310 -2.170 107.270 8.630 -9.350 102.230 
-3.590 -12.950 106.550 -7.910 -8.630 103.670 
2.340 -14.750 104.030 6.470 12.590 108.350 
2.530 14.390 106.550 -2.870 12.950 108.710 
8.270 8.630 107.820 -4.310 2.170 107.270 
-7.550 6.850 107.270 1.620 -0.730 111.420 
-7.550 -6.850 107.270 6.830 -12.590 105.830 
2.700 -14.030 109.070 4.670 12.950 113.750 
7.910 7.550 113.750 -1.620 2.530 119.700 
-5.030 10.790 112.670 -6.830 7.020 111.950 
6.830 2.890 113.390 -1.430 1.090 115.380 
7.910 -4.330 107.100 6.470 -2.170 111.230 
-3.590 -2.170 111.420 7.910 -9.710 109.790 
-2.510 -12.230 112.860 -6.110 -9.710 111.950 
-0.350 12.950 115.550 7.190 6.660 119.870 
-3.950 3.610 123.490 -5.030 3.610 114.470 
7.190 -3.970 115.910 -2.150 -2.170 122.770 
-6.110 -5.410 114.830 7.550 -9.350 114.110 
-5.030 -7.910 119.870 3.950 -12.950 115.190 
5.750 11.150 118.790 -3.590 10.790 118.790 
5.030 -1.810 118.980 -2.870 -2.170 119.150 
6.830 -8.270 121.310 -2.150 -11.870 118.790 
5.030 9.350 126.350 1.090 11.150 123.110 
-2.510 9.350 126.900 5.390 3.250 124.910 
1.620 1.810 125.460 -5.030 4.330 129.060 
6.110 -5.410 125.990 3.590 -2.170 125.270 
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Table B17 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.670 -3.970 126.010 4.670 -11.510 120.590 
0.730 -10.790 124.190 5.030 6.470 131.030 
-4.670 7.910 133.740 -3.950 2.170 135.710 
1.980 -1.450 130.500 -2.870 -1.450 130.500 
3.590 -9.350 128.700 -3.590 -8.630 126.370 
1.070 10.070 133.020 -3.950 8.270 139.310 
3.230 2.170 134.460 2.870 -2.170 138.420 
-5.030 -4.140 133.740 4.310 -7.910 133.190 
-2.510 -9.710 130.500 1.790 9.350 140.030 
4.670 5.580 138.230 4.310 -3.250 133.740 
-3.230 -1.810 137.340 1.790 -9.710 137.150 
-3.230 -9.350 135.350 -2.510 7.550 145.790 
2.870 2.890 142.910 -3.230 2.530 141.830 
3.950 -5.050 142.550 -0.710 -1.810 143.270 
1.790 -8.990 142.190 -4.310 -7.550 140.390 
3.590 7.550 147.780 3.950 -2.530 149.050 
-3.230 -4.330 145.790 -0.710 -7.910 146.870 
-2.510 2.890 149.410 4.140 -2.170 155.340 
-2.870 -2.890 151.570 5.750 2.170 152.820 
-2.870 7.550 153.540 5.390 -7.910 151.930 
6.110 8.270 154.620 -2.870 2.530 155.530 
11.150 -3.060 156.610 -3.590 -2.890 157.670 
17.630 8.990 160.550 11.340 8.990 161.630 
20.870 3.250 160.380 14.390 3.780 157.690 
8.820 2.890 160.550 3.970 8.270 161.630 
1.620 2.170 161.270 -2.870 6.110 160.550 
20.870 -3.250 160.380 14.410 -1.620 161.630 
5.390 -2.170 160.550 -2.150 -5.750 161.630 
19.430 -7.910 160.380 14.410 -9.710 160.380 
9.540 -8.630 158.770 4.500 -8.270 161.630 
0.730 -8.270 156.610 -5.030 6.660 120.230 
5.030 1.810 118.620 -3.060 1.810 90.900 
4.670 2.170 88.020 -8.270 3.970 59.390 
10.790 1.450 55.790 -3.590 19.070 41.220 
3.230 20.870 41.580 -10.790 5.940 42.660 
10.430 0.540 42.660    
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Table B18. Target points in the VCAF spleen. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.148 -5.702 52.679 -1.721 -7.409 52.783 
-2.070 -6.462 52.315 -2.099 -3.355 53.280 
-2.347 -8.158 53.179 -2.030 -2.887 54.194 
-1.026 -6.811 53.284 -1.368 -7.942 53.737 
-3.103 -8.467 53.795 -2.174 -8.795 54.112 
-0.580 -6.530 54.356 -0.770 -7.520 54.569 
-1.436 -8.525 54.673    
 
 
Table B19. Target points in the VCAF stomach. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.516 -4.622 51.736 3.334 -6.088 50.832 
1.246 -6.404 50.839 3.517 -4.313 52.859 
4.871 -5.828 52.276 3.215 -7.769 52.297 
0.904 -8.003 52.290 5.252 -4.666 54.457 
3.964 -6.646 54.583 1.771 -8.338 54.450 
4.396 -5.105 56.740 2.441 -7.715 56.534 
 
 
Table B20. Target points in the VCAF thymus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.340 0.180 30.060 1.260 0.180 30.060 
1.980 1.260 30.060 1.980 -1.260 30.060 
1.980 -0.180 29.340 2.700 -0.900 28.620 
2.700 0.900 28.620 1.980 -0.900 28.620 
1.980 0.900 28.620    
 
 
Table B21. Target points in the VCAF thyroid. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
5.209 0.439 26.280 5.080 1.091 26.359 
5.339 -0.169 26.147 5.238 -0.868 26.150 
5.069 1.008 27.184    
 
 
Table B22. Target points in the VCAF uterus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.197 0.911 77.527 -0.264 -0.732 76.881 
-0.148 0.687 76.839 -2.647 0.127 77.993 
-1.441 -0.742 77.622    
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11. Appendix C – Target Point Locations in MAX 
 
 
Table C1. Target points in the MAX adrenals. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.649 1.285 53.269 -1.145 -2.938 53.748 
-1.422 -2.952 53.312 -0.916 -2.782 54.185 
-0.464 1.656 54.374    
 
 
Table C2. Target points in the MAX BFO (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.360 -17.820 30.780 0.360 -17.460 32.220 
-0.180 -17.100 33.660 -0.720 -18.900 35.100 
-0.360 -19.800 36.540 -1.620 -19.800 37.980 
-1.980 -19.800 39.420 -1.980 -19.800 40.860 
-2.880 -20.880 42.300 -2.880 -20.880 43.740 
-3.420 -21.240 45.180 -3.780 -21.600 46.620 
-4.140 -21.960 48.060 -4.500 -22.500 49.500 
-4.860 -22.500 50.940 -5.220 -23.220 52.380 
-5.040 -23.220 53.820 -5.040 -23.220 55.260 
-5.040 -23.220 56.700 -5.400 -23.580 58.140 
-4.860 -23.220 59.580    
 
 
Table C3. Target points in the MAX BFO (left leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.540 -9.540 81.900 -1.440 -12.060 84.060 
-2.520 -13.140 86.220 -2.520 -12.780 88.380 
-1.980 -13.140 89.820 -1.800 -13.140 90.540 
-1.080 -13.140 92.700 -1.260 -12.780 94.860 
-0.720 -12.960 97.020 -0.360 -12.780 99.180 
-0.180 -12.960 101.340 -0.000 -12.960 103.500 
-0.000 -12.780 105.660 -0.000 -12.780 107.820 
-0.000 -12.780 109.980 0.180 -12.420 112.140 
0.180 -12.420 114.300 0.180 -12.420 116.460 
0.180 -12.420 118.620 -0.000 -12.780 120.780 
-0.180 -12.780 122.940 -0.900 -12.780 125.100 
 
 
Table C4. Target points in the MAX BFO (mandible). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.839 5.533 15.977 4.172 4.482 15.970 
0.893 -4.784 15.930 1.296 4.878 19.692 
6.134 3.377 21.190 9.572 0.155 16.330 
4.378 -1.584 16.283 6.016 -3.787 20.707 
1.606 -4.820 19.696 8.824 0.180 21.503 
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Table C5. Target points in the MAX BFO (pelvis). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.068 3.960 70.571 -6.206 3.366 71.528 
-2.840 4.248 72.691 -5.339 3.179 73.278 
-3.215 2.182 73.206 -3.366 -5.177 72.954 
-4.003 -6.829 72.115 -5.296 -6.451 72.760 
-3.474 3.820 74.048 -4.936 -4.972 73.865 
-6.725 -5.468 74.401 -3.395 -6.948 74.164 
-4.831 -6.790 74.556 -2.783 -8.122 75.424 
0.601 7.049 78.044 -0.770 5.814 78.372 
-0.886 -9.101 78.221 -0.572 7.186 79.942 
0.443 5.515 79.938 -1.883 5.602 79.675 
0.468 -8.140 80.237 -2.243 -7.985 79.704 
-0.817 -9.461 79.693 -3.992 -6.725 85.777 
-3.424 3.578 86.699    
 
 
Table C6. Target points in the MAX BFO (ribs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.580 12.060 27.900 -5.940 -12.060 27.900 
-4.500 7.020 29.700 -4.140 -9.180 29.700 
2.340 7.380 31.500 1.260 -9.180 31.500 
0.900 5.220 33.300 4.140 -0.900 35.100 
4.860 -7.380 36.900 -3.060 -12.060 38.700 
-8.100 6.660 40.500 0.900 10.980 42.300 
8.460 0.180 44.100 6.120 -12.420 45.900 
-5.400 -12.060 47.700 -5.220 10.980 49.500 
6.660 11.340 51.300 10.440 -8.100 53.100 
-5.220 -12.780 54.900 -7.380 6.660 56.700 
1.260 12.420 58.500 -4.860 -12.420 60.300 
 
 
Table C7. Target points in the MAX BFO (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.360 16.560 30.780 0.360 16.560 32.220 
-0.180 16.020 33.660 -0.720 18.180 34.740 
0.180 17.820 36.540 -0.720 18.540 37.980 
-0.720 18.900 39.420 -1.080 19.260 40.860 
-1.620 19.800 42.300 -1.800 19.980 43.740 
-1.980 20.160 45.180 -2.700 20.700 46.620 
-3.060 21.240 48.060 -3.240 21.420 49.500 
-3.420 21.600 50.940 -3.780 21.960 52.380 
-3.600 22.140 53.820 -4.140 22.140 55.260 
-3.960 22.320 56.700 -3.060 22.860 58.140 
-3.600 22.860 59.580    
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Table C8. Target points in the MAX BFO (right leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 7.020 81.900 -1.440 9.360 84.060 
-2.160 10.620 86.220 -2.340 10.260 88.380 
-1.260 10.620 90.540 -1.080 10.980 92.700 
-0.180 10.440 94.860 -0.000 10.440 97.020 
0.540 10.440 99.180 0.720 10.440 101.340 
0.720 10.440 103.500 1.080 10.260 105.660 
0.900 10.440 107.820 0.900 10.440 109.980 
0.900 10.440 112.140 0.900 10.260 114.300 
0.900 10.440 116.460 0.720 10.260 118.620 
0.900 10.440 120.780 0.900 10.620 122.940 
0.180 11.340 125.100    
 
 
Table C9. Target points in the MAX BFO (skull). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.875 5.994 3.096 6.210 2.844 2.650 
0.270 0.619 0.360 -5.526 2.477 1.930 
5.299 -2.354 2.650 0.428 -4.921 3.308 
-5.188 -3.150 2.668 5.926 6.026 7.715 
-0.482 7.459 9.306 -5.062 7.139 5.540 
8.561 0.770 7.740 2.236 1.228 8.424 
-3.643 0.940 11.070 -9.734 2.286 6.797 
6.433 -4.126 7.708 1.516 -5.256 8.525 
-4.100 -6.458 8.194 -8.964 -2.999 6.790 
-1.980 7.398 14.602 -7.427 6.354 10.638 
2.369 0.709 14.296 -9.943 0.580 13.169 
-0.871 -6.005 14.184 -7.434 -4.532 12.096 
-4.813 3.744 16.168 -4.169 -2.495 16.200 
 
 
Table C10. Target points in the MAX BFO (spine). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.260 0.540 17.460 -1.260 0.360 19.980 
-1.260 -0.360 22.500 -2.340 -0.000 25.020 
-3.060 -0.540 27.540 -3.060 -0.720 30.060 
-3.780 -0.900 32.580 -4.500 -1.080 35.100 
-4.860 -1.080 37.620 -5.220 -0.720 40.140 
-5.580 -0.900 42.660 -5.220 -0.900 45.180 
-4.860 -1.260 47.700 -4.500 -1.080 50.220 
-4.140 -1.260 52.740 -4.140 -1.260 55.260 
-3.780 -1.260 57.780 -3.420 -1.440 60.300 
-2.700 -2.340 62.820 -1.980 -2.160 65.340 
-1.620 -2.340 67.860 -1.620 -1.800 70.380 
-4.140 -1.440 72.900 -7.020 -1.440 75.420 
-8.820 -1.260 77.940    
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Table C11. Target points in the MAX bladder. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.263 1.066 76.986 3.830 -1.901 75.733 
0.281 -3.218 76.961 4.630 0.439 79.355 
0.896 1.260 81.958 1.962 -3.503 81.544 
-2.455 -1.757 79.402    
 
 
Table C12. Target points in the MAX bone (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.360 -17.820 30.780 0.360 -17.460 32.220 
-0.180 -17.100 33.660 -0.720 -18.900 35.100 
-0.360 -19.800 36.540 -1.620 -19.800 37.980 
-1.980 -19.800 39.420 -1.980 -19.800 40.860 
-2.880 -20.880 42.300 -2.880 -20.880 43.740 
-3.420 -21.240 45.180 -3.780 -21.600 46.620 
-4.140 -21.960 48.060 -4.500 -22.500 49.500 
-4.860 -22.500 50.940 -5.220 -23.220 52.380 
-5.040 -23.220 53.820 -5.040 -23.220 55.260 
-5.040 -23.220 56.700 -5.400 -23.580 58.140 
-4.860 -23.220 59.580    
 
 
Table C13. Target points in the MAX bone (left leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.540 -9.540 81.900 -1.440 -12.060 84.060 
-2.520 -13.140 86.220 -2.520 -12.780 88.380 
-1.980 -13.140 89.820 -1.800 -13.140 90.540 
-1.080 -13.140 92.700 -1.260 -12.780 94.860 
-0.720 -12.960 97.020 -0.360 -12.780 99.180 
-0.180 -12.960 101.340 -0.000 -12.960 103.500 
-0.000 -12.780 105.660 -0.000 -12.780 107.820 
-0.000 -12.780 109.980 0.180 -12.420 112.140 
0.180 -12.420 114.300 0.180 -12.420 116.460 
0.180 -12.420 118.620 -0.000 -12.780 120.780 
-0.180 -12.780 122.940 -0.900 -12.780 125.100 
 
 
Table C14. Target points in the MAX bone (mandible). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.839 5.533 15.977 4.172 4.482 15.970 
0.893 -4.784 15.930 1.296 4.878 19.692 
6.134 3.377 21.190 9.572 0.155 16.330 
4.378 -1.584 16.283 6.016 -3.787 20.707 
1.606 -4.820 19.696 8.824 0.180 21.503 
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Table C15. Target points in the MAX bone (pelvis). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.068 3.960 70.571 -6.206 3.366 71.528 
-2.840 4.248 72.691 -5.339 3.179 73.278 
-3.215 2.182 73.206 -3.366 -5.177 72.954 
-4.003 -6.829 72.115 -5.296 -6.451 72.760 
-3.474 3.820 74.048 -4.936 -4.972 73.865 
-6.725 -5.468 74.401 -3.395 -6.948 74.164 
-4.831 -6.790 74.556 -2.783 -8.122 75.424 
0.601 7.049 78.044 -0.770 5.814 78.372 
-0.886 -9.101 78.221 -0.572 7.186 79.942 
0.443 5.515 79.938 -1.883 5.602 79.675 
0.468 -8.140 80.237 -2.243 -7.985 79.704 
-0.817 -9.461 79.693 -3.992 -6.725 85.777 
-3.424 3.578 86.699    
 
 
Table C16. Target points in the MAX bone (ribs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.580 12.060 27.900 -5.940 -12.060 27.900 
-4.500 7.020 29.700 -4.140 -9.180 29.700 
2.340 7.380 31.500 1.260 -9.180 31.500 
0.900 5.220 33.300 4.140 -0.900 35.100 
4.860 -7.380 36.900 -3.060 -12.060 38.700 
-8.100 6.660 40.500 0.900 10.980 42.300 
8.460 0.180 44.100 6.120 -12.420 45.900 
-5.400 -12.060 47.700 -5.220 10.980 49.500 
6.660 11.340 51.300 10.440 -8.100 53.100 
-5.220 -12.780 54.900 -7.380 6.660 56.700 
1.260 12.420 58.500 -4.860 -12.420 60.300 
 
 
Table C17. Target points in the MAX bone (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.360 16.560 30.780 0.360 16.560 32.220 
-0.180 16.020 33.660 -0.720 18.180 34.740 
0.180 17.820 36.540 -0.720 18.540 37.980 
-0.720 18.900 39.420 -1.080 19.260 40.860 
-1.620 19.800 42.300 -1.800 19.980 43.740 
-1.980 20.160 45.180 -2.700 20.700 46.620 
-3.060 21.240 48.060 -3.240 21.420 49.500 
-3.420 21.600 50.940 -3.780 21.960 52.380 
-3.600 22.140 53.820 -4.140 22.140 55.260 
-3.960 22.320 56.700 -3.060 22.860 58.140 
-3.600 22.860 59.580    
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Table C18. Target points in the MAX bone (right leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 7.020 81.900 -1.440 9.360 84.060 
-2.160 10.620 86.220 -2.340 10.260 88.380 
-1.260 10.620 90.540 -1.080 10.980 92.700 
-0.180 10.440 94.860 -0.000 10.440 97.020 
0.540 10.440 99.180 0.720 10.440 101.340 
0.720 10.440 103.500 1.080 10.260 105.660 
0.900 10.440 107.820 0.900 10.440 109.980 
0.900 10.440 112.140 0.900 10.260 114.300 
0.900 10.440 116.460 0.720 10.260 118.620 
0.900 10.440 120.780 0.900 10.620 122.940 
0.180 11.340 125.100    
 
 
Table C19. Target points in the MAX bone (skull). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.875 5.994 3.096 6.210 2.844 2.650 
0.270 0.619 0.360 -5.526 2.477 1.930 
5.299 -2.354 2.650 0.428 -4.921 3.308 
-5.188 -3.150 2.668 5.926 6.026 7.715 
-0.482 7.459 9.306 -5.062 7.139 5.540 
8.561 0.770 7.740 2.236 1.228 8.424 
-3.643 0.940 11.070 -9.734 2.286 6.797 
6.433 -4.126 7.708 1.516 -5.256 8.525 
-4.100 -6.458 8.194 -8.964 -2.999 6.790 
-1.980 7.398 14.602 -7.427 6.354 10.638 
2.369 0.709 14.296 -9.943 0.580 13.169 
-0.871 -6.005 14.184 -7.434 -4.532 12.096 
-4.813 3.744 16.168 -4.169 -2.495 16.200 
 
 
Table C20. Target points in the MAX bone (spine). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.260 0.540 17.460 -1.260 0.360 19.980 
-1.260 -0.360 22.500 -2.340 -0.000 25.020 
-3.060 -0.540 27.540 -3.060 -0.720 30.060 
-3.780 -0.900 32.580 -4.500 -1.080 35.100 
-4.860 -1.080 37.620 -5.220 -0.720 40.140 
-5.580 -0.900 42.660 -5.220 -0.900 45.180 
-4.860 -1.260 47.700 -4.500 -1.080 50.220 
-4.140 -1.260 52.740 -4.140 -1.260 55.260 
-3.780 -1.260 57.780 -3.420 -1.440 60.300 
-2.700 -2.340 62.820 -1.980 -2.160 65.340 
-1.620 -2.340 67.860 -1.620 -1.800 70.380 
-4.140 -1.440 72.900 -7.020 -1.440 75.420 
-8.820 -1.260 77.940    
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Table C21. Target points in the MAX brain. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.465 3.571 4.612 -1.598 4.882 5.512 
3.596 2.938 4.626 1.728 1.822 4.122 
-0.153 3.478 4.477 -2.322 2.736 4.230 
-3.744 3.892 5.324 -5.706 2.117 5.321 
3.946 0.688 4.129 1.861 -0.457 4.068 
-0.101 1.422 4.025 -2.302 0.551 3.750 
-4.244 1.494 4.126 3.600 -1.296 4.810 
0.817 -2.084 4.608 -0.576 -0.763 4.169 
-3.625 -0.767 4.550 -5.476 -0.079 5.029 
-7.088 0.288 6.199 2.300 -2.840 5.339 
-2.081 -1.969 4.633 -4.442 -2.300 5.674 
2.657 4.673 5.933 0.392 4.842 6.286 
-2.538 5.321 7.009 5.836 2.786 7.690 
4.709 3.370 5.994 2.297 2.970 6.919 
0.551 2.437 6.480 -1.685 3.013 6.311 
-3.438 3.067 7.564 -5.540 3.593 6.487 
5.368 1.379 5.753 2.887 1.336 5.861 
1.026 0.263 5.803 -0.997 1.094 5.735 
-3.499 1.505 6.088 -7.250 2.117 7.394 
5.569 -0.875 5.724 2.041 -1.073 6.732 
-0.310 -1.379 6.566 -2.120 -0.198 6.343 
-4.514 -0.425 6.782 3.884 -2.560 6.836 
1.166 -3.074 6.973 -0.814 -3.154 5.429 
-2.585 -1.854 7.092 -6.329 -1.656 6.808 
-1.044 -3.690 7.391 -2.959 -3.672 6.102 
-5.094 -3.535 7.200 4.018 4.194 7.700 
1.555 4.777 8.006 -0.196 5.577 8.473 
-2.956 5.238 9.054 -4.565 4.835 7.578 
4.115 1.814 7.992 1.953 1.220 8.150 
-0.918 3.892 7.902 -2.657 2.617 9.259 
-6.718 3.503 8.377 5.782 0.446 7.682 
3.794 -0.137 6.642 -1.480 1.595 7.891 
-3.470 0.493 8.330 -5.476 1.228 7.423 
5.321 -1.732 7.830 3.596 -0.569 8.701 
0.198 0.382 7.909 -1.354 -0.544 8.662 
-7.621 -0.274 8.125 2.876 -2.693 8.604 
1.289 -1.264 8.744 -0.684 -2.099 8.780 
-2.995 -1.760 9.443 -4.464 -1.894 8.363 
-6.847 -2.405 8.683 0.821 -3.798 8.766 
-2.959 -3.881 8.302 -5.094 -3.852 9.392 
0.936 4.457 10.019 -1.382 5.206 10.235 
-3.751 4.133 10.080 -5.422 4.662 9.619 
0.648 2.531 8.849 -1.116 3.413 9.817 
-4.964 2.491 8.795 -6.934 3.193 10.364 
-6.624 1.102 9.720 -8.381 1.714 9.432 
0.774 -2.894 10.307 -1.487 -3.643 9.911 
-7.745 -0.979 9.920 -3.679 -3.463 10.390 
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Table C22. Target points in the MAX breast. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.340 8.820 35.820 1.620 8.100 34.740 
3.780 7.380 35.820 4.500 6.660 35.820 
4.500 5.940 35.820 3.420 -9.900 36.540 
4.140 -9.180 36.180 4.860 -8.460 36.720 
5.400 -7.740 36.720 5.040 -6.660 36.000 
 
 
Table C23. Target points in the MAX colon. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
4.579 4.352 59.533 3.100 5.530 59.324 
0.376 5.793 59.336 5.947 4.640 59.526 
5.432 2.347 58.907 2.149 4.554 59.468 
7.020 0.541 58.860 5.429 0.922 59.440 
4.064 3.236 59.569 7.895 0.691 59.594 
7.375 -0.905 60.664 7.027 -2.333 59.189 
7.088 -2.666 59.894 6.213 -5.677 59.948 
1.300 7.952 62.107 2.034 7.398 61.168 
-0.446 7.794 61.222 2.149 5.411 62.935 
0.756 5.868 62.791 2.221 7.556 63.724 
1.516 7.704 64.681 2.959 6.278 63.511 
-0.137 6.505 63.443 2.560 6.973 66.247 
1.814 6.707 67.288 0.371 6.887 65.074 
3.172 5.839 65.398    
 
 
Table C24. Target points in the MAX esophagus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.080 0.360 28.260 -1.080 -0.180 28.980 
-0.720 -1.080 50.580 0.360 -1.800 49.500 
0.180 -1.980 48.780 -1.800 -1.800 31.860 
-2.160 -1.440 34.380 -2.440 -1.580 37.500 
-2.340 -1.080 39.420 -2.160 -0.900 41.940 
-1.620 -1.440 44.460 -0.720 -1.440 46.980 
 
 
Table C25. Target points in the MAX heart. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.215 -2.402 40.520 1.631 -2.340 44.413 
5.251 -2.308 43.220 2.327 -2.344 44.562 
4.101 -3.090 46.666    
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Table C26. Target points in the MAX kidneys. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.328 -6.614 55.617 -3.256 4.968 55.124 
-4.029 6.762 58.133 -4.432 -8.147 56.124 
-4.130 -8.392 58.776    
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Table C27. Target points in the MAX liver. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.992 9.504 50.267 1.976 9.670 50.123 
-0.025 9.410 50.209 -2.995 9.266 49.889 
3.913 7.661 49.662 1.523 7.276 49.777 
-1.166 8.467 49.871 -4.259 7.996 50.386 
-5.443 7.207 51.862 0.335 6.091 50.382 
-1.282 6.901 50.357 -3.298 6.613 49.864 
4.108 4.313 50.072 3.287 5.720 50.195 
1.318 4.223 49.673 -0.072 3.265 50.324 
-1.523 4.518 49.590 -3.568 5.256 50.508 
4.961 1.951 49.979 2.783 2.833 50.418 
2.041 1.368 49.723 8.863 1.480 51.793 
4.183 0.112 50.008 2.282 -0.914 50.249 
0.338 1.256 50.710 7.218 -2.905 49.896 
6.912 -0.554 50.047 4.756 -2.369 49.608 
4.226 9.529 52.038 1.854 10.274 52.178 
-0.306 10.307 51.912 -2.257 9.875 52.060 
-4.198 9.616 52.132 6.073 8.348 52.157 
2.023 7.960 51.728 0.101 8.125 52.268 
-2.128 8.021 52.340 7.276 5.918 51.991 
4.892 6.692 53.017 3.704 6.700 51.808 
1.296 6.116 53.096 -0.623 6.134 53.186 
-1.292 5.184 52.067 -5.450 5.695 51.404 
7.870 3.827 52.895 4.810 4.212 52.103 
3.085 4.090 52.780 1.721 5.026 51.757 
0.360 3.596 52.546 4.903 2.142 51.973 
3.053 1.368 52.301 7.492 0.925 52.312 
4.828 -0.320 51.736 1.976 10.037 53.885 
-0.209 10.418 54.068 -2.225 10.206 53.996 
4.655 9.022 54.745 3.802 8.798 53.453 
0.176 8.536 54.133 -3.694 8.950 54.464 
-4.975 8.482 53.248 8.118 5.746 55.159 
7.574 6.494 53.723 3.424 5.486 54.162 
2.210 7.492 54.104 0.256 6.181 55.415 
6.016 4.489 53.240 5.022 3.434 55.102 
2.192 2.916 54.882 0.720 4.295 54.572 
6.286 1.987 52.834 3.798 2.614 54.317 
8.435 0.414 54.346 6.444 0.166 54.968 
2.336 10.112 55.505 0.184 10.213 56.340 
-1.562 9.673 56.239 -3.103 9.724 56.542 
6.772 7.481 56.297 2.430 7.747 55.739 
6.466 7.902 54.443 2.696 5.112 55.534 
7.729 4.183 55.433 5.558 5.278 55.188 
4.554 7.006 55.699 8.514 2.581 54.475 
6.379 2.074 54.846 2.117 9.925 57.712 
4.640 9.198 56.689 0.932 9.666 59.191 
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Table C28. Target points in the MAX lungs. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.902 5.000 38.938 -3.496 -7.880 38.070 
2.732 6.095 42.408 -1.937 4.486 43.463 
-1.044 -9.047 44.338 4.252 -9.040 43.607 
 
 
Table C29. Target points in the MAX muscle (head and neck). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.500 2.700 23.940 3.420 6.840 8.820 
3.780 -4.500 10.260 4.140 5.220 11.700 
2.700 -4.140 13.140 0.900 2.340 14.580 
-5.220 -3.780 16.020 -5.220 3.420 17.460 
1.620 2.340 18.900 1.980 -2.700 20.340 
3.780 0.360 21.780 -5.220 -2.700 23.220 
 
 
Table C30. Target points in the MAX muscle (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.340 -24.300 85.500 -3.060 -23.220 76.500 
-4.500 -21.780 71.460 -1.620 -22.500 66.420 
-2.340 -23.940 61.380 -5.580 -20.340 56.340 
-7.380 -22.860 51.300 -4.500 -24.300 46.260 
-2.340 -22.140 41.220 -4.140 -21.780 36.180 
-4.500 -20.340 31.140    
 
 
Table C31. Target points in the MAX muscle (lower legs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-6.300 12.060 129.780 -7.020 -12.060 129.780 
-4.860 9.540 133.740 -5.580 -9.900 133.740 
-7.380 14.940 137.700 -7.740 -15.660 137.700 
-4.500 10.260 141.660 -4.500 -10.260 141.660 
-6.300 13.140 145.620 -7.380 -13.500 145.620 
-7.020 14.580 149.580 -7.380 -15.660 149.580 
-5.220 12.780 153.540 -5.940 -13.140 153.540 
-5.940 13.860 157.500 -5.940 -14.220 157.500 
-5.580 14.580 161.460 -5.580 -15.300 161.460 
-6.300 14.220 165.420 -5.580 -14.940 165.420 
-1.980 13.860 173.340 -0.900 -16.020 173.340 
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Table C32. Target points in the MAX muscle (lower torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.500 7.380 72.180 -3.780 -12.780 75.420 
-7.380 4.860 78.660 3.060 -13.140 81.900 
3.060 9.900 85.140 -6.660 -9.540 88.380 
-0.180 4.860 91.620 -0.900 -8.100 91.620 
-0.540 6.300 94.500 -0.540 -8.100 94.500 
 
 
Table C33. Target points in the MAX muscle (mid torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-9.540 2.340 48.780 10.620 -0.540 50.940 
-8.820 -7.740 53.100 -8.100 8.100 55.260 
-8.100 -7.380 57.420 -4.860 2.340 59.580 
-3.060 -5.940 61.740 3.780 10.620 63.900 
2.700 -13.140 66.060 -3.420 -5.940 68.220 
0.180 3.780 70.380    
 
 
Table C34. Target points in the MAX muscle (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.060 23.580 85.140 -1.260 23.940 76.500 
-3.420 22.500 71.460 -3.060 25.020 66.420 
-0.000 22.860 61.380 -1.980 18.180 56.340 
-0.900 21.780 51.300 -5.580 19.260 46.260 
1.980 18.900 41.220 -2.340 21.420 36.180 
-3.780 19.980 31.140    
 
 
Table C35. Target points in the MAX muscle (upper legs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.540 13.860 95.580 0.180 -16.380 95.580 
-2.700 4.860 98.820 -3.780 -6.660 98.820 
0.540 4.860 102.060 0.900 -7.740 102.060 
4.860 12.780 105.660 2.700 -15.300 105.660 
-3.780 5.940 109.260 -4.140 -7.020 109.260 
0.540 14.220 112.500 -0.900 -16.020 112.500 
3.780 7.740 116.100 3.780 -10.980 116.100 
-4.500 9.180 119.700 -4.500 -9.540 119.700 
1.980 7.020 123.300 1.980 -9.180 123.300 
-4.860 13.140 126.900 -6.660 -14.220 126.900 
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Table C36. Target points in the MAX muscle (upper torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.220 2.700 25.380 -5.220 -5.220 27.540 
-7.380 5.940 29.700 0.180 7.740 31.860 
3.420 -7.740 34.380 -9.540 -4.140 36.540 
-9.540 1.620 38.700 -7.380 12.060 40.860 
-5.580 -14.940 43.020 -9.540 1.980 45.180 
-1.260 13.500 47.340    
 
 
Table C37. Target points in the MAX pancreas. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.464 -1.832 54.014 1.742 -3.787 54.018 
-0.037 -3.414 54.067 1.116 -0.994 55.339 
-0.407 -2.794 55.498    
 
 
Table C38. Target points in the MAX prostate. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.533 -0.749 83.135 0.115 -0.864 83.801 
0.050 -1.793 83.887 0.252 -0.835 84.676 
0.256 -1.699 84.726 -0.234 -1.354 86.141 
 
 
Table C39. Target points in the MAX salivary glands. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.980 -7.020 14.940 1.980 7.380 14.940 
2.340 6.300 18.540 2.700 -5.940 18.540 
4.500 4.140 21.780 4.500 -3.060 21.780 
3.420 -4.140 21.060 3.780 4.860 21.060 
4.860 0.900 19.980 3.420 0.900 19.980 
3.060 -0.540 19.980 4.860 -0.540 19.980 
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Table C40. Target points in the MAX skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-7.190 2.510 1.090 4.670 -3.230 1.810 
-0.730 -6.110 3.250 -6.830 -3.230 1.810 
4.670 2.510 0.370 2.510 7.910 5.410 
8.990 5.030 8.650 -2.510 8.270 4.690 
-7.190 7.550 6.130 8.630 -3.950 8.290 
-0.730 -8.270 9.540 -9.710 -4.670 7.930 
1.620 8.270 16.910 7.910 5.750 14.750 
-10.790 3.950 10.070 8.990 -3.590 14.580 
-1.430 -8.990 15.110 -10.430 -2.870 12.590 
10.790 0.710 20.870 -12.230 1.260 31.330 
-7.190 6.830 15.830 5.390 -6.110 18.710 
-7.910 2.150 22.140 -10.790 9.350 29.530 
5.750 1.790 25.380 1.260 5.390 23.580 
-12.590 -9.350 35.650 -7.190 -4.310 19.260 
-10.790 -6.660 28.450 -4.310 24.830 32.050 
3.590 21.590 32.770 -5.750 18.350 26.650 
-8.990 19.790 32.220 3.230 17.630 28.090 
-5.220 10.070 25.930 -10.790 16.550 35.460 
5.750 7.020 30.970 3.230 10.620 27.730 
4.310 -7.380 28.450 4.310 -14.580 28.810 
-7.910 -14.750 26.650 -3.060 -9.350 25.930 
2.150 -20.510 28.090 -6.110 -21.590 28.090 
0.710 24.470 40.310 6.470 17.990 39.230 
-10.070 14.750 40.670 8.270 0.730 36.010 
7.910 -4.140 35.650 8.990 -8.100 37.810 
7.910 -15.470 37.090 -2.340 -17.460 44.460 
2.870 -23.390 35.990 -4.670 -25.550 35.290 
-11.150 -16.910 35.290 2.510 22.670 46.980 
-6.470 25.550 43.570 -8.990 20.340 47.510 
8.270 12.060 38.340 10.430 4.860 41.050 
11.870 -8.460 49.500 -12.590 -0.540 39.060 
8.990 -13.310 43.740 -9.710 -19.090 44.100 
-7.550 -25.550 42.300 2.870 -21.230 45.540 
1.790 23.030 53.460 -6.830 24.830 54.350 
6.470 13.310 47.700 -11.510 7.190 48.420 
11.870 3.060 47.700 11.870 -3.420 47.170 
4.310 -16.190 49.670 -8.990 -23.220 51.660 
-1.450 -26.630 47.340 2.150 24.110 61.570 
-6.470 20.890 65.870 -8.630 12.230 52.380 
3.230 14.390 55.980 11.870 2.700 59.220 
-1.980 15.110 46.620 -11.870 3.590 57.230 
11.150 -10.790 54.350 11.870 -2.700 58.500 
-12.230 -2.340 48.780 8.990 -11.870 60.110 
-8.990 -13.310 50.750 -7.910 -23.580 64.260 
-0.010 -24.470 65.510 1.430 24.470 70.190 
3.230 14.030 62.820 -5.750 15.470 76.330 
-7.190 13.310 57.970 11.150 4.310 66.950 
-10.430 9.350 64.620 -10.430 0.180 64.620 
11.150 1.430 71.990 -11.510 -8.270 55.980 
3.950 -15.470 61.020 -7.550 -14.750 60.490 
-2.510 26.990 72.710 -2.700 14.390 65.340 
-9.350 12.590 70.570 7.910 10.430 65.870 
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Table C40 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
11.150 -5.750 67.310 1.070 -16.910 73.620 
2.150 -16.190 66.780 -8.270 -14.390 69.300 
-1.450 -27.350 76.140 -3.590 25.210 79.020 
1.980 15.470 82.980 -3.590 17.270 87.130 
-11.510 5.750 74.340 1.070 15.110 73.620 
-11.510 -0.900 82.260 6.830 10.790 72.900 
-11.870 0.180 71.290 8.270 -9.350 83.700 
8.270 -10.430 71.460 -11.870 -6.300 73.790 
3.950 -16.190 78.490 -4.670 -26.270 81.730 
-10.070 -12.950 77.050 6.110 22.690 83.890 
-8.630 13.670 82.260 6.470 12.590 84.420 
-10.790 7.190 91.430 7.910 7.190 80.100 
9.350 1.790 81.370 -1.980 -1.980 89.270 
8.270 -6.830 77.940 -11.510 -8.630 85.500 
4.310 -16.910 83.890 -6.830 -16.550 80.100 
4.310 22.670 93.230 5.750 23.220 91.260 
-10.790 8.100 82.980 7.910 11.510 91.090 
10.430 -2.150 88.020 8.270 -8.290 94.500 
-7.550 -15.660 86.940 2.510 -25.190 84.060 
-5.390 -23.750 90.540 -1.430 27.710 85.330 
-2.510 22.860 92.510 8.270 12.230 97.930 
8.270 4.690 101.700 -6.110 0.730 98.100 
-10.430 0.730 91.430 10.070 1.790 91.430 
-10.790 -5.940 92.510 7.190 -15.110 91.090 
-0.010 -22.310 93.590 -7.910 -14.750 98.270 
2.870 -20.700 91.980 -6.830 -17.270 92.340 
-5.390 16.550 99.180 -7.190 15.470 91.620 
5.750 15.470 100.810 -7.550 2.170 102.780 
-8.270 11.510 100.980 6.110 1.090 97.740 
-0.180 -0.350 95.030 5.750 -5.050 104.030 
-0.180 -2.890 105.300 8.270 -13.670 101.700 
-7.550 -15.470 107.100 5.390 -17.630 102.060 
10.790 9.350 57.230 -11.510 -8.270 43.740 
-1.980 -15.830 55.620 -7.550 -25.550 57.610 
0.710 -24.110 56.340 -5.390 25.550 61.570 
-7.910 3.610 109.070 -8.270 -5.770 104.220 
6.830 -9.540 110.340 -8.270 -14.030 114.830 
6.110 -16.190 112.310 -1.430 -19.070 102.780 
3.590 16.910 110.510 -3.590 16.550 111.230 
7.190 6.850 111.950 -7.910 5.770 114.110 
-0.370 2.530 117.350 -2.170 -3.610 114.110 
3.590 -6.130 116.100 -7.910 -6.490 115.550 
0.180 -18.710 112.670 3.590 15.470 118.070 
6.110 7.210 119.700 -3.950 3.970 124.550 
-7.190 11.510 121.500 5.030 -8.650 121.670 
-7.190 -7.930 125.270 -3.230 -17.630 118.620 
3.230 14.030 128.870 -2.510 16.190 122.050 
5.030 8.650 125.990 -4.310 6.130 132.830 
5.030 -14.750 123.110 -8.630 -14.750 127.810 
0.350 10.090 139.670 -8.270 14.030 130.860 
-1.090 -5.410 125.990 -2.340 -17.270 126.350 
0.350 16.910 138.060 -1.090 -8.650 135.180 
11.150 9.350 50.410 -12.590 6.830 39.950 
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Table C40 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.070 -16.190 133.550 -10.790 -15.110 135.900 
-9.710 16.190 137.700 -8.990 -7.570 137.700 
-7.550 -19.070 139.670 -1.450 17.270 148.310 
-9.350 16.550 146.870 -8.630 7.570 142.380 
-0.370 -17.270 144.350 -4.690 -7.930 146.510 
-10.430 -14.220 147.950 -2.530 10.090 149.750 
-8.270 13.330 157.670 -2.170 -13.330 156.230 
-6.830 -18.350 155.510 -1.090 16.190 160.020 
-5.050 11.890 168.130 0.350 -17.990 165.610 
-7.910 -14.410 165.970 3.780 -18.710 171.900 
3.060 17.990 171.900 10.790 -12.420 171.730 
10.790 12.610 171.730 -8.630 15.830 171.900 
-7.020 -12.250 171.900 -7.910 13.670 110.510 
0.540 17.630 101.340 3.230 2.170 109.430 
7.910 12.950 109.620 -7.550 -23.750 71.630 
-10.430 -8.460 64.260    
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Table C41. Target points in the MAX small intestine. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.833 -7.146 59.162 2.133 -9.016 60.570 
2.315 -9.184 62.622 4.964 -0.108 65.610 
4.723 -3.352 67.511    
 
 
Table C42. Target points in the MAX spleen. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.585 -11.225 52.520 -4.277 -10.091 52.009 
-0.130 -12.064 52.999 -3.946 -11.272 53.482 
-1.926 -12.132 54.079    
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Table C43. Target points in the MAX stomach. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-3.316 -9.677 49.320 1.163 -4.831 50.591 
0.104 -4.590 50.490 -1.411 -4.939 50.364 
1.760 -6.149 50.620 0.889 -6.523 50.324 
0.032 -5.857 50.393 -1.310 -6.210 50.310 
-2.887 -6.538 50.141 3.020 -6.167 50.882 
2.459 -7.250 50.620 -1.937 -7.416 50.476 
3.737 -8.334 50.821 0.886 -8.773 50.202 
-0.302 -7.459 50.274 -1.483 -8.388 50.522 
2.261 -9.562 50.285 -0.749 -9.644 50.260 
-2.408 -9.511 50.116 0.508 -12.247 50.317 
-0.277 -10.930 50.274 -1.825 -10.951 50.155 
-1.073 -12.427 50.198 6.286 -5.155 51.080 
5.350 -5.404 50.861 4.532 -5.047 51.091 
2.884 -4.288 51.901 1.246 -4.313 51.638 
-0.382 -4.568 51.358 -1.984 -4.752 51.325 
-2.887 -5.080 50.638 6.667 -7.362 50.954 
5.699 -6.401 51.836 4.331 -6.487 50.886 
3.542 -5.148 51.008 2.282 -5.047 50.692 
1.742 -5.526 51.941 0.641 -5.630 51.595 
-0.835 -5.648 51.419 7.063 -7.196 51.991 
5.454 -6.872 50.810 3.683 -7.337 50.616 
3.049 -6.476 51.934 1.202 -7.621 50.612 
-0.266 -6.998 51.239 -1.422 -6.962 51.419 
6.559 -8.406 50.936 5.954 -8.366 51.948 
5.116 -7.942 50.868 4.486 -7.423 51.984 
2.408 -8.384 50.486 1.912 -7.877 51.876 
0.652 -8.042 51.545 6.041 -10.040 50.836 
5.256 -9.061 50.789 3.758 -9.238 50.616 
-0.043 -8.687 50.760 7.909 -4.288 52.164 
6.822 -4.424 52.052 6.707 -3.413 53.003 
6.721 -5.879 52.430 5.551 -4.205 52.034 
4.298 -4.244 52.117 8.496 -5.414 52.218 
7.596 -5.832 51.746 5.515 -5.242 52.315 
4.309 -6.016 52.006 2.592 -5.288 52.081 
8.492 -6.826 52.222 3.427 -7.351 52.013 
1.865 -6.804 51.944 7.715 -7.891 52.085 
7.405 -6.707 53.197 5.670 -7.463 52.261 
4.478 -8.582 52.024 2.920 -8.104 51.937 
7.337 -8.852 52.070 5.908 -9.342 52.232 
4.946 -9.734 51.764 7.686 -3.542 53.244 
8.647 -4.414 53.248 6.379 -4.666 53.399 
5.580 -3.758 53.050 7.344 -5.022 53.172 
6.073 -6.052 53.392 4.742 -4.995 53.194 
8.978 -7.186 53.150 8.158 -5.890 53.305 
6.116 -7.268 53.176 7.837 -7.873 53.309 
6.646 -8.176 53.158 7.927 -9.414 52.999 
  124 
Table C44. Target points in the MAX testes. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
6.386 -0.137 91.764 7.474 -0.425 91.566 
7.258 -1.890 91.764 7.229 -3.348 91.544 
7.207 0.086 92.678 7.142 0.313 91.876 
7.222 -2.506 92.603 6.451 -2.462 91.642 
7.668 -2.704 91.692 6.696 -3.060 92.210 
6.728 -0.335 93.226 6.361 -2.030 92.394 
6.696 -2.491 93.247    
 
 
Table C45. Target points in the MAX thymus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.638 0.187 34.517 1.883 -0.922 34.718 
0.752 -0.688 34.657 2.268 -0.378 35.424 
1.177 -0.014 35.399    
 
 
Table C46. Target points in the MAX thyroid. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.599 -0.338 30.719 1.897 -0.025 30.834 
2.628 -1.066 30.701 1.966 -1.300 30.794 
1.548 -0.677 30.784    
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12. Appendix D – Target Point Locations in FAX 
 
 
Table D1. Target points in the FAX adrenals. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.243 -1.811 52.668 -2.632 -2.297 52.146 
-3.049 -1.944 52.459 -2.185 3.748 52.726 
-2.229 4.196 53.453    
 
 
Table D2. Target points in the FAX BFO (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.440 -14.940 29.340 -0.000 -15.660 30.780 
-0.720 -16.020 32.220 -1.080 -16.560 33.660 
-1.260 -16.740 35.100 -2.520 -17.100 36.540 
-2.880 -17.100 37.980 -3.240 -17.640 39.420 
-3.420 -17.640 40.860 -3.960 -18.000 42.300 
-4.140 -18.540 43.740 -4.500 -18.900 45.180 
-5.040 -19.080 46.620 -5.400 -19.620 48.060 
-5.400 -19.980 49.500 -5.580 -19.800 50.940 
-5.400 -20.160 52.380 -6.660 -20.340 53.820 
-5.760 -20.340 55.260 -6.120 -19.980 56.700 
 
 
Table D3. Target points in the FAX BFO (left leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 -8.280 77.580 -0.000 -10.440 79.380 
-0.000 -11.700 81.180 0.540 -11.340 82.980 
-0.180 -11.160 84.780 -0.180 -11.160 86.580 
0.180 -10.620 88.380 0.540 -10.620 90.180 
0.720 -10.440 91.980 0.900 -10.260 93.780 
1.080 -9.900 95.580 1.080 -9.720 97.380 
1.260 -9.720 99.180 1.440 -9.360 100.980 
1.080 -9.360 102.780 1.440 -9.180 104.580 
1.440 -9.000 106.380 1.440 -8.820 108.180 
1.440 -8.640 109.980 1.260 -8.460 111.780 
1.260 -8.100 113.580 0.720 -8.280 115.380 
 
 
Table D4. Target points in the FAX BFO (mandible). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.013 4.471 15.268 -0.108 3.751 14.933 
3.791 -4.129 16.366 1.246 -2.408 14.908 
0.497 -4.781 16.304 0.918 4.410 18.608 
4.817 3.478 18.623 3.798 1.552 16.776 
7.610 0.580 15.257 7.103 -1.645 18.198 
3.978 -1.516 16.758 4.860 -2.365 19.616 
1.580 -4.144 18.871 6.700 1.022 19.624 
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Table D5. Target points in the FAX BFO (pelvis). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.879 -5.346 68.670 -5.508 6.217 70.189 
-6.786 5.987 69.131 -5.101 -5.353 69.944 
-4.500 6.790 70.826 -5.159 4.975 70.200 
-7.085 5.256 70.175 -5.645 3.913 70.488 
-4.111 -4.234 70.096 -5.465 -3.352 70.272 
-5.843 -4.799 71.014 -3.679 -5.994 70.297 
-4.435 7.243 72.486 -5.479 6.102 71.770 
-6.390 5.245 71.467 -3.100 -6.656 71.784 
-3.017 7.949 72.756 -0.266 -8.316 73.537 
-1.253 9.400 74.160 -2.830 8.104 74.524 
-1.721 -7.405 73.598 -0.706 9.263 75.488 
-2.110 8.413 75.575 -0.806 -7.600 75.064 
0.328 -8.280 75.125 -2.034 -7.438 75.546 
-4.208 7.207 79.643    
 
 
Table D6. Target points in the FAX BFO (ribs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.180 5.940 25.020 3.060 -2.340 26.460 
3.780 7.380 27.900 -6.480 -8.280 29.340 
-6.480 9.360 30.780 3.600 -11.160 32.220 
1.800 12.600 33.660 -2.520 12.240 35.100 
5.760 -10.800 36.540 3.420 12.600 37.980 
-7.020 -3.240 39.420 -4.680 12.240 40.860 
7.560 -8.280 42.300 6.120 11.160 43.740 
-7.560 -6.660 45.180 -7.200 10.440 46.620 
5.760 -11.160 48.060 6.660 9.180 49.500 
-6.660 -7.740 50.940 -5.580 10.800 52.380 
0.900 -11.880 53.820 -2.520 12.780 55.260 
-0.540 -11.700 56.700    
 
 
Table D7. Target points in the FAX BFO (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.620 14.760 29.340 -0.000 15.660 30.780 
-0.900 15.660 32.220 -1.080 16.560 33.660 
-1.080 16.740 35.100 -2.340 17.100 36.540 
-2.880 17.100 37.980 -3.240 17.640 39.420 
-3.420 17.820 40.860 -3.960 18.000 42.300 
-4.140 18.540 43.740 -4.500 19.080 45.180 
-5.040 19.080 46.620 -5.400 19.620 48.060 
-5.580 19.980 49.500 -5.580 19.800 50.940 
-5.400 20.160 52.380 -6.660 20.340 53.820 
-5.760 20.160 55.260 -6.120 19.800 56.700 
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Table D8. Target points in the FAX BFO (right leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 8.460 77.580 -0.000 10.440 79.380 
0.180 11.880 81.180 0.540 11.340 82.980 
-0.180 11.160 84.780 -0.000 11.160 86.580 
0.360 10.620 88.380 0.540 10.620 90.180 
0.900 10.440 91.980 0.900 10.260 93.780 
1.080 10.080 95.580 1.260 9.720 97.380 
1.260 9.720 99.180 1.440 9.360 100.980 
1.440 9.360 102.780 1.440 9.180 104.580 
1.440 9.000 106.380 1.440 8.820 108.180 
1.260 8.640 109.980 1.260 8.460 111.780 
1.080 8.100 113.580 0.720 7.920 115.380 
 
 
Table D9. Target points in the FAX BFO (skull). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.353 2.804 1.566 -5.857 3.874 3.017 
4.849 -0.547 1.836 -1.066 -4.313 2.732 
-6.322 -1.264 1.516 6.120 3.312 7.297 
-0.803 6.106 7.772 -7.812 4.946 8.593 
6.718 -2.736 7.996 -10.390 -0.151 7.121 
1.393 -5.749 8.921 -6.646 -5.357 7.445 
5.220 4.457 12.805 -0.565 5.904 14.281 
-5.548 5.198 13.903 2.365 -1.066 13.561 
-3.528 -0.954 15.120 -9.608 -0.191 13.835 
-2.963 -6.383 13.504    
 
 
Table D10. Target points in the FAX BFO (spine). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.900 -0.000 16.740 -1.620 -0.180 19.620 
-1.620 -0.360 22.500 -3.420 -0.180 25.380 
-4.140 -0.180 28.260 -4.500 -0.180 31.140 
-4.500 0.180 34.020 -4.500 -0.360 36.900 
-4.860 0.180 39.780 -4.500 0.360 42.660 
-3.780 0.540 45.540 -3.780 0.720 48.420 
-3.780 0.540 51.300 -3.420 0.720 54.180 
-3.420 0.720 57.060 -2.700 0.720 59.940 
-2.340 0.720 62.820 -2.700 0.360 65.700 
-3.780 0.540 68.580 -7.380 -0.000 71.460 
-9.360 -0.000 74.340 -9.360 -0.000 77.220 
-8.820 0.180 80.100 -7.380 0.360 82.980 
 
 
Table D11. Target points in the FAX bladder. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.054 2.009 73.548 0.216 2.354 76.961 
2.477 -0.436 74.920 -0.511 -1.076 74.826 
-0.197 -1.276 79.092 1.249 0.842 80.172 
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Table D12. Target points in the FAX bone (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.440 -14.940 29.340 -0.000 -15.660 30.780 
-0.720 -16.020 32.220 -1.080 -16.560 33.660 
-1.260 -16.740 35.100 -2.520 -17.100 36.540 
-2.880 -17.100 37.980 -3.240 -17.640 39.420 
-3.420 -17.640 40.860 -3.960 -18.000 42.300 
-4.140 -18.540 43.740 -4.500 -18.900 45.180 
-5.040 -19.080 46.620 -5.400 -19.620 48.060 
-5.400 -19.980 49.500 -5.580 -19.800 50.940 
-5.400 -20.160 52.380 -6.660 -20.340 53.820 
-5.760 -20.340 55.260 -6.120 -19.980 56.700 
 
 
Table D13. Target points in the FAX bone (left leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 -8.280 77.580 -0.000 -10.440 79.380 
-0.000 -11.700 81.180 0.540 -11.340 82.980 
-0.180 -11.160 84.780 -0.180 -11.160 86.580 
0.180 -10.620 88.380 0.540 -10.620 90.180 
0.720 -10.440 91.980 0.900 -10.260 93.780 
1.080 -9.900 95.580 1.080 -9.720 97.380 
1.260 -9.720 99.180 1.440 -9.360 100.980 
1.080 -9.360 102.780 1.440 -9.180 104.580 
1.440 -9.000 106.380 1.440 -8.820 108.180 
1.440 -8.640 109.980 1.260 -8.460 111.780 
1.260 -8.100 113.580 0.720 -8.280 115.380 
 
 
Table D14. Target points in the FAX bone (mandible). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.013 4.471 15.268 -0.108 3.751 14.933 
3.791 -4.129 16.366 1.246 -2.408 14.908 
0.497 -4.781 16.304 0.918 4.410 18.608 
4.817 3.478 18.623 3.798 1.552 16.776 
7.610 0.580 15.257 7.103 -1.645 18.198 
3.978 -1.516 16.758 4.860 -2.365 19.616 
1.580 -4.144 18.871 6.700 1.022 19.624 
  129 
Table D15. Target points in the FAX bone (pelvis). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.879 -5.346 68.670 -5.508 6.217 70.189 
-6.786 5.987 69.131 -5.101 -5.353 69.944 
-4.500 6.790 70.826 -5.159 4.975 70.200 
-7.085 5.256 70.175 -5.645 3.913 70.488 
-4.111 -4.234 70.096 -5.465 -3.352 70.272 
-5.843 -4.799 71.014 -3.679 -5.994 70.297 
-4.435 7.243 72.486 -5.479 6.102 71.770 
-6.390 5.245 71.467 -3.100 -6.656 71.784 
-3.017 7.949 72.756 -0.266 -8.316 73.537 
-1.253 9.400 74.160 -2.830 8.104 74.524 
-1.721 -7.405 73.598 -0.706 9.263 75.488 
-2.110 8.413 75.575 -0.806 -7.600 75.064 
0.328 -8.280 75.125 -2.034 -7.438 75.546 
-4.208 7.207 79.643    
 
 
Table D16. Target points in the FAX bone (ribs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.180 5.940 25.020 3.060 -2.340 26.460 
3.780 7.380 27.900 -6.480 -8.280 29.340 
-6.480 9.360 30.780 3.600 -11.160 32.220 
1.800 12.600 33.660 -2.520 12.240 35.100 
5.760 -10.800 36.540 3.420 12.600 37.980 
-7.020 -3.240 39.420 -4.680 12.240 40.860 
7.560 -8.280 42.300 6.120 11.160 43.740 
-7.560 -6.660 45.180 -7.200 10.440 46.620 
5.760 -11.160 48.060 6.660 9.180 49.500 
-6.660 -7.740 50.940 -5.580 10.800 52.380 
0.900 -11.880 53.820 -2.520 12.780 55.260 
-0.540 -11.700 56.700    
 
 
Table D17. Target points in the FAX bone (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.620 14.760 29.340 -0.000 15.660 30.780 
-0.900 15.660 32.220 -1.080 16.560 33.660 
-1.080 16.740 35.100 -2.340 17.100 36.540 
-2.880 17.100 37.980 -3.240 17.640 39.420 
-3.420 17.820 40.860 -3.960 18.000 42.300 
-4.140 18.540 43.740 -4.500 19.080 45.180 
-5.040 19.080 46.620 -5.400 19.620 48.060 
-5.580 19.980 49.500 -5.580 19.800 50.940 
-5.400 20.160 52.380 -6.660 20.340 53.820 
-5.760 20.160 55.260 -6.120 19.800 56.700 
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Table D18. Target points in the FAX bone (right leg). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.180 8.460 77.580 -0.000 10.440 79.380 
0.180 11.880 81.180 0.540 11.340 82.980 
-0.180 11.160 84.780 -0.000 11.160 86.580 
0.360 10.620 88.380 0.540 10.620 90.180 
0.900 10.440 91.980 0.900 10.260 93.780 
1.080 10.080 95.580 1.260 9.720 97.380 
1.260 9.720 99.180 1.440 9.360 100.980 
1.440 9.360 102.780 1.440 9.180 104.580 
1.440 9.000 106.380 1.440 8.820 108.180 
1.260 8.640 109.980 1.260 8.460 111.780 
1.080 8.100 113.580 0.720 7.920 115.380 
 
 
Table D19. Target points in the FAX bone (skull). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
0.353 2.804 1.566 -5.857 3.874 3.017 
4.849 -0.547 1.836 -1.066 -4.313 2.732 
-6.322 -1.264 1.516 6.120 3.312 7.297 
-0.803 6.106 7.772 -7.812 4.946 8.593 
6.718 -2.736 7.996 -10.390 -0.151 7.121 
1.393 -5.749 8.921 -6.646 -5.357 7.445 
5.220 4.457 12.805 -0.565 5.904 14.281 
-5.548 5.198 13.903 2.365 -1.066 13.561 
-3.528 -0.954 15.120 -9.608 -0.191 13.835 
-2.963 -6.383 13.504    
 
 
Table D20. Target points in the FAX bone (spine). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.900 -0.000 16.740 -1.620 -0.180 19.620 
-1.620 -0.360 22.500 -3.420 -0.180 25.380 
-4.140 -0.180 28.260 -4.500 -0.180 31.140 
-4.500 0.180 34.020 -4.500 -0.360 36.900 
-4.860 0.180 39.780 -4.500 0.360 42.660 
-3.780 0.540 45.540 -3.780 0.720 48.420 
-3.780 0.540 51.300 -3.420 0.720 54.180 
-3.420 0.720 57.060 -2.700 0.720 59.940 
-2.340 0.720 62.820 -2.700 0.360 65.700 
-3.780 0.540 68.580 -7.380 -0.000 71.460 
-9.360 -0.000 74.340 -9.360 -0.000 77.220 
-8.820 0.180 80.100 -7.380 0.360 82.980 
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Table D21. Target points in the FAX brain. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.562 1.343 3.442 -0.400 1.469 3.092 
-2.347 2.603 4.032 -3.694 1.098 3.146 
-4.561 2.444 3.845 3.298 0.126 3.406 
1.418 -0.076 2.462 -2.066 0.666 2.714 
-3.852 -0.839 2.945 -5.742 0.641 3.355 
1.588 -1.526 3.485 -0.515 -1.040 2.678 
-2.056 -1.634 3.269 -3.859 -2.513 4.144 
-5.645 -1.350 3.611 -4.100 3.283 5.702 
3.215 1.386 4.982 1.285 1.840 5.083 
-0.605 2.380 4.874 -3.672 1.548 5.674 
-6.005 2.048 5.184 4.637 0.061 5.450 
1.368 -0.407 4.918 -0.320 0.018 4.115 
-2.117 0.846 4.961 -4.626 0.284 4.968 
-6.602 -0.202 5.310 3.323 -1.152 4.576 
-0.824 -1.433 5.598 -2.545 -0.626 4.979 
-4.349 -1.361 5.486 -5.976 -2.430 5.483 
-0.047 -2.380 4.212 -2.034 -2.930 4.961 
-4.000 -3.460 6.030 0.374 3.064 6.368 
-0.331 3.424 7.888 -2.027 3.334 6.116 
-5.893 2.956 7.027 3.949 1.958 6.757 
2.228 2.585 7.013 -1.814 1.872 6.959 
-3.809 2.621 7.567 -5.540 1.051 7.114 
-7.416 1.242 6.581 4.198 0.565 7.614 
2.376 0.216 6.314 0.302 1.292 7.070 
-0.306 0.389 6.026 -1.811 0.022 7.340 
-3.596 0.292 7.121 -7.366 -1.177 6.811 
3.503 -1.501 6.336 1.076 -1.098 6.966 
-0.673 -1.508 7.610 -2.891 -1.660 6.869 
-5.267 -0.824 7.060 1.692 -2.484 5.688 
-0.130 -3.182 6.404 -2.045 -3.229 6.973 
-6.458 -2.657 7.502 -3.744 3.442 9.324 
-7.164 2.149 8.575 2.138 0.871 7.934 
1.206 2.549 8.856 -1.030 1.786 8.986 
-2.002 3.427 8.582 -3.107 1.192 8.957 
-5.080 1.001 8.942 -7.211 0.788 9.781 
0.302 0.324 8.604 -1.296 -0.242 9.611 
-7.247 -0.148 8.338 4.687 -0.954 7.556 
2.974 -2.369 7.654 0.497 -1.469 9.274 
-1.991 -1.868 8.968 -3.636 -1.030 8.910 
-5.396 -0.860 8.856 1.120 -2.995 8.039 
-0.706 -3.478 8.802 -3.110 -3.395 8.748 
-4.554 -2.797 7.546 -5.188 -2.988 9.392 
-7.088 -1.894 9.292 0.126 3.712 10.066 
-5.609 2.732 9.115 -0.072 1.728 10.692 
0.126 -0.540 10.919 0.425 -2.992 10.526 
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Table D22. Target points in the FAX breast. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
9.549 -8.091 36.177 8.460 -8.842 36.266 
8.107 11.286 37.890 8.568 9.929 37.148 
7.898 9.623 36.191 8.428 -10.156 37.062 
8.158 -11.192 37.958 8.125 11.466 39.337 
9.094 10.400 38.189 9.896 -6.829 37.940 
10.667 -6.934 39.283 9.958 -8.298 38.354 
8.550 -9.958 38.855 9.428 -10.321 38.027 
9.421 -11.063 39.229 8.154 -11.351 39.280 
9.338 10.944 39.136 10.292 10.004 39.514 
9.310 8.867 39.056 8.698 9.954 39.787 
10.674 8.647 39.226 9.792 9.403 38.048 
10.004 7.740 38.304 9.990 6.134 39.118 
10.073 -5.778 39.373 9.702 -7.495 39.690 
10.886 -8.471 39.200 9.385 -9.191 39.424 
10.336 -9.871 39.175 9.536 -10.966 40.496 
8.222 -11.524 40.568 9.529 11.045 40.471 
8.244 11.311 40.662 10.595 9.576 40.648 
9.770 10.314 41.256 10.868 8.226 40.435 
8.683 9.803 41.288 9.454 8.748 40.457 
10.872 7.106 39.550 9.745 7.452 39.910 
10.418 5.810 40.165 10.001 4.716 40.493 
10.048 -4.986 40.471 10.969 -6.318 40.644 
9.817 -6.613 40.813 11.156 -7.668 40.471 
9.598 -8.464 40.424 10.832 -8.921 40.468 
10.375 -10.163 40.489 8.690 -10.026 40.334 
8.028 10.645 42.995 10.289 9.356 42.138 
10.832 8.204 41.566 9.439 8.424 41.558 
10.919 6.613 41.036 9.698 6.984 41.065 
10.138 5.537 41.627 9.817 4.342 41.947 
10.282 -5.029 41.627 10.166 -6.152 41.875 
10.937 -7.690 41.800 9.853 -7.830 41.501 
10.721 -9.209 41.674 9.256 -9.396 41.335 
9.583 -10.350 41.951 8.528 -11.084 41.609 
8.492 11.099 41.965 9.256 9.886 42.692 
10.642 7.488 42.296 9.421 6.905 42.548 
10.361 6.005 42.602 9.814 -4.914 42.790 
10.411 -6.548 42.689 9.418 -7.470 42.851 
10.048 -8.986 42.649 9.331 -9.173 43.679 
8.950 -10.094 43.013 8.035 -10.955 42.739 
8.802 9.551 43.765 10.231 8.590 43.232 
9.086 8.287 42.840 10.289 7.225 43.636 
9.724 5.990 44.071 9.803 4.867 43.225 
10.001 -5.929 43.636 9.839 -6.926 44.262 
10.534 -7.945 43.160 9.670 -8.140 44.266 
9.191 8.410 44.305 9.450 7.304 44.359 
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Table D23. Target points in the FAX colon. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.654 5.551 53.629 4.046 4.594 54.616 
1.940 -6.710 54.400 5.346 5.216 54.806 
2.783 5.238 54.652 5.033 4.493 58.183 
3.589 8.068 59.872 3.542 6.811 59.602 
4.957 5.512 58.820 2.495 -8.633 59.749 
2.786 8.846 59.861 4.054 8.035 61.182 
4.676 6.538 60.242 5.180 4.741 60.052 
5.627 2.970 60.250 0.850 10.948 62.312 
3.071 9.335 60.959 2.516 9.889 62.208 
3.398 7.020 61.218 5.029 5.202 61.290 
3.938 5.756 61.099 5.670 3.485 61.380 
5.731 1.595 61.618 3.607 8.500 62.309 
4.723 6.754 62.122 3.712 6.844 62.676 
5.828 2.304 62.784 5.962 0.529 62.996 
-0.299 -8.741 64.973 3.420 -7.625 67.903 
4.507 -5.940 70.340 2.790 -3.467 73.840 
-7.414 -1.284 75.157 -9.124 -0.529 75.376 
-7.355 1.573 76.770 -8.328 0.701 76.700 
-5.155 2.084 77.738 -6.278 1.940 77.216 
-5.204 0.696 76.779 -6.365 0.839 78.034 
-7.369 0.007 77.501 -4.856 -0.792 78.142 
-4.496 1.051 78.311 -4.126 -0.076 78.739 
-5.951 -0.644 77.692    
 
 
Table D24. Target points in the FAX esophagus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.440 -0.360 25.020 -1.620 -0.900 26.820 
-1.800 -0.360 28.620 -1.440 -0.900 30.420 
-1.620 -0.540 32.220 -1.800 -0.720 34.020 
-2.160 -1.080 35.820 -2.340 -1.260 37.620 
-2.520 -1.440 39.420 -2.520 -1.260 41.220 
-2.340 -1.260 43.020    
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Table D25. Target points in the FAX heart. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.244 1.789 37.422 0.446 1.296 36.972 
4.795 -0.648 37.447 0.079 -1.480 37.343 
1.714 1.843 38.282 4.637 1.044 38.513 
2.701 0.195 40.111 0.292 -0.220 38.574 
5.051 -1.696 39.197 4.007 -2.862 37.591 
2.675 -0.618 36.248 0.662 -1.404 40.306 
1.778 -2.747 37.206 4.885 1.638 42.016 
5.087 0.194 40.270 3.128 -1.764 41.098 
2.799 -2.333 38.648 5.076 -0.688 42.451 
3.096 0.475 42.188 5.411 -2.232 41.389 
1.739 -1.721 43.013 0.922 -3.193 41.785 
4.273 -3.892 42.116 2.297 -4.388 42.181 
2.329 -3.841 44.176 4.111 -5.090 43.970 
 
 
Table D26. Target points in the FAX kidneys. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.084 7.643 59.292 -3.327 7.073 57.407 
-2.340 -4.854 55.974 -2.267 -5.804 57.644 
-2.291 -6.292 59.200    
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Table D27. Target points in the FAX liver. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.049 7.427 45.072 5.015 5.720 44.802 
3.056 4.954 44.413 1.098 6.001 45.076 
5.033 3.859 44.582 0.968 4.147 44.276 
5.986 9.983 46.865 3.596 8.874 46.584 
1.742 9.238 46.584 3.539 6.260 46.516 
1.530 7.405 46.526 -0.144 6.743 46.818 
5.756 5.800 46.987 1.955 4.799 46.444 
6.250 4.075 46.292 4.043 4.280 46.512 
5.094 2.250 45.850 2.855 2.920 45.205 
0.432 3.218 46.242 6.329 0.630 46.170 
3.686 1.253 46.411 4.990 -0.284 46.663 
3.046 10.703 48.244 -0.688 10.681 48.578 
4.270 9.389 48.384 1.249 10.465 48.272 
-0.115 8.777 47.891 5.332 7.848 47.268 
2.099 8.413 48.550 -1.894 7.607 48.535 
5.267 6.084 48.726 3.517 7.092 48.175 
1.814 6.044 48.337 0.259 7.189 48.805 
3.568 4.644 48.474 1.544 3.913 48.485 
0.018 5.036 47.326 5.584 1.354 48.298 
4.457 2.869 47.851 2.466 2.617 47.434 
-0.673 3.618 48.478 3.740 0.691 48.658 
1.339 1.069 46.375 0.392 2.005 47.999 
2.527 11.696 50.036 0.601 11.585 49.846 
4.176 10.264 50.314 2.225 9.619 50.159 
0.090 9.202 50.087 -1.944 8.975 49.795 
5.076 8.104 49.622 3.362 7.992 50.357 
1.332 7.434 50.501 -1.033 7.056 50.684 
-3.157 6.980 50.537 5.087 6.142 50.594 
0.504 5.360 49.946 -1.408 5.778 48.935 
4.640 4.273 50.238 3.024 6.005 50.170 
2.160 4.273 50.422 -1.926 4.712 50.281 
4.928 2.592 49.975 2.988 2.340 49.687 
1.105 2.048 49.712 2.758 11.423 51.952 
0.410 11.758 51.336 -1.408 11.794 52.178 
-1.699 10.742 50.472 3.881 9.619 52.038 
1.379 9.943 51.710 -0.706 9.817 52.232 
-2.794 10.156 52.445 2.052 8.406 52.434 
-0.140 8.028 52.088 -2.538 8.525 51.703 
-0.378 5.623 51.937 -2.855 5.911 51.973 
0.727 11.560 53.287 -1.318 10.998 54.270 
4.216 9.004 53.910 2.650 10.487 53.748 
-1.616 10.004 55.804 -3.211 9.468 54.148 
2.311 8.150 54.227 0.562 9.443 53.888 
-1.537 8.528 54.011 0.310 7.092 53.917 
-1.703 6.750 53.107 0.652 10.850 55.231 
4.684 9.781 55.908 2.491 9.068 55.678 
0.194 8.564 55.559 2.362 10.937 55.764 
-0.007 10.822 56.938    
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Table D28. Target points in the FAX lungs. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.217 5.414 29.390 0.432 -5.580 28.634 
-1.076 8.201 31.928 -2.531 -6.458 30.816 
-0.518 -8.111 32.951 0.464 9.558 36.673 
-3.132 7.862 36.662 1.138 -9.209 37.498 
-3.172 -7.913 38.988 2.286 8.975 39.931 
-3.398 7.477 40.435 -0.994 10.451 41.202 
-3.503 8.327 44.309 -1.868 -8.586 45.220 
 
 
Table D29. Target points in the FAX muscle (head and neck). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-6.660 2.700 15.300 -7.740 0.180 16.740 
-7.200 1.980 18.180 -6.840 -1.980 18.900 
4.140 1.260 19.620 3.780 -1.260 20.340 
-5.580 2.700 21.060 -5.940 -2.340 21.780 
-6.300 1.620 22.500 -5.940 -3.420 23.220 
 
 
Table D30. Target points in the FAX muscle (left arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.440 -20.700 81.180 -5.040 -19.440 67.500 
-3.420 -21.420 63.900 -2.340 -19.260 60.300 
-5.580 -17.460 56.700 -5.580 -21.060 53.100 
-7.200 -18.180 49.500 -5.940 -17.460 45.900 
-5.040 -20.700 42.300 -8.280 -17.640 38.700 
-4.860 -18.180 35.100 -3.420 -17.460 31.500 
-1.440 -16.740 27.900    
 
 
Table D31. Target points in the FAX muscle (lower legs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.220 7.740 160.740 -4.500 -8.100 160.740 
-8.460 8.100 152.460 -8.460 -8.100 152.460 
-4.860 10.260 120.420 -5.220 -10.260 120.420 
-5.580 8.100 123.300 -5.580 -7.740 123.300 
-6.300 10.620 126.180 -6.300 -10.980 126.180 
-5.940 7.020 129.060 -5.940 -7.020 129.060 
-8.100 10.620 131.940 -8.100 -10.620 131.940 
-6.660 6.660 134.820 -6.660 -7.020 134.820 
-8.100 9.540 137.700 -8.100 -9.900 137.700 
-7.020 8.100 140.580 -7.020 -8.100 140.580 
-8.100 8.820 143.460 -8.460 -9.180 143.460 
-7.740 8.460 146.340 -7.740 -8.460 146.340 
-8.100 8.460 149.220 -8.100 -8.460 149.220 
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Table D32. Target points in the FAX muscle (lower torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.940 6.300 64.980 -7.020 -2.340 67.140 
-4.140 10.260 69.300 -3.060 -10.620 71.460 
-5.940 10.980 73.620 1.620 -12.060 75.780 
1.620 13.860 77.940 -1.620 2.340 80.100 
0.540 -4.860 82.260 -5.940 -11.340 84.420 
 
 
Table D33. Target points in the FAX muscle (mid torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-1.260 -13.680 44.820 6.480 10.620 46.980 
-4.860 11.340 49.140 -6.660 -5.580 51.300 
-7.920 7.380 53.460 8.640 -0.180 55.620 
-6.300 -4.860 57.780 -6.300 5.940 59.940 
-6.660 -1.620 62.100    
 
 
Table D34. Target points in the FAX muscle (right arm). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-2.700 21.060 80.100 -3.240 16.920 27.180 
-3.420 18.180 30.780 -0.180 18.900 34.380 
-5.940 18.180 37.980 -5.580 20.700 41.580 
-1.260 18.540 45.180 -4.680 17.820 48.780 
-5.940 18.180 52.380 -3.060 20.700 55.980 
-5.940 17.460 59.580 -4.140 21.420 63.180 
-5.040 19.080 66.780    
 
 
Table D35. Target points in the FAX muscle (upper legs). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.580 10.980 85.500 -5.580 -10.980 85.500 
2.340 13.140 88.380 2.340 -12.780 88.380 
-3.420 11.340 91.260 -2.700 -11.700 91.260 
-3.420 8.100 94.140 -3.420 -7.740 94.140 
-3.420 11.700 97.020 -3.420 -11.340 97.020 
0.900 12.420 99.900 0.900 -12.420 99.900 
-3.420 10.620 102.780 -3.060 -10.980 102.780 
-5.220 8.460 105.660 -5.220 -8.100 105.660 
0.900 5.940 108.540 1.260 -5.940 108.540 
3.420 7.020 111.420 3.600 -8.100 111.420 
-3.060 6.660 114.300 -2.700 -6.300 114.300 
-4.500 8.820 117.180 -4.500 -9.180 117.180 
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Table D36. Target points in the FAX muscle (upper torso). 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.340 -0.180 24.300 -1.620 11.700 26.460 
-1.260 -13.500 28.620 -8.280 5.220 30.780 
-4.500 -16.740 32.940 -6.660 13.860 35.100 
-0.900 -13.860 37.260 7.740 4.140 39.420 
-8.280 -6.300 41.580 -1.980 -13.500 43.740 
 
 
Table D37. Target points in the FAX ovaries. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.536 4.576 71.118 -0.515 -3.852 71.165 
0.014 4.910 71.453 0.328 5.303 71.935 
0.817 -4.187 72.040    
 
 
Table D38. Target points in the FAX pancreas. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.851 0.187 52.506 3.272 -1.278 51.991 
1.919 -1.973 52.466 2.444 1.487 53.712 
2.837 -0.778 53.503    
 
 
Table D39. Target points in the FAX salivary glands. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.260 6.300 12.420 0.900 -6.300 12.420 
1.260 6.300 16.380 1.260 -6.300 16.380 
2.340 3.060 20.340 0.540 3.780 20.340 
0.540 -3.780 20.340 1.980 -3.060 20.340 
4.500 0.900 19.260 2.700 0.900 19.260 
2.340 -1.260 19.260 4.140 -0.900 19.260 
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Table D40. Target points in the FAX skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
3.950 -0.350 0.370 -7.910 2.510 2.170 
-0.730 5.030 2.530 6.110 -3.950 5.770 
-3.590 -4.310 1.810 -10.790 -2.150 7.210 
6.830 3.950 7.930 -3.230 7.190 8.650 
7.550 -3.230 13.500 -1.090 -7.190 8.290 
4.670 5.750 15.110 -2.150 6.470 17.630 
-9.350 3.950 12.590 8.630 0.710 19.070 
1.070 -7.190 16.190 -7.550 -5.390 13.140 
-6.110 14.390 24.490 2.150 12.950 26.290 
-9.710 9.350 27.370 -8.270 2.870 21.970 
-6.470 -10.260 24.130 1.070 -17.630 28.450 
-1.810 20.150 28.810 -8.270 19.070 32.410 
-2.700 5.580 23.410 3.590 6.110 25.570 
-9.710 -5.410 26.650 4.310 -5.030 25.930 
-8.630 -2.870 18.350 0.350 -12.060 24.490 
-9.350 -14.030 28.810 -5.390 -19.430 28.090 
3.230 17.630 33.850 7.910 9.710 34.210 
-10.070 12.230 34.020 6.830 1.620 29.530 
0.540 -4.310 21.060 -10.070 3.250 32.050 
8.630 -3.420 34.570 6.470 -8.630 31.330 
7.380 -13.670 38.510 3.230 -17.630 33.850 
-9.350 -18.710 36.540 10.790 12.230 39.610 
-1.450 21.950 37.980 -9.350 19.430 41.940 
3.590 15.110 41.940 7.190 11.870 47.870 
-10.070 10.070 41.030 -10.070 2.890 39.060 
10.070 1.620 38.890 -2.340 -15.300 43.190 
-10.070 -4.860 33.300 11.510 -11.510 39.610 
-10.070 -11.700 37.260 -3.420 -21.950 35.460 
-2.170 22.670 46.260 -8.630 19.790 50.750 
12.230 6.490 43.550 -3.420 15.300 43.190 
-9.710 2.700 47.700 -10.070 -4.140 41.580 
12.590 -7.380 42.470 9.350 -9.350 48.590 
-9.710 -9.710 45.900 3.950 -14.750 47.340 
0.710 -20.150 42.470 -8.990 -17.650 45.350 
10.430 6.660 53.100 -9.710 9.710 48.780 
10.430 -0.180 48.780 -9.710 -5.220 51.660 
-6.110 -13.310 51.470 6.110 -11.510 55.980 
-8.270 -19.790 55.070 -2.530 -22.310 60.660 
-3.420 14.750 48.420 -4.310 13.670 57.060 
7.550 9.710 57.420 -9.350 8.630 55.980 
-9.350 1.620 54.900 10.430 -6.470 55.620 
-9.350 -8.630 57.780 0.350 -14.390 56.150 
-8.270 19.980 59.940 2.870 13.670 59.940 
-9.710 7.910 63.370 -9.350 -0.900 60.660 
10.790 0.180 58.860 2.510 -13.670 65.340 
-5.030 -12.950 61.740 -10.070 -8.630 66.250 
-1.090 -19.810 66.780 -1.090 20.870 63.900 
9.350 6.830 63.710 2.510 13.670 65.340 
9.710 -0.710 68.030 -10.430 1.260 68.220 
8.990 -7.190 63.900 -5.390 -22.670 71.820 
1.790 15.110 72.010 -7.190 21.230 67.670 
7.550 8.630 69.660 -6.470 12.230 64.810 
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Table D40 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.750 15.470 72.010 7.550 3.420 75.230 
-11.510 8.100 72.900 7.550 -8.630 71.630 
-7.550 -13.310 70.570 1.790 -16.190 74.170 
3.230 16.550 78.130 -1.620 23.030 73.620 
-12.230 12.230 79.210 7.190 11.510 77.410 
-13.310 3.250 77.410 7.190 -1.620 79.190 
-4.140 0.370 85.310 -12.590 -5.940 74.170 
5.390 -14.390 77.770 -0.370 -22.670 80.100 
-7.190 -16.190 76.330 7.910 12.950 85.500 
1.790 21.230 82.430 -6.830 16.910 78.130 
7.910 5.770 84.250 -13.310 5.940 84.060 
3.060 0.730 84.780 7.910 -9.010 81.010 
-13.310 -4.140 82.620 -10.070 -12.950 87.470 
8.270 -12.230 88.190 -12.230 -12.230 79.740 
2.870 17.270 89.270 -4.310 21.590 83.340 
-9.350 14.030 86.390 7.550 11.870 93.590 
-11.150 10.790 90.900 2.340 0.730 91.980 
-10.790 3.250 87.830 7.190 -4.690 87.660 
-11.870 -6.850 89.270 5.030 -16.190 86.220 
-0.370 -18.350 89.630 -5.750 -17.630 84.590 
-4.670 17.270 89.990 7.550 5.410 92.510 
-11.150 10.790 97.550 -1.260 0.730 98.100 
-6.470 1.090 92.700 -4.140 -0.730 86.940 
-9.710 -3.970 98.270 6.830 -5.050 95.580 
4.310 -2.890 101.870 -11.150 -10.790 97.020 
7.190 -11.870 95.390 2.870 -15.830 96.470 
-5.390 -16.550 94.140 2.510 15.830 97.910 
-5.390 16.550 95.390 6.830 10.790 102.060 
-8.990 12.590 103.670 5.390 3.970 100.980 
-10.430 4.690 97.550 -7.910 2.890 103.310 
-8.630 -5.050 108.350 2.510 -14.750 105.830 
-5.030 -15.830 101.150 -4.140 15.470 103.140 
2.870 14.390 106.740 -9.710 8.100 107.270 
4.670 3.610 108.540 -2.700 1.090 106.740 
-0.540 -1.810 109.980 6.830 -6.300 109.980 
-7.190 -4.690 116.820 6.830 -10.790 104.390 
-3.950 -14.390 110.150 -9.350 -11.150 105.830 
-3.230 14.390 111.230 6.830 9.710 110.870 
0.350 14.030 117.350 1.070 2.170 115.910 
-6.470 3.970 114.660 -3.250 -2.530 124.190 
0.710 -2.170 116.630 1.070 -14.030 115.190 
-7.550 -10.430 116.460 -6.110 14.030 122.410 
5.750 7.210 116.990 -8.990 6.490 123.130 
-7.550 10.430 115.740 -0.730 -6.490 131.390 
1.430 -11.150 124.550 5.390 -8.100 118.070 
-9.710 -6.490 125.650 -5.750 -14.390 122.770 
-2.530 14.390 127.430 2.870 9.710 122.750 
-10.430 -11.510 132.490 -3.610 -14.390 131.750 
-0.010 8.290 131.750 -10.070 11.510 130.690 
-7.910 -3.970 135.350 -2.170 -8.290 140.390 
-7.910 -13.310 140.390 -6.660 14.390 135.710 
-2.170 9.710 140.390 -10.790 7.210 140.220 
-6.300 3.970 136.430 -7.550 12.230 146.510 
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Table D40 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-10.430 -7.210 145.260 -5.050 -11.510 149.940 
-6.130 5.050 146.870 -7.910 -5.410 154.620 
-2.170 -11.510 159.130 -2.890 11.510 158.410 
-10.070 7.570 154.260 -10.790 -8.630 162.540 
6.470 10.070 162.540 -0.900 4.690 162.710 
-10.430 6.850 163.070 6.470 -10.070 162.540 
-1.260 -4.690 162.710 -6.830 -22.670 45.180 
-1.810 -21.950 51.300 3.590 14.390 52.190 
-2.530 22.310 54.900 -2.170 2.530 123.110 
-6.470 2.890 129.230    
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Table D41. Target points in the FAX small intestine. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
4.860 -2.156 59.375 3.035 -0.986 59.591 
4.046 -3.942 59.288 2.149 -4.219 58.824 
2.783 6.753 66.027 3.798 0.990 66.733 
3.158 7.791 68.528 4.469 4.115 67.951 
1.635 4.527 65.952 3.788 1.627 69.659 
1.897 2.563 68.411 2.986 6.171 71.469 
 
 
Table D42. Target points in the FAX spleen. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.972 -8.737 50.573 0.522 -9.940 50.807 
2.430 -9.842 54.086 1.076 -9.630 54.922 
-0.562 -9.079 54.968    
 
 
Table D43. Target points in the FAX stomach. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.596 -3.776 48.334 4.428 -4.946 48.229 
2.164 -6.149 47.956 5.242 -6.757 47.912 
3.704 -6.718 50.195 1.638 -5.807 49.741 
3.622 -7.517 48.233 4.936 -4.327 51.800 
3.748 -4.536 50.180 4.432 -6.350 52.049 
5.364 -4.712 53.953 5.879 -0.504 54.763 
5.573 -2.653 53.705    
 
 
Table D44. Target points in the FAX thymus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.544 0.536 27.108 1.357 -0.025 27.029 
2.066 -0.914 27.202 2.495 0.529 27.792 
1.901 0.536 27.598 1.836 -0.212 27.760 
1.555 -0.695 27.068 3.020 -0.202 28.292 
2.574 -0.058 28.202 3.672 -0.068 29.124 
3.215 -0.371 28.883 4.396 -0.043 29.855 
 
 
Table D45. Target points in the FAX thyroid. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
1.858 1.433 21.362 1.228 1.440 21.251 
0.695 1.469 21.226 2.455 1.300 21.640 
2.506 -1.292 21.604 1.976 -1.505 21.578 
0.745 -1.519 21.287 1.415 -1.516 21.402 
1.541 1.541 21.856 0.828 1.526 21.848 
1.742 -1.451 22.226 0.799 -1.508 21.794 
1.177 -1.325 23.188    
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Table D46. Target points in the FAX uterus. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-0.083 -0.587 72.342 -2.081 0.673 74.632 
-2.329 -0.666 74.866 -2.531 0.713 75.938 
-2.610 -0.630 76.187    
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13. Appendix E – Skin Target Points for CAM 
 
 
Table E1. Target points in the CAM skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
6.376 2.274 2.551 11.706 4.609 46.529 
-2.294 5.104 2.171 7.297 -20.034 40.378 
-1.593 9.217 11.056 -6.280 -17.754 38.256 
8.664 -4.747 8.777 -0.856 -22.857 43.461 
1.057 -4.493 1.637 8.832 10.975 54.184 
-7.379 -3.738 4.879 -1.372 23.011 59.106 
6.354 6.030 9.692 -10.943 6.807 52.872 
12.175 0.560 14.797 12.503 -4.753 52.217 
-0.058 -8.278 10.538 -11.338 3.789 46.446 
-6.630 -5.188 14.800 7.992 -10.716 48.309 
0.932 11.453 29.717 3.182 -15.196 45.843 
-8.687 3.626 8.172 -9.179 3.093 60.257 
6.860 -0.603 26.153 6.718 -19.777 48.117 
-8.206 1.870 17.016 -8.436 -13.859 44.003 
9.132 -3.179 18.617 0.889 -23.213 53.541 
-3.058 -3.056 24.703 0.538 14.941 52.195 
5.448 16.763 35.331 7.374 10.254 61.392 
-2.468 6.375 16.756 12.660 4.157 55.452 
-5.930 12.011 33.673 -6.963 13.978 56.007 
5.604 5.249 19.998 11.357 -4.866 60.245 
-1.741 4.366 24.480 8.714 -8.919 66.680 
2.029 -6.233 18.823 -10.895 -3.550 52.243 
-6.650 -10.493 34.381 1.240 -13.492 56.590 
-1.228 -21.057 35.103 -11.238 -8.733 48.252 
-2.244 18.764 33.395 5.933 -18.538 55.677 
5.593 6.431 31.213 -3.767 -20.696 60.108 
8.203 -3.173 35.231 1.662 13.892 62.060 
-5.579 5.112 31.593 -7.989 10.803 61.894 
4.781 -8.780 31.032 7.483 -11.598 56.600 
-10.614 -5.517 41.232 -8.819 -6.649 70.099 
4.092 -16.056 33.051 2.953 -21.914 63.390 
-2.324 -11.321 30.071 -7.724 -13.136 54.890 
6.661 20.720 44.581 -3.059 -21.413 68.741 
-1.460 22.501 38.405 -5.000 12.670 68.259 
-3.055 16.381 44.445 11.730 2.347 75.409 
8.158 11.600 39.717 -8.814 4.533 69.340 
-9.885 5.303 40.167 11.343 2.434 64.941 
11.446 -3.903 44.398 -7.731 -12.419 77.654 
-7.011 -2.309 34.381 4.642 -20.101 71.569 
8.266 -11.129 39.669 -5.186 -12.410 66.063 
-4.138 -19.961 50.050 3.958 13.518 79.494 
-2.292 22.551 48.850 3.830 21.062 69.247 
-8.608 13.854 47.920 -3.419 20.302 67.304 
7.046 11.707 47.252 -10.253 8.765 77.604 
5.955 19.706 55.191 9.193 8.516 77.507 
-8.671 13.822 40.481 3.181 13.142 71.113 
9.196 3.546 38.083 11.378 -3.946 70.869 
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Table E1 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-8.789 -9.854 60.130 -8.778 10.686 103.751 
11.375 -1.923 81.735 4.696 -1.790 100.059 
-2.314 -13.855 73.646 -7.401 -2.498 101.337 
3.015 -13.125 64.772 9.549 -10.103 102.029 
-3.052 -21.411 76.864 -3.388 -14.576 109.594 
8.861 9.182 69.022 -1.902 -20.931 105.701 
-5.516 13.281 75.535 3.196 20.754 108.207 
-3.877 15.783 83.369 3.571 16.498 106.424 
-11.693 1.132 76.629 7.734 13.494 110.722 
10.024 -7.152 78.341 -4.117 2.341 102.428 
-8.803 -3.112 62.896 -6.655 3.800 109.179 
3.328 -14.171 82.322 8.813 -4.867 107.932 
-11.317 -6.967 79.022 -5.298 -2.804 111.462 
3.811 -21.014 80.295 6.111 -18.929 101.108 
0.955 22.534 89.073 2.290 -22.739 95.337 
-11.436 11.621 85.193 2.703 -20.887 108.753 
3.790 21.070 80.128 -3.972 14.641 109.406 
10.621 3.608 86.349 8.501 4.929 116.248 
-2.259 22.198 76.207 -7.991 9.807 114.236 
-14.200 4.537 85.915 1.839 -0.442 107.638 
5.807 -11.558 74.885 8.952 5.203 107.236 
4.514 -2.421 92.353 -8.814 -9.173 107.037 
-1.230 -22.483 86.841 7.879 -13.376 110.062 
-5.557 -14.935 84.455 4.471 -15.178 116.316 
-12.771 -10.966 86.979 -7.740 -9.430 116.786 
-11.108 12.995 94.885 0.772 14.968 117.894 
8.106 8.814 84.913 7.373 12.428 119.833 
7.481 10.439 94.501 0.548 0.909 116.585 
3.637 1.803 92.196 -6.297 4.538 120.025 
-5.575 1.267 92.636 8.503 -4.849 115.687 
7.939 -10.339 86.772 6.889 -12.125 124.246 
-14.116 -3.574 86.790 -4.131 -14.215 111.554 
-12.295 -3.544 94.170 8.157 6.280 125.566 
3.270 -16.013 91.125 -1.595 1.988 123.511 
-6.991 -16.376 92.648 7.733 -4.137 122.720 
7.633 -11.134 95.751 1.983 -1.284 127.761 
6.027 19.452 98.452 -5.726 -4.291 122.771 
-3.291 22.375 97.541 -2.992 -13.133 122.162 
4.200 15.056 89.362 4.539 13.152 128.003 
-5.950 16.197 90.623 -4.163 12.278 123.015 
-13.789 6.912 94.069 6.148 3.725 133.464 
-8.813 3.440 100.440 -4.460 4.456 129.677 
9.541 -4.323 88.855 7.373 -5.907 131.290 
-1.524 -1.241 96.124 5.574 -5.583 139.856 
9.365 -0.243 97.746 -5.169 -7.400 131.145 
-3.777 -15.284 101.939 -0.511 -13.131 129.407 
-12.771 -9.822 96.166 -2.164 11.050 132.413 
-3.060 -22.851 98.919 4.224 3.157 143.467 
-8.458 -14.549 101.077 -1.034 -1.752 135.597 
-1.971 21.094 105.684 -3.770 -9.512 140.711 
9.532 10.300 101.700 3.811 -11.685 134.835 
-3.320 16.428 99.871 -0.590 9.534 156.414 
9.901 0.918 95.195 4.494 10.614 137.348 
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Table E1 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-4.733 -3.207 142.394 3.861 -7.994 160.947 
2.346 10.253 146.857 -2.554 -3.305 162.640 
-4.838 7.757 151.275 20.119 9.033 174.042 
-3.754 2.351 148.803 -3.151 8.104 171.567 
1.574 -10.593 146.273 15.375 -1.074 171.830 
-5.207 7.587 140.382 -3.263 -8.005 171.568 
3.915 4.496 154.362 5.794 8.534 165.368 
-0.563 -9.891 154.954 9.178 9.257 175.503 
4.517 -4.477 150.991 7.937 -8.413 168.350 
-5.210 -5.607 151.454 11.784 -9.297 175.504 
7.693 2.528 167.488 2.724 -2.188 174.835 
-2.679 3.424 162.948 21.895 -7.033 174.761 
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14. Appendix F – Skin Target Points for CAF 
 
 
Table F1. Target points in the CAF skin. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
2.772 4.707 2.551 5.303 13.671 31.752 
-1.928 4.130 1.482 3.803 9.094 28.356 
6.253 -0.791 2.237 -5.567 9.829 30.788 
1.611 -0.859 0.206 -4.437 6.069 28.127 
-6.299 -0.509 2.001 7.091 0.157 30.947 
-1.920 -3.770 1.281 5.273 6.278 29.042 
7.811 4.649 7.968 -5.580 2.845 29.709 
3.422 6.309 6.644 7.791 -3.858 33.346 
-5.550 4.699 4.418 -4.789 -4.082 28.121 
8.876 0.455 6.075 4.832 -6.748 28.558 
-8.818 1.426 6.859 5.676 -11.192 31.245 
4.381 -4.850 4.178 3.591 -15.197 30.482 
-1.978 -6.296 4.940 1.146 -17.430 30.466 
-7.004 -4.126 6.351 -3.410 -14.517 30.065 
8.466 3.613 13.747 6.653 18.553 36.730 
-0.540 7.736 11.837 3.285 21.090 36.677 
-2.377 6.753 7.844 -3.885 19.432 35.187 
-7.258 4.271 11.062 6.669 13.267 36.557 
-8.807 0.052 13.312 -4.458 14.170 30.830 
8.045 -3.627 9.527 -5.930 16.044 35.324 
3.206 -6.646 9.490 7.074 9.833 34.533 
-1.923 -8.267 11.021 -3.414 16.048 39.214 
-7.353 -4.127 11.332 -8.449 8.725 35.116 
4.148 5.942 13.930 7.838 4.334 33.659 
11.430 -0.036 13.538 9.633 -1.841 38.126 
-3.494 5.364 15.690 -7.005 1.389 33.301 
7.570 -4.385 14.706 -7.016 -3.094 32.961 
2.696 -5.936 15.919 7.580 -8.823 35.378 
-2.617 -5.878 15.190 -6.300 -8.784 31.891 
3.138 5.572 17.519 6.463 -14.117 35.804 
8.854 2.010 19.385 -7.726 -11.326 34.756 
-6.123 2.270 17.380 -0.130 -20.324 34.054 
8.357 -2.551 19.509 -4.099 -19.212 35.207 
-1.604 -4.087 22.860 3.186 20.707 41.643 
-4.732 -3.738 17.639 -3.391 19.233 41.542 
2.513 4.865 21.952 6.474 17.717 43.115 
5.604 1.986 23.626 -8.032 12.687 37.189 
2.559 -4.856 22.054 6.125 12.442 41.984 
0.516 10.065 27.183 11.145 8.140 39.606 
-1.380 4.394 22.934 -9.159 4.185 36.908 
-4.080 0.999 22.224 11.651 5.705 39.660 
5.640 -1.353 26.086 9.730 2.277 38.258 
1.112 -9.887 27.222 -10.238 3.792 40.511 
-2.594 -10.169 28.035 -9.450 -1.054 41.351 
-0.230 20.080 33.032 13.895 -5.650 42.395 
2.611 17.337 31.128 11.160 -6.807 39.188 
-1.122 14.846 29.012 -9.177 -3.346 37.269 
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Table F1 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
6.998 -10.167 37.994 -6.077 13.001 48.554 
-9.892 -8.087 39.063 9.216 8.100 53.477 
-5.564 -16.505 35.319 -0.293 12.833 53.611 
-8.099 -12.304 38.089 -9.451 8.340 49.336 
6.725 -18.403 37.257 11.346 5.266 51.391 
3.350 -20.779 36.709 -8.811 7.252 53.130 
1.580 -21.058 41.764 11.373 -3.275 52.619 
4.522 19.972 46.980 -8.436 -1.774 54.182 
-0.701 21.194 41.560 14.283 -7.170 47.010 
0.490 13.336 43.948 10.346 -6.605 52.793 
-7.412 12.986 44.342 -9.112 -6.360 51.274 
-7.736 12.838 40.700 8.860 -8.704 52.975 
12.414 9.894 45.242 2.643 -12.056 52.936 
9.649 10.987 45.969 -8.445 -8.781 53.597 
-10.198 9.163 43.952 0.008 -13.822 51.143 
13.855 4.073 43.983 -6.252 -12.055 55.433 
10.620 0.568 42.985 -5.570 -13.135 51.981 
-10.618 6.143 42.682 5.222 -17.518 53.132 
12.423 -2.695 44.850 -3.735 -16.821 52.498 
7.341 -11.683 45.736 -0.123 -21.420 50.500 
9.888 -0.019 40.021 1.290 21.161 60.496 
-10.611 -6.985 44.098 3.884 16.599 57.603 
9.320 -11.304 42.035 -3.379 18.809 59.349 
5.983 -18.040 45.478 6.697 10.622 52.781 
4.093 -13.959 40.737 -6.826 11.169 56.182 
-5.196 -13.498 41.168 10.253 4.505 58.626 
6.668 -17.278 41.609 -8.455 3.432 55.602 
-3.059 -19.610 41.653 10.647 1.930 55.634 
0.082 21.425 47.990 -8.083 4.170 59.417 
5.585 17.513 50.471 9.274 -6.822 59.353 
-3.704 18.778 47.599 3.352 -12.002 57.845 
1.529 13.933 50.555 0.519 -12.229 59.843 
0.089 13.867 47.329 -7.007 -8.808 62.860 
6.758 11.003 48.533 -7.736 -7.310 59.513 
14.588 6.662 46.671 -3.763 -12.414 58.669 
10.956 0.247 46.314 3.428 -15.614 56.535 
-9.850 3.138 48.662 -3.419 -18.865 57.630 
11.373 -0.576 49.219 1.785 -20.979 55.101 
-9.412 -0.901 47.033 -1.393 21.594 67.040 
-10.231 -3.933 47.601 4.149 18.915 64.048 
11.997 -10.047 45.725 -3.051 18.304 65.062 
7.004 -10.701 51.589 -2.333 12.800 61.300 
1.952 -12.413 44.772 3.422 12.053 57.060 
-0.280 -13.720 46.498 -6.277 10.303 59.470 
-6.291 -13.114 46.104 9.979 -5.851 64.903 
-8.814 -10.948 46.038 10.355 -2.909 60.209 
5.586 -17.091 50.093 -8.055 -3.378 59.108 
-3.777 -18.521 46.664 6.456 -10.168 58.999 
2.629 -20.999 46.758 -4.432 -12.416 65.775 
0.318 21.410 53.100 1.588 -21.030 60.316 
4.493 18.893 54.610 3.070 21.133 68.676 
-3.310 19.447 54.351 3.889 12.112 65.232 
-4.968 13.152 53.587 -1.292 13.903 69.361 
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Table F1 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
7.785 9.187 63.862 -4.711 15.766 79.117 
1.146 12.440 61.515 9.174 7.014 75.457 
-6.457 10.239 65.029 -11.916 9.535 77.286 
10.308 1.917 62.562 10.280 1.702 79.404 
8.108 8.472 59.791 -12.779 5.431 77.225 
-8.819 6.799 67.149 -13.075 -3.655 80.450 
10.643 3.064 66.524 9.985 -4.995 75.561 
-9.175 -4.188 67.872 9.974 -3.629 79.395 
-8.089 3.499 63.572 -11.658 -2.460 76.335 
-8.049 -2.463 64.664 -3.755 -16.000 78.679 
4.625 -11.697 64.697 -10.246 -11.332 76.869 
0.157 -12.775 65.716 1.537 -22.405 76.199 
3.795 -17.043 61.665 -0.061 23.256 87.951 
4.173 -17.039 65.887 -2.267 22.067 80.950 
-2.953 -17.132 63.908 3.495 16.037 85.025 
-1.253 -21.398 64.988 -4.156 16.972 83.698 
-2.993 20.605 73.135 -8.750 13.204 78.760 
4.146 17.857 72.293 7.013 11.335 79.740 
3.096 12.496 68.853 0.281 16.980 86.327 
-4.416 12.552 66.631 -12.741 10.919 82.401 
8.852 7.448 67.294 8.474 6.009 82.315 
3.795 13.227 73.134 3.742 1.989 85.347 
-10.593 3.020 70.399 -11.321 2.731 85.453 
11.016 1.479 70.083 -12.741 2.712 80.065 
-6.999 0.182 66.109 8.093 1.003 84.773 
10.376 -4.303 68.050 -3.079 1.264 86.061 
-9.171 -7.339 69.664 -5.427 0.909 84.957 
7.304 -9.412 67.356 8.567 -4.292 83.029 
-6.976 -10.950 68.582 3.802 -1.766 84.816 
0.159 -13.858 70.479 7.830 -8.477 82.042 
4.506 -18.750 69.695 -13.125 -8.254 79.619 
0.535 -22.132 70.048 7.467 -10.398 79.960 
2.334 22.143 81.710 4.340 -14.839 79.792 
-0.432 22.569 75.003 -8.816 -13.475 79.806 
3.413 19.278 77.228 -13.135 -10.577 84.071 
-0.292 16.004 77.400 4.375 -15.158 84.389 
-4.246 14.710 72.924 -4.025 -16.726 82.630 
-7.569 12.451 73.133 2.576 -21.794 81.556 
8.176 8.876 72.034 -2.339 -21.779 79.207 
-9.172 10.198 72.171 -3.737 20.540 89.697 
10.612 2.371 73.620 5.213 18.900 94.953 
-10.258 0.394 81.880 -7.295 16.043 86.513 
10.428 -4.173 72.072 -10.356 14.055 85.269 
-10.979 -0.033 71.598 7.418 9.289 82.299 
7.003 -10.193 72.697 -11.575 8.918 89.702 
3.593 -12.930 73.133 4.672 2.405 88.378 
-11.334 -6.999 74.349 -2.952 1.983 91.230 
1.594 -15.276 77.252 -6.639 2.350 93.371 
-3.772 -14.923 74.026 -13.450 7.352 85.099 
-6.961 -12.989 73.133 -1.177 -1.282 88.750 
3.774 -18.527 75.445 -2.723 -1.285 88.265 
-3.059 -20.304 71.889 -8.903 -2.264 88.162 
3.783 15.303 79.790 -11.987 -3.376 85.274 
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Table F1 continued. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
7.435 -6.739 89.368 -8.071 8.889 99.995 
-12.671 -7.322 87.289 7.573 3.394 99.729 
6.773 -11.200 86.836 0.706 0.907 99.281 
3.236 -16.328 91.561 -4.474 2.365 102.370 
1.938 -16.737 86.318 8.121 -4.500 98.854 
-10.491 -13.847 85.498 2.136 -0.426 103.616 
5.361 -18.257 95.171 -2.148 -1.266 103.957 
-5.487 -15.991 90.852 -5.473 -2.972 100.206 
-5.920 -16.727 85.983 7.037 -13.469 98.222 
0.873 -22.776 86.310 4.131 -15.296 99.011 
-3.754 -21.420 86.857 -3.746 -13.455 101.970 
-2.416 21.671 93.820 1.850 -19.260 100.634 
2.698 19.620 99.899 4.297 14.943 100.998 
5.607 13.883 87.216 -3.625 13.197 103.599 
4.232 22.225 90.763 8.496 9.171 101.780 
1.375 16.747 93.431 1.701 0.902 107.729 
-4.891 16.039 90.934 -7.688 8.210 104.182 
7.445 9.425 88.236 7.427 3.526 106.053 
-9.326 10.417 93.419 6.718 -2.322 103.756 
7.127 5.583 89.736 -3.971 -2.254 107.184 
0.609 0.903 92.271 8.481 -9.022 102.296 
-9.759 3.847 90.151 -3.416 -12.750 106.654 
5.606 -3.405 88.855 -7.735 -8.196 103.844 
-2.267 -1.271 95.717 2.480 -14.567 104.143 
-5.867 -1.954 93.132 6.293 12.413 108.244 
6.832 -12.874 91.020 2.551 14.212 106.413 
-1.201 -15.268 97.338 -2.668 12.794 108.627 
-10.953 -9.280 90.736 8.109 8.634 107.946 
5.716 -18.232 92.270 -4.112 2.346 107.228 
-1.000 -16.022 93.420 -7.377 7.280 107.191 
1.873 -23.216 90.544 1.795 -0.753 111.633 
-2.992 -21.180 92.435 -7.356 -6.999 107.268 
-1.144 20.029 98.609 6.711 -12.325 105.902 
8.094 12.414 94.547 2.881 -13.851 109.006 
5.595 14.603 92.049 4.493 12.773 113.660 
-7.929 13.978 93.295 7.732 7.466 113.624 
-8.090 6.315 96.648 -1.608 2.703 120.032 
7.552 3.272 93.936 -4.707 10.708 112.741 
-4.483 2.347 98.753 -6.637 7.182 112.097 
6.368 -1.854 93.792 6.672 3.103 113.503 
2.079 -0.411 97.048 -1.253 1.278 115.727 
-8.090 -6.600 98.890 7.786 -4.483 107.270 
8.842 -6.872 94.353 6.293 -2.333 111.210 
-8.946 -4.932 93.462 -3.384 -2.267 111.644 
8.520 -11.206 94.863 7.809 -9.222 109.939 
-6.999 -11.644 97.930 -2.314 -12.054 113.146 
-8.064 -13.778 93.418 -5.939 -9.418 112.137 
4.018 -20.751 96.080 0.085 12.799 115.407 
-1.544 -19.844 97.774 7.041 6.779 119.705 
7.013 13.146 100.039 -3.751 3.783 123.721 
0.066 15.307 98.753 -4.853 3.786 114.531 
8.879 7.553 95.715 7.020 -4.129 115.754 
-4.544 13.686 98.416 -1.724 -2.130 123.211 
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Table F1 concluded. 
 
x  (cm) y  (cm) z  (cm) x  (cm) y  (cm) z  (cm) 
-5.839 -5.489 115.008 -2.570 -1.488 130.597 
7.416 -9.068 113.978 3.534 -9.152 128.799 
-4.845 -7.602 119.865 -3.412 -8.453 126.584 
4.130 -12.683 115.282 0.918 9.915 133.188 
5.574 10.974 118.622 -3.476 8.448 139.167 
-3.255 10.783 118.643 3.398 2.375 134.731 
5.199 2.147 118.698 2.751 -2.196 138.676 
-4.858 6.861 120.276 -4.821 -3.785 134.082 
4.872 -1.966 119.137 4.241 -7.513 133.172 
-2.353 -2.175 119.167 -2.332 -9.537 130.611 
6.680 -7.835 121.346 1.623 9.189 140.009 
-1.962 -11.672 118.791 4.493 5.580 138.065 
4.869 9.216 126.240 4.155 -3.308 133.885 
1.469 11.005 122.987 -3.022 -1.910 137.513 
-2.282 9.272 127.049 1.836 -9.445 137.192 
5.224 3.467 124.949 -3.042 -9.174 135.512 
1.972 1.991 125.565 -2.289 7.402 145.774 
-4.859 4.508 129.134 2.890 3.294 142.775 
5.934 -5.543 125.829 -3.048 2.743 141.975 
3.452 -2.347 125.132 4.407 -2.129 155.635 
-4.418 -3.805 126.523 -2.643 -2.991 151.956 
4.595 -11.206 120.729 5.871 2.460 152.821 
1.108 -10.556 124.344 -2.653 7.444 153.606 
4.863 6.430 130.876 5.436 -7.699 152.286 
-4.325 8.070 133.949 6.006 8.227 154.779 
-3.770 2.353 135.893 -2.686 2.703 155.710 
2.277 -1.580 130.550 11.306 -2.814 156.830 
3.774 -5.160 142.374 -3.286 -2.819 157.687 
-0.408 -1.957 143.116 17.472 8.822 160.686 
1.651 -8.790 142.067 11.580 8.857 161.462 
-4.109 -7.353 140.517 20.783 3.671 160.581 
3.455 7.672 147.932 14.354 4.102 157.879 
3.933 -2.638 149.438 9.097 3.416 160.529 
-2.786 -4.147 145.813 4.358 8.163 161.462 
-0.268 -7.627 146.959 1.815 2.550 161.175 
-2.129 3.060 149.601 -2.516 6.264 160.386 
14.625 -9.535 160.549 20.707 -3.385 160.387 
9.674 -8.416 158.945 14.815 -1.297 161.462 
4.538 -8.042 161.463 5.341 -2.293 160.381 
0.969 -8.099 156.846 -1.914 -5.500 161.464 
19.375 -7.615 160.446    
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